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Introduction and outline of this thesis
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Introduction and outline of this thesis 
Brain injury, whatever its cause, is associated with considerable short-term and long-term morbidity 
and mortality. Primary brain injury occurs at the acute disease moment and secondary brain injury 
is an indirect result of the primary disease process. There are multiple causes of secondary brain 
injury, such as cerebral ischemia due to reduced cerebral blood flow, cerebral edema due to cerebral 
hyperperfusion, inflammatory processes, free radicals, and excitotoxicity.
In intensive care medicine, besides primary neurological and neurosurgical patients, patients after 
cardiac arrest and sepsis are vulnerable to secondary brain injury resulting in high mortality and 
morbidity [1, 2]. Crucial in the intensive care treatment of these patients is to limit secondary brain 
injury as much as possible and to create an optimal environment for cerebral recovery. This treatment 
includes an adequate cerebral blood flow (CBF), since cerebral autoregulation and vascular tone are 
frequently disturbed in patients after cardiac arrest and in sepsis patients [3-7]. 
Cerebral autoregulation
The term “cerebral autoregulation” was introduced by Lassen in 1959 [8]. He described the response 
of CBF to long-term changes in blood pressure with gradual onset (static cerebral autoregulation). 
Cerebral autoregulation keeps blood flow at a constant level when mean arterial pressure (MAP) is 
between approximately 50 and 150 mmHg (the plateau phase) (Figure 1). 
figure 1 the concept of cerebral autoregulation according to lassen
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More recently however, data support the opinion that cerebral autoregulation does not maintain 
constant blood flow through a broad MAP range of 50-150 mmHg, but probably in a smaller range [9, 
10] (Figure 2). Cerebral autoregulation is more effective in the range above baseline MAP, compared 
to the range below baseline MAP [11] (Figure 2). 
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figure 2 cerebral autoregulation does not maintain constant blood flow through a broad MAP range of 
  50-150 mmHg, but in a smaller range. cerebral autoregulation is more effective in the range 
  above baseline mean arterial pressure, compared to the range below 
The upper en lower limits of cerebral autoregulation are not ﬁxed [12]. For example, chronic 
hypertension shifts these limits to higher MAP ranges. This adaptation protects the brain against 
high blood pressures, but makes the brain also more vulnerable to hypoperfusion during periods of 
lower blood pressures.
Clinically more relevant is dynamic cerebral autoregulation instead of static autoregulation, because 
it protects the brain against rapid alterations in blood pressure. Various methods and models are 
available for the estimation of dynamic cerebral autoregulation, using both spontaneous and 
induced fluctuations in blood pressure. 
Estimation of dynamic cerebral autoregulation
There are a number of methods to quantify dynamic cerebral autoregulation. 
The most frequently used method is transfer function analysis (TFA), with the calculation of 
coherence, gain and phase. TFA is considered to be the gold standard for the estimation of dynamic 
cerebral autoregulation. TFA uses beat-to-beat blood pressure variation and CBF as input signals 
[13]. Blood pressure variation is measured invasively by an arterial catheter or non-invasively by 
photoplethysmography. CBF in the middle cerebral artery (MCA) is approximated by the blood flow 
velocity using non-invasive transcranial Doppler (TCD).
More recently near-infrared spectroscopy (NIRS) was validated as a tool for measuring 
cerebrovascular autoregulation. NIRS measures cerebral oxygen saturation using the differences of 
near-infrared light absorption between oxygenated and deoxygenated hemoglobin [14]. Correlating 
changes in oxygen saturation  with fluctuations in arterial blood pressure can detect an impairment 
in autoregulation [15, 16]. 
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Spontaneous blood pressure oscillations range from 0.02 to 0.4 Hz, independent of external stimuli 
[17]. Blood pressure fluctuations evoked by sympathetic modulation of vascular tone occur in the low 
frequency band (LF, 0.07-0.2Hz) [18]. Intrinsic vascular myogenic changes in arterial blood pressure 
affect both the LF and very low frequency band (VLF, 0.02-0.07Hz) [19]. Endothelial nitric oxide (NO) 
affects blood pressure oscillations in the high frequency band in animals (HF, 0.2-0.5Hz) [20].
TFA determines coherence, gain and phase in the VLF, LF and HF band. The white paper on TFA 
methodology provides recommendations on the optimal cut-off values of coherence and parameter 
settings [13]. High quality signals are essential for reliable estimation of cerebral autoregulation [21]. 
Previous literature shows an improvement of reproducibility of the autoregulation estimation by 
increasing blood pressure variability using a sit-to-stand manoeuvre [22, 23]. Other methods which 
can be used to increase blood pressure variability are the thigh cuff method [24], the lower body 
negative pressure technique [25] and the Valsalva maneuver [26]. In the literature no minimal blood 
pressure variation is described which is necessary to determine dynamic cerebral autoregulation 
[13].
Critical closing pressure
The critical closing pressure (CrCP) is a method to describe and quantify characteristics of the 
cerebrovascular bed in more detail and is deﬁned as the lower limit of arterial blood pressure below 
which vessels collapse and flow ceases [27, 28]. Because CrCP cannot be measured directly, several 
models have been developed to estimate CrCP indirectly from other measurable physiological 
parameters or their derivatives. CrCP in the model of Burton is the sum of intracranial pressure 
(ICP) and vascular wall tension [28]. This model is not usable due to the generation of negative 
pressures. Varsos proposed a modiﬁcation of CrCP calculation, using a model of cerebrovascular 
impedance. With this model, the generation of negative values for CrCP is prevented and the model 
can accurately detect changes in vascular properties induced by changes in ICP, PaCO2 and blood 
pressure [29]. CrCP is a valuable and clinically relevant tool in cerebrovascular research, as it allows 
to estimate changes in cerebrovascular tone and minimal cerebral perfusion pressure to prevent 
collapse of vessels and ischemia [30-32]. 
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Outline of this thesis
The aim of the current thesis is to better understand cerebral hemodynamics in patients after 
cardiac arrest en in sepsis patients. Both patient groups have an inflammatory state, are vulnerable 
to secondary brain injury and have changes in CBF in the course of their underlying disease. 
Understanding of cerebral hemodynamics can be helpful in guiding clinical decisions regarding 
hemodynamic target values for the individual patient.
This thesis is divided into two sections, discussing cerebral hemodynamics in patients after cardiac 
arrest in Section I, and in sepsis patients in Section II.
Section I starts with a review of cerebral perfusion and cerebral autoregulation after cardiac arrest 
(chapter 2). The subsequent study evaluates the middle cerebral artery flow, the critical closing 
pressure, and the optimal mean arterial pressure in comatose cardiac arrest survivors (chapter 3). 
This chapter also describes the differences in critical closing pressure between survivors and non-
survivors. In the same patient population, the spontaneous variability in the time and frequency 
domain in mean flow velocity and mean arterial pressure is described (chapter 4). This chapter also 
determines possible differences in spontaneous variability between survivors and non-survivors. 
Chapter 5 evaluates the effect of induced blood pressure variability on cerebral autoregulation 
measurements in patients after cardiac arrest.
Section II begins with a review of cerebral perfusion and cerebral autoregulation in sepsis and 
human endotoxemia (chapter 6). The subsequent study evaluates cerebral autoregulation and 
critical closing pressure in sepsis patients and in healthy volunteers after low (2 ng/kg) and high (4 
ng/kg) dose lipopolysaccharide (LPS). The critical closing pressure is used as a measure of cerebral 
vascular tone.  (chapter 7). Chapter 8 provides a description of the effects of different vasopressors 
on the cerebral vasculature during experimental human endotoxemia and sepsis. In the last two 
chapters (chapter 9 and 10) a “summary, conclusions,future perspectives and clinical implications” 
and a translation in Dutch are provided.
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section i  
cerebral hemodynamics in patients 
after cardiac arrest
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chapter 2
Cerebral perfusion and cerebral 
autoregulation after cardiac arrest
Judith M.D. van den Brule
Johannes G. van der Hoeven
Cornelia W.E. Hoedemaekers
BioMed Research International, 2018 
https://doi.org/10.1155/2018/4143636
proefschrift_Judith_Brule_final.indd   19 09/11/2018   13:36
526134-L-bw-Brule
Processed on: 12-11-2018 PDF page: 20
20
se
ct
io
n
 i 
ce
re
br
al
 h
em
o
dy
n
am
ic
s 
in
 p
at
ie
n
ts
 a
ft
er
 c
ar
di
ac
 a
rr
es
t
Abstract
Out of hospital cardiac arrest is the leading cause of death in industrialized countries. Recovery of 
hemodynamics does not necessarily lead to recovery of cerebral perfusion. The neurological injury, 
induced by a circulatory arrest mainly determines the prognosis of patients after cardiac arrest and 
rates of survival with a favourable neurological outcome are low. 
This review focuses on the temporal course of cerebral perfusion and changes in cerebral 
autoregulation after out of hospital cardiac arrest. In the early phase after cardiac arrest, patients 
have a low cerebral blood flow that gradually restores towards normal values during the ﬁrst 72 hours 
after cardiac arrest. Whether modiﬁcation of the cerebral blood flow after return of spontaneous 
circulation impacts patient outcome remains to be determined. 
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Introduction
The prognosis of cardiac arrest patients is mainly determined by the extent of neurological injury 
induced by the circulatory arrest. Return of spontaneous circulation (ROSC) does not naturally 
result in recovery of cerebral perfusion, as cerebral perfusion failure after ROSC is well described 
in animal models with no-reflow, hypoperfusion and hyperperfusion. In animals, cerebral blood 
flow (CBF) ultimately restores towards normal [1]. Human studies have revealed that, in the early 
phase after cardiac arrest, patients have a low CBF that gradually restores towards normal values 
during the ﬁrst 72 hours following the arrest [2-4]. In the ﬁrst part of this review, the temporal 
course of cerebral blood flow after ROSC is described. This is relevant, because changes in cerebral 
blood flow can contribute to secondary brain injury. The second part of this review will focus on 
cerebral autoregulation after cardiac arrest, because this is an important factor in the development 
of ischaemia and secondary brain damage.
 
Cerebral blood flow after cardiac arrest
Cerebral perfusion after resuscitation is characterized by early hyperemia followed by hypoperfusion 
and, ﬁnally, restoration of normal blood flow. Furthermore, the blood flow is heterogeneous, with 
areas of no flow, low flow, and increased flow at the level of the microcirculation [5].
Early hyperemia (vasoparalysis) (0-20min after ROSC)
Reduction of vascular tone due to tissue acidosis leads to vasoparalysis [6], which does not respond 
to changes in blood pressure or CO2 [7]. Hypoxia-induced vasoparalysis has been demonstrated 
in rats in the very early phase of cardiac arrest [8], and is suggested to result from an imbalance 
between vasodilatory and vasoconstrictive mediators in the cerebral circulation, including nitric 
oxide (NO) [9] and adenosine [10]. There is no direct evidence for this phenomenon in vivo. 
Hyperemia, in combination with brain swelling, can cause increase intracranial pressure, which 
usually normalizes before the hypoperfusion phase initiates [11]. Antioxidants and polynitroxyl 
albumin represent therapies that may be of value in the early hyperemia phase [12, 13].
Hypoperfusion phase (20min-12h after ROSC)
The hypoperfusion phase is due to an impairment of the metabolic/hemodynamic coupling 
mechanisms, and its severity is independent of the duration of ischaemia [14]. We conﬁrmed this 
lack of a relationship between ischaemia duration and the severity of hypoperfusion in comatose 
patients after cardiac arrest (data not published) [15]. During the hypoperfusion phase, the CBF 
decreases by approximately 50% [16, 17]. Several factors are implicated to play a role,  including 
endothelial damage and an imbalance of local vasodilators (NO) and vasoconstrictors such as 
endotheline [18]. In this phase, impairment of the autoregulation may further decrease CBF in the 
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setting of low blood pressure. Viable therapies for this hypoperfusion phase have been examined 
in animal models, and include 20-hydroxyeicosatetraenoic Acid Inhibition by HET0016, nimodipine 
and endothelin type A-antagonists [19-23].
Restoration of normal blood flow (12-72h after ROSC)
Finally, CBF returns to normal, remains low or increases [24, 25]. In more recent literature, only a 
return to normal or an increase in CBF are described [2, 26]. Bisschops et al. described a low mean 
flow velocity in the middle cerebral artery (MFVMCA) on admission, which remained relatively stable 
during the ﬁrst day and increased to normal levels at 48 hours [2]. 
The MFVMCA was shown to be similar in survivors and non-survivors upon ICU admission [26]. 
However, in survivors of cardiac arrest, the MFVMCA increases towards normal values in the following 
72 hours, whereas a much more pronounced increase in MFVMCA, resulting in an overshoot of CBF, 
was observed in non-survivors [26]. This overshoot is most likely the result of a loss in vascular tone 
resulting in a decrease in cerebrovascular resistance in these non-survivors [26]. 
Low CBF after cardiac arrest may cause a mismatch between cerebral oxygen demand and supply. 
A reduction in cerebral metabolism after cardiac arrest has been described in humans and animals 
[27-31]. In the ﬁrst 48 hours after cardiac arrest, cerebral oxygen extraction remains normal with 
a low CBF. This low CBF is not associated with anaerobic metabolism, determined by the jugular 
venous-to-arterial CO2/arterial-to-jugular venous O2 content difference ratio [32]. The jugular 
venous CO2 content signiﬁcantly decreases after cardiac arrest, suggestive of low CO2 production 
due to low cerebral metabolism [32]. 
In survivors, the MFVMCA is low immediately after cardiac arrest, accompanied by low metabolism, 
with a gradual restoration towards normal values accompanied by restoration of metabolism. This 
gradual increase of metabolism in survivors is consistent with recovery of neuronal activity. These 
results imply that the cerebrovascular coupling is intact in patients with a favourable neurological 
outcome. 
In contrast, in non-survivors with cerebral hyperfusion, the cerebral oxygen extraction is strongly 
reduced, suggesting decoupling of cerebral flow and metabolism in non-survivors. This ongoing low 
metabolism likely reflects irreversible neuronal damage [32].
 
Cerebral autoregulation following cardiac arrest
Cerebral autoregulation
Generally, it is assumed that cerebral autoregulation maintains CBF at a constant level when the 
mean arterial pressure (MAP) is between approximately 50 and 150 mmHg (the plateau phase) 
(Figure 1). However, more recent data suggest that cerebral autoregulation maintains constant 
blood flow in a smaller range [33, 34] (Figure 2). Cerebral autoregulation is more effective in the 
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range above baseline MAP than below baseline MAP [35] (Figure 2). 
The upper and lower limits of cerebral autoregulation are not ﬁxed [36]. For example, chronic 
hypertension shifts these limits up. This adaptation protects the brain against high blood pressure, 
but makes it also more vulnerable to hypoperfusion during periods of hypotension. 
Dynamic cerebral autoregulation is clinically more relevant than static autoregulation, because it 
protects the brain against rapid alterations in blood pressure. Various methods and models are 
available for estimating dynamic cerebral autoregulation, using both spontaneous and induced 
fluctuations in blood pressure. 
Cerebral autoregulation following cardiac arrest
Cerebral autoregulation after cardiac arrest has been investigated in various studies. Initially, a linear 
relationship was demonstrated between MAP and CBF [37], suggesting a completely dysfunctional 
(static) cerebral autoregulation after cardiac arrest. Static cerebral autoregulation curves were 
constructed for patients after cardiac arrest by stepwise increasing MAP with vasopressors and 
simultaneous determination of CBF using TCD [38]. Of the 18 patients after cardiac arrest studied 
by Sundgreen et al., static cerebral autoregulation was absent in 8 and present in 10 patients. In 
ﬁve out of ten patients with preserved cerebral autoregulation, the lower limit of autoregulation 
was shifted upwards (range 80-120 mmHg) [38]. In fact, autoregulation may remain intact, but with 
a narrowed and upward shifted intact zone. This study demonstrated the heterogeneous nature of 
cerebral autoregulation in cardiac arrest patients.
Ameloot et al. showed that (dynamic) cerebrovascular autoregulation, determined by the moving 
correlation coefﬁcient between MAP and the ratio of oxygenated versus deoxygenated hemoglobin 
(COX), was not preserved in one third of post cardiac arrest patients [39]. Disturbed autoregulation 
was associated with unfavorable outcome [39, 40]. A MAP below the optimal autoregulatory range 
during the ﬁrst 48 hours after cardiac arrest was associated with worse outcomes compared to 
patients with higher blood pressures [41]. 
The relationship between brain tissue oxygen saturation and MAP can also be used to determine 
the optimal MAP in individual patients after cardiac arrest. The feasibility of this technique to 
obtain real-time values for optimal MAP was demonstrated in a small prospective cohort study 
[42]. The optimal MAP for patients after cardiac arrest in this study was found to be 75 mmHg. 
In a retrospective study, Ameloot estimated the optimal MAP in patients after cardiac arrest to 
be 85 mmHg in patients with preserved autoregulation, and 100 mmHg in patients with disturbed 
autoregulation [39]. 
Taken together, these results emphasize the importance of accurate blood pressure control in 
patients after cardiac arrest. Larger prospective cohort studies are required to establish the value of 
a tailored blood pressure targeted therapy versus conventional blood pressure targets.
The CBF changes after cardiac arrest. The critical closing pressure (CrCP) is a reliable method to 
quantify characteristics of the cerebrovascular bed and is deﬁned as the lower limit of arterial blood 
pressure below which vessels collapse and flow ceases [43, 44]. Immediately following cardiac arrest, 
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CrCP was shown to be high, accompanied by increased cerebrovascular resistance [26]. The CrCP 
decreased in the ﬁrst 48 hours after admission towards normal values [26]. The CrCP was signiﬁcantly 
higher in patients who survived compared to those who deceased [26]. Apparently, vasoactive tone 
was lost in patients with unfavourable outcome, resulting in reduced cerebrovascular resistance and 
a subsequent increased CBF. In contrast, vasoactive tone and cerebral blood flow velocities returned 
to normal values in patients with favorable neurological outcome.
In addition, immediately following cardiac arrest, spontaneous variability of MFV was found to be 
low [15]. MFV variability increased to normal values in patients who survived, whereas it further 
decreased in patients who did not survive after cardiac arrest [15]. It is plausible that these changes 
are the consequence of the associated severe brain damage, resulting in impaired control of 
intrinsic myogenic vascular function and autonomic dysregulation. These changes in spontaneous 
fluctuations in MFV imply changes in dynamic cerebral autoregulation after ROSC.
Bisschops et al. showed a preserved cerebrovascular reactivity to fluctuations in PaCO2 during mild 
therapeutic hypothermia after cardiac arrest [2]. Previously, Yenari et al. demonstrated a preserved 
cerebrovascular reactivity to changes in PaCO2 under normothermic conditions in patients after 
ROSC [45]. This emphasizes the importance of strict control of blood gas values during mechanical 
ventilation in cardiac arrest patients, because secondary neurological damage as a result of cerebral 
ischaemia could be prevented by avoiding iatrogenic hypocapnia.
 
Conclusion 
CBF is low after cardiac arrest, and returns towards normal values in patients that ultimately survive. 
In patients with severe postanoxic encephalopathy disturbed autoregulation, loss of normal vascular 
tone and increased CBF may contribute to the development of secondary brain damage, ultimately 
leading to fatal brain injury.
The changes in CBF after cardiac arrest may be regarded merely as a feature of severe primary 
brain damage resulting from ischaemia and reperfusion injury. Alternatively, they may contribute to 
the development of secondary brain damage. Whether modulation of the CBF after ROSC, e.g. by 
maintaining MAP at optimal autoregulation ranges,  impacts the outcome of these patients remains 
to be determined. 
In addition, differences between CBF in the microcirculation are poorly understood and deserve 
more attention.
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Figures
figure 1 cerebral autoregulation maintains cerebral blood flow at a constant level when the mean arterial 
   pressure is between approximately 50 and 150 mmHg (the plateau phase)
figure 2 more recent data support the opinion that cerebral autoregulation does not maintain constant 
  blood flow through a broad mean arterial pressure range of 50-150 mmHg, but probably in a smaller 
  range. cerebral autoregulation is more effective in the range above baseline mean arterial pressure, 
  compared to the range below 
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Middle cerebral artery flow, the critical 
closing pressure, and the optimal mean 
arterial pressure in comatose cardiac arrest 
survivors - an observational study
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Abstract
Objective
This study estimated the critical closing pressure (CrCP) of the cerebrovascular circulation during 
the post-cardiac arrest syndrome and determined if CrCP differs between survivors and non-
survivors. We also compared patients after cardiac arrest to normal controls. 
Methods
A prospective observational study was performed at the ICU of a tertiary university hospital in 
Nijmegen the Netherlands. We studied 11 comatose patients successfully resuscitated from a cardiac 
arrest and treated with mild therapeutic hypothermia and 10 normal control subjects. Mean flow 
velocity (MFV) in the middle cerebral artery was measured by transcranial Doppler at several time 
points after admission to the ICU. CrCP was determinded by a cerebrovascular impedance model.
Results
MFV was similar in survivors and non-survivors upon admission to the ICU, but increased stronger 
in non-survivors compared to survivors throughout the observation period (P<0.001). MFV was 
signiﬁcantly lower in survivors immediately after cardiac arrest compared to normal controls 
(P<0.001), with a gradual restoration towards normal values. CrCP decreased signiﬁcantly from 
61.4[51.0-77.1] mmHg to 41.7[39.9-51.0] mmHg in the ﬁrst 48 hrs, after which it remained stable 
(P<0.001). CrCP was signiﬁcantly higher in survivors compared to non-survivors (P=0.002).  CrCP 
immediately after cardiac arrest was signiﬁcantly higher compared to the control group (P=0.02). 
Conclusions
CrCP is high after cardiac arrest with high cerebrovascular resistance and low MFV. This suggests 
that cerebral perfusion pressure should be maintained at a sufﬁcient high level to avoid secondary 
brain injury. Failure to normalize the cerebrovascular proﬁle may be a parameter of poor outcome.
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Introduction
Prognosis after cardiac arrest is mainly determined by the neurological injury induced by the 
circulatory arrest. Return of spontaneous circulation (ROSC) does not automatically restore cerebral 
perfusion. Cerebral perfusion failure after restoration of circulation is a well known phenomenon in 
animal models with no-reflow, cerebral hyperperfusion and hypoperfusion that ultimately restores 
towards normal cerebral blood flow (CBF) [1]. Humans have a similar flow pattern after cardiac 
arrest with low CBF in the initial phase after cardiac arrest that gradually restores towards normal 
values during the post-resuscitation syndrome [2-4]. This so called “delayed hypoperfusion phase” 
renders the brain at risk for ischaemia and secondary brain injury. 
The cerebral vascular tone plays an essential role in changes in CBF after cardiac arrest. Increased 
cerebrovascular resistance has been suggested to contribute to the delayed hypoperfusion phase, 
based on high transcranial Doppler pulsatility indexes of the middle cerebral artery (MCA) measured 
during the early post-cardiac arrest period [2-4]. A subsequent strong decrease in transcranial 
Doppler (TCD) pulsatility index with increased mean flow velocities (MFV) during the ﬁrst 24 
hours after the arrest was measured in non-survivors, whereas in survivors these parameters 
normalized [5]. In addition, autoregulation is disturbed in approximately 1/3 of patients after cardiac 
arrest, mainly in those with a poor outcome [6, 7]. Taken together, these data indicate that the 
cerebrovascular resistance is altered after cardiac arrest, mainly in patients with a poor neurological 
outcome. 
The critical closing pressure (CrCP) is a method to describe and quantify characteristics of the 
cerebrovascular bed in more detail and is deﬁned as the lower limit of arterial blood pressure below 
which vessels collapse and flow ceases [8, 9]. Because CrCP cannot be measured directly, several 
models have been developed to estimate CrCP indirectly from other measurable physiological 
parameters or their derivatives. CrCP in the model of Burton is the sum of intracranial pressure 
(ICP) and vascular wall tension [8]. Varsos proposed a modiﬁcation of CrCP calculation, using a 
model of cerebrovascular impedance. With this model, the generation of negative values for CrCP is 
prevented and the model can accurately detect changes in vascular properties induced by changes in 
ICP, PaCO2 and blood pressure [10]. CrCP is a valuable and clinically relevant tool in cerebrovascular 
research, as it allows to estimate changes in cerebrovascular tone and minimal cerebral perfusion 
pressure to prevent collapse of vessels and ischemia [11-13]. 
The aim of the current study was to estimate the CrCP of cerebrovascular motor tone during the 
post-cardiac arrest syndrome and to determine if CrCP differs between survivors and non-survivors. 
To place these values in a broader context, we also compared CrCP in post-cardiac arrest patients 
to normal controls.
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Methods
Study
A prospective observational study was performed at the ICU of a tertiary university hospital in the 
Netherlands. All experiments were in accordance with the Declaration of Helsinki and Good Clinical 
Practice guidelines.
Population
We studied 11 comatose patients successfully resuscitated from a cardiac arrest and treated with 
mild therapeutic hypothermia. Inclusion criteria were age ≥18 years and coma (Glasgow coma scale 
≤ 6) after return of spontaneous circulation. “Survivors” and “non-survivors” denotes survival to 
hospital discharge. As a control group, we included 10 subjects without brain injury. Seven controls 
were patients admitted to the ICU for pre-operative haemodynamic optimization one day before 
esophagectomy. Three controls were healthy volunteers who participated in an experimental study. 
These healthy volunteers were included after written informed consent and approval of the protocol 
by the local Institutional Review Board. For the patients after cardiac arrest and patients admitted 
for haemodynamic optimization the local Institutional Review Board waived the need for informed 
consent. Exclusion criteria for all patients were an irregular heart rhythm, insufﬁcient transtemporal 
bone window, pregnancy, thrombolytic therapy, refractory cardiogenic shock or a life expectancy 
<24 hours.
Patient management
The post-cardiac arrest patients were treated with hypothermia by rapid infusion of 30 mL/kg 
bodyweight of cold Ringer’s lactate at 4°C followed by external cooling using two water-circulating 
blankets (Blanketroll II, Cincinnati Subzero, The Surgical Company, Amersfoort, The Netherlands). 
Temperature was maintained at 32-34°C for 24 hours, followed by passive rewarming to normothermia 
(deﬁned as 37°C). Cardiac arrest patients were sedated with midazolam and/or propofol and 
sufentanil. Sedation was stopped as soon as temperature was ≥36 °C. In case of shivering, patients 
were paralysed using intravenous bolus injections of rocuronium. All patients were intubated and 
mechanically ventilated to obtain PaO2 >75 mmHg and PaCO2 34-41 mmHg. Mean arterial pressure 
(MAP) was maintained between 80-100 mmHg. If necessary, patients were treated with volume 
infusion and dobutamine and/or milrinone and/or noradrenaline (norepinephrine).
Controls were admitted to the ICU the day before surgery for haemodynamic optimization or to 
the research unit of the ICU. All measurements in this group were performed while subjects were 
awake, without mechanical ventilation and before fluid resuscitation, pre-operative or study related 
interventions were initiated. 
Data collection
Demographic, pre-hospital and clinical data were collected upon and during admission. An arterial 
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catheter was used for monitoring of blood pressure in all subjects. 
MFV in the middle cerebral artery (MFVMCA) was measured by TCD through the temporal window 
with a 2-Mhz probe (Multi-Dop T Digital, Compumedics DWL, Singen, Germany) according to 
the method developed by Aaslid [14]. The probe was positioned over the temporal bone window 
above the zygomatic arch and ﬁxed. This procedure ensured that the angle and individual depth 
of insonation remained constant during investigation. The temporal acoustic window and Doppler 
depth giving the highest velocities were used for all measurements. Two investigators performed 
all measurements (J.B. and C.H.). Recordings were made with subjects in supine position, the head 
elevated to 30°.
A minimum of 10-12 minute windows of MFV, heart rate and arterial blood pressure (ABP) were 
simultaneously recorded on a computer and stored on a hard disk with a sample rate of 200 Hz by 
an A/D converter (NI USB-6211, National Instrument, Austin, TX, USA). During the measurements, 
PaO2, PaCO2 and temperature were within normal ranges and patients were normotensive.
In patients after cardiac arrest, measurements were performed on admission to the ICU and at 6, 12, 
24, 36, 48, 60 and 72 hours. Subjects in the control group were measured once. 
Data analysis
ABP and MFV data were analysed using custom-written MATLAB scripts (Matlab R2014b, The 
MathWorks Inc. Massachusetts, USA. First, the time series were ﬁltered with an 5th-order low-pass 
Butterworth ﬁlter (25 Hz), to ascertain signal stationarity. Second, periods of 5 minutes of artefact- 
and calibration-free data were selected by visual inspection for subsequent analysis. Last, mean 
blood pressure and cerebral blood flow velocity were obtained synchronically using a 4th order 
low-pass Butterworth ﬁlter.
CrCP was determined according to the method suggested by Varsos [10, 15]. 
CrCP = ABP -
With CVR cerebrovascular resistance, Ca compliance of the vascular bed and HR heart rate. The 
multiplication of CVR and Ca is called the time constant Tau (t). CPP is deﬁned as ABP – ICP, 
however in this study ICP was not measured. Therefore ABPmean was used as an approach of CPP, 
as described by Varsos [10]. CVR was calculated by dividing ABPmean by MFVmean. To determine 
Ca, cerebral arterial blood volume (CABV) was calculated by integrating the MFV signal over time. 
Then Ca was calculated by dividing the amplitude of the ﬁrst harmonic of the CABV by the amplitude 
of the ﬁrst harmonic of the ABP. HR was deﬁned as the ﬁrst harmonic frequency of ABP.
CPP
√(CVR·Ca·HR·2π)²+1
proefschrift_Judith_Brule_final.indd   35 09/11/2018   13:36
526134-L-bw-Brule
Processed on: 12-11-2018 PDF page: 36
36
se
ct
io
n
 i 
ce
re
br
al
 h
em
o
dy
n
am
ic
s 
in
 p
at
ie
n
ts
 a
ft
er
 c
ar
di
ac
 a
rr
es
t
Statistical analysis 
Statistical analysis was performed using GraphPad Prism version 5.0 (GraphPad Software, La Jolla, 
CA). Data are presented as median with 25th and 75th percentile. Figures also show minimum and 
maximum (whiskers) values. Changes over time were analyzed with the repeated-measures test for 
nonparametric data. Differences between survivors and non-survivors were analyzed with two-way 
analysis of variance. The Mann Whitney test was used for comparison between groups. A p-value of 
<0.05 was considered to indicate signiﬁcance. 
 
Results
Demographic and clinical data
We included 9 male and 2 female (n = 11) comatose patients after cardiac arrest. The demographic 
data of the patients and controls are shown in Table 1. Eight patients had ventricular ﬁbrillation or 
ventricular tachycardia as initial rhythm, 3 patients initially had a pulseless electrical activity or 
asystole Four patients died in the ICU, all as result of severe postanoxic brain damage. The clinical 
data are summarized in Table 2. Cardiac arrest patients had a signiﬁcantly higher hemoglobin 
on admission (P=0.03). The pH was lower (P=0.002) and the arterial carbondioxide tension was 
signiﬁcantly higher (P=0.01) immediately after cardiac arrest compared to normal control patients. 
Cerebral blood flow velocity 
As expected, MFV increased signiﬁcantly after cardiac arrest from 28.0[25.0-39.0] upon ICU 
admission to 78.0[65.0-123.0] cm/sec after 72 hrs, P<0.001 (Figure 1). The MFVMCA was similar in 
survivors and non-survivors upon admission to the ICU, but the MFVMCA increased stronger in 
non-survivors compared to survivors throughout the observation period (P=0.001). MFVMCA was 
signiﬁcantly lower in survivors immediately after cardiac arrest compared to normal controls 
(P<0.001), with a gradual restoration towards normal values. 
MAP decreased after cardiac arrest from 91.0[83.0-123] on admission to 82.5[77.8-87.8] at 48 hrs 
and 88.0[83.0-98.0] mmHg at 72 hrs (P=0.009) with no signiﬁcant differences between survivors 
and non-survivors (P=0.09) (data not shown). MAP in the control patients was 92.6[86.3-105.1] and 
comparable to the cardiac arrest group (data not shown). 
Critical closing pressure
After cardiac arrest, the CrCP decreased signiﬁcantly from 61.4[51.0-77.1] on admission to 41.7[39.9-
51.0] mmHg at 48 hrs, after which it remained stable (P<0.001), (Figure 2). The CrCP was signiﬁcantly 
higher in survivors compared to non-survivors (P=0.002). The CrCP immediately after cardiac arrest 
was signiﬁcantly higher compared to the control group (P=0.02). 
The Ca represents the change of arterial blood volume in response to change in arterial pressure 
and is estimated as a ratio of pulse amplitude of CABV derived from the cerebral blood flow velocity 
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and pulse amplitude of the ABP. After cardiac arrest, Ca increased signiﬁcantly from 0.05[0.05-
0.08] upon admission to 0.10[0.08-0.16] mmHg/cm3 at 72 hrs (P=0.02), with no differences between 
survivors and non-survivors (P=0.81) (data not shown). Ca values immediately after cardiac arrest 
were signiﬁcantly lower compared to normal values (0.11[0.08-0.25] mmHg/cm3, P=0.007). 
The CVR is the resistance of small cerebral arteries and arterioles and was estimated from the ABP 
and cerebral blood flow velocity. The initial CVR in patients after cardiac arrest was high (3.91[2.94-
5.37]) and signiﬁcantly decreased after 72 hrs to 1.35[0.88-1.81] mmHg*sec/cm (P<0.001), with a 
stronger decline in non-survivors (P=0.02), (Figure 3). The CVR on admission was signiﬁcantly higher 
in the cardiac arrest group compared to normal controls (1.67[1.25-2.62] mmHg*sec/cm, P<0.001). 
Tau (t) is the time constant of cerebral arterial bed and is the product of brain arterial compliance 
Ca  and CVR. It estimates how fast cerebral blood arrives in the cerebral arterial bed during each 
cardiac cycle. Tau decreased signiﬁcantly from 0.22[0.19-0.26] to 0.13[0.11-0.20] sec (P=0.005), with 
a stronger decrease in non-survivors compared to survivors (P=0.01), (Figure 4). Tau in the control 
group was 0.18[0.15-0.25] sec, and did not differ signiﬁcantly from values on admission after cardiac 
arrest. 
 
Discussion
Cerebral hemodynamic parameters change signiﬁcantly after cardiac arrest. MFVMCA is low in the ﬁrst 
hours after cardiac arrest, with a high CrCP and CVR. During the ﬁrst 72 hours, the MFV gradually 
increases towards normal values, with a concomitant decrease in CrCP and CVR. This change in 
cerebrovascular proﬁle after cardiac arrest is most likely the result of a change in cerebrovascular 
motor tone, switching from vasoconstriction at admission to vasodilation after 72 hours. 
CrCP is the sum of cerebral artery smooth muscle tone and ICP [8]. In theory, changes in CrCP can 
originate from changes in both components. Most likely, the increased CrCP after cardiac arrest is 
the result of cerebral vasoconstriction in the ﬁrst hours after ROSC. In our patients, the resistance 
of small cerebral arteries and arterioles, estimated by the CVR, was high and gradually decreased 
towards normal values. In humans, the transcranial Doppler pulsatility index of the MCA is high 
during the early post-cardiac arrest period and decreases towards normal values after 24-48 hours 
[2-4], also implicating increased cerebral arterial resistance. The combination of low cerebral blood 
flow velocities with high CVR is a characteristic of the “delayed cerebral hypoperfusion phase” 
described in post-resuscitation animal models [1]. An imbalance between local vasoconstrictors and 
vasodilators, characterized by high endothelin levels, gradually decreasing nitrate concentrations, 
and gradually increasing cGMP levels is suggested to underlie the cerebral perfusion changes after 
cardiac arrest [3]. Other factors that contribute to this reduced blood flow include a reduction in 
neuronal activity, vasospasm, edema, platelet and leukocyte adhesion and changes in viscosity [1, 
3, 16-19]. 
The incidence of intracranial hypertension after cardiac arrest is unknown, and has been studied in 
proefschrift_Judith_Brule_final.indd   37 09/11/2018   13:36
526134-L-bw-Brule
Processed on: 12-11-2018 PDF page: 38
38
se
ct
io
n
 i 
ce
re
br
al
 h
em
o
dy
n
am
ic
s 
in
 p
at
ie
n
ts
 a
ft
er
 c
ar
di
ac
 a
rr
es
t
only a small number of highly selected patients [20-24]. In those patients, ICP upon admission to 
the ICU was low, even in patients who developed intracranial hypertension later during the course 
of admission [21]. As CrCP was high on admission and decreased in the ﬁrst hours after ROSC, 
increased ICP is probably not a major factor determining CrCP in our population. This is supported 
by the fact that CrCP was lower in non-survivors compared to survivors, whereas post-cardiac arrest 
patients with intracranial hypertension (resulting in high CrCP) had a poor outcome in all studies 
[20-24]. 
Our results stress the importance of maintaining a sufﬁciently high cerebral perfusion pressure, 
especially in the ﬁrst hours after cardiac arrest to avoid secondary brain ischemia. Our data suggest 
that the widely used MAP range of 65-70 mmHg is probably suboptimal [25]. This is in agreement 
with a previous study on the optimal cerebral perfusion pressure after cardiac arrest, suggesting an 
optimal MAP between 85-105 mmHg [6]. 
Survivors and non-survivors revealed signiﬁcantly different cerebral perfusion characteristics 
during the post-cardiac arrest period. Non-survivors showed a more pronounced increase in 
MFVMCA in the ﬁrst 72 hours after the arrest. This was accompanied by a stronger decrease in CrCP 
and CVR in non-survivors. Differences in systemic parameters such as MAP, pH or PaCO2 tension or 
differences in use of vaso-active drugs did not account for these differences in cerebral perfusion. 
These data are in accordance with previous observations of a signiﬁcant decrease in pulsatility index 
and an increase in MFVMCA in non-survivors after cardiac arrest [5]. Apparently, vasoactive tone is 
lost in patients with poor outcome, resulting in a decrease in CVR and subsequently an increase in 
cerebral blood flow. Under normal circumstances, cerebral blood flow is maintained at a constant 
level through the mechanism of cerebrovascular autoregulation. Autoregulation is disturbed in 
approximately 1/3 of patients after cardiac arrest, mainly in those with poor outcome [6, 7]. A loss 
of autoregulation may have resulted in increased blood flow with low CVR in the non-survivors. 
In addition, the ischemia-reperfusion response activates a large number of pathophysiological 
pathways including oxidative stress, inflammation and coagulation resulting in reactive hyperemia 
[26, 27]. This reactive hyperemia is likely to be more pronounced in more severely affected patients, 
explaining the increased flow with low resistance in non-survivors. 
We compared the cardiac arrest patients upon admission to normal control subjects. MFVMCA was 
signiﬁcantly lower immediately after cardiac arrest compared to normal control patients. CrCP and 
CVR were higher compared to controls. Use of sedatives and vasopressors is common during the 
post-cardiac arrest period and may influence the cerebrovascular perfusion characteristics. Normal 
control patients were measured without any sedatives or vasopressive agents. The post-resuscitation 
perfusion pattern was different in survivors versus non-survivors, despite similar levels of blood 
pressure, use of sedatives and vasopressors and laboratory values, strongly suggesting a distinct 
pathophysiological entity rather than an ICU or drug-induced effect on cerebral blood flow. 
A unique feature of the treatment after cardiac arrest was the use of mild hypothermia in our 
patients. Hypothermia may delay restoration of cerebral blood flow towards normal values, but 
does not alter the pattern of hypoperfusion followed by normal or hyperperfusion and is probably 
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not a major determinant of the cerebral blood flow after cardiac arrest [2, 28]. The contribution of 
hypothermia to the high CrCP and CVR upon admission cannot be established from this study, but 
seems relatively minor since both CrCP and resistance decrease while temperatures decline in the 
ﬁrst hours after admission. 
This study has a number of limitations. First, CrCP cannot be measured in vivo but is estimated 
using a mathematical model, with its inherent risks of bias. Most importantly, ICP is required for 
a most accurate calculation of the model. Since ICP is low under normal conditions, it does not 
signiﬁcantly alter the estimation of CrCP. ICP is unlikely to have a major influence on our results, 
as CrCP decreases in non-survivors (whereas raised ICP would increase CrCP). We measured ABP 
through a catheter in the radial artery. Measurement of the ABP in the MCA would have resulted in 
a more accurate estimation of cerebral perfusion pressure but is not feasible in patients. Second, the 
cerebral perfusion changes after cardiac arrest are probably heterogeneously distributed through 
the brain, with some areas more affected than others. As CrCP is derived from the MFVMCA, these 
heterogeneities cannot be measured by this technique. This study also has limitations inherent in 
comparing subjects with regimented hemodynamics and ventilation to awake control subjects. ABP 
and HR are both components in the method of Varsos, but there were no signiﬁcant differences 
in these components between cardiac arrest patients and normal controls. Another component 
in the method of Varsos is MFV, which is influenced by the diameter of the MCA and thus by pH/
carbondioxide tension. pH/carbondioxide tension was different between cardiac arrest patients and 
normal controls on admission and may have affected the results, but this component normalised 
early after admission.
Although we studied only 11 patients, the results appear to be physiologically sound. 
 
Conclusions
In conclusion, CrCP is high after cardiac arrest with high cerebrovascular resistance and low 
cerebral blood flow velocities. This suggests that cerebral perfusion pressure should be maintained 
at a sufﬁcient high level to avoid secondary brain injury. Failure to normalize the cerebrovascular 
proﬁle may be a parameter of poor outcome. 
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Tables and figures 
table 1      demographic data cardiac arrest patients and controls
characteristics cardiac arrest control p value
Number of patients, n 11 10
Male, n (%) 9 (81%) 8 (80%)
Age (yrs) 57[55-61] 65[31-67] 0.75
SAPS II 60[41-69] 13[7.3-18] <0.001
APACHE II 26[24-30] 4.5[0.8-9.0] <0.001
Number of survivors, n (%) 7 (64%) 10 (100%) 0.36
SAPS II: Simpliﬁed Acute Physiology Score II
APACHE II: Acute Physiology and Chronic Health Evaluation II
table 2      clinical and laboratory data 
characteristics cardiac arrest* normal p value
Mechanical ventilation 11 (100%) 0 (0%)
MAP (mmHg) 91.0[84.5-114.5] 91.1[86.3-105.1] 0.92
Heart rate (bpm) 85.0[80.0-92.0] 69.5[62.5-76.5] 0.09
Temperature (°C) 35.5[34.3-35.9] 37.0[36.8-37.1] 0.006
Noradrenaline 1 (9.1%) 0 (0%)
Dose (µg/kg/min) 0.12
Milrinone (0%) 0 (0%)
Dobutamine 0 (0%) 0 (0%)
Hemoglobin (g/dL) 14.7[12.9-14.7] 11.6[10.8-12.6] 0.03
pH 7.31[7.26-7.37] 7.45[7.43-7.46] 0.002
PaO2 (mmHg) 102[81-168] 87[78-105] 0.28
PaCO2 (mmHg) 42.0[39.0-43.5] 35.6[34.5-36.8] 0.01
*data represent values upon admission to the ICU
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figure  1 MFV of survivors and non-survivors in comatose patients succesfully resuscitated from a cardiac 
   arrest and treated with mild hypothermia, during 72 hours of ICU admission
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figure 2 CrCP of survivors and non-survivors in comatose patients succesfully resuscitated from a cardiac 
   arrest and treated with mild hypothermia, during 72 hours of ICU admission 
CrCP critical closing pressure
 Time after admission to the ICU (hrs)
C
rC
P 
(m
m
H
g)
survivors
non-survivors
controls
survivors
non-survivors
controls
proefschrift_Judith_Brule_final.indd   43 09/11/2018   13:36
526134-L-bw-Brule
Processed on: 12-11-2018 PDF page: 44
44
se
ct
io
n
 i 
ce
re
br
al
 h
em
o
dy
n
am
ic
s 
in
 p
at
ie
n
ts
 a
ft
er
 c
ar
di
ac
 a
rr
es
t
figure 3 CVR of survivors and non-survivors in comatose patients succesfully resuscitated from a cardiac 
   arrest and treated with mild hypothermia, during 72 hours of ICU admission 
CVR cerebrovascular resistance 
figure 4 Tau (time constant) of survivors and non-survivors in comatose patients succesfully resuscitated 
  from a cardiac arrest and treated with mild hypothermia, during 72 hours of ICU admission  
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Low spontaneous variability in cerebral 
blood flow velocity in non-survivors after 
cardiac arrest 
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Abstract
Objective
To investigate spontaneous variability in the time and frequency domain in mean flow velocity 
(MFV) and mean arterial pressure (MAP) in comatose patients after cardiac arrest, and determine 
possible differences between survivors and non-survivors. 
Methods
A prospective observational study was performed at the ICU of a tertiary care university hospital 
in the Netherlands. We studied 11 comatose patients and 10 controls. MFV in the middle cerebral 
artery was measured with simultaneously recording of MAP. Coefﬁcient of variation (CV) was used 
as a standardized measure of dispersion in the time domain. In the frequency domain, the average 
spectral power of MAP and MFV were calculated in the very low, low and high frequency bands. 
Results
In survivors CV of MFV increased from 4.66 [3.92-6.28] to 7.52 [5.52-15.23] % at T=72 hours. In 
non-survivors CV of MFV decreased from 9.02 [1.70-9.36] to 1.97 [1.97-1.97] %. CV of MAP was low 
immediately after admission (1.46 [1.09-2.25] %) and remained low at 72 hours (3.05 [1.87-3.63] %) 
(p=0.13). There were no differences in CV of MAP between survivors and non-survivors (p=0.30). We 
noticed signiﬁcant differences between survivors and non-survivors in the VLF band for average 
spectral power of MAP (p=0.03) and MFV (p=0.003), whereby the power of both MAP and MFV 
increased in survivors during admission, while remaining low in non-survivors.
Conclusions
Cerebral blood flow is altered after cardiac arrest, with decreased spontaneous fluctuations in non-
survivors. Most likely, these changes are the consequence of impaired intrinsic myogenic vascular 
function and autonomic dysregulation. 
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Introduction
The incidence of post-anoxic encephalopathy after cardiac arrest is high, resulting in high mortality 
and morbidity [1]. Crucial in the ICU treatment after cardiac arrest is to create an optimal 
environment, for cerebral recovery including adequate cerebral blood flow (CBF). 
Under normal circumstances, CBF exhibits rapid spontaneous fluctuations, in order to maintain 
cerebrovascular homeostasis. The adaptation of CBF to perturbations in cerebral perfusion pressure 
is regulated by central control mechanisms [2, 3] and by an intrinsic variation via myogenic 
vasoconstriction [4, 5]. 
Arterial pressure also varies spontaneously. Beat-to-beat changes in arterial pressure are regulated by 
cardiovascular control mechanisms, such as the arterial baroreflex [6], the renin-angiotensin system 
[7], the vascular myogenic response [8] and the endothelial nitric oxide release [9]. Blood pressure 
fluctuations elicited by sympathetic modulation of vascular tone occur in the low frequency band 
(LF, 0.07-0.15Hz). Intrinsic vascular myogenic changes in arterial blood pressure affects both the LF 
and very low frequency (VLF, 0.02-0.07Hz) components of cardiovascular variability. Endothelial 
NO affects blood pressure variability in the high frequency range in animals (HF, 0.15-0.40Hz). The 
effect of NO in humans is controversial since the HF band is largely dependent on respiration. 
The impact of the renin-angiotensin system on blood pressure variability is unknown. To what level 
cerebral blood flow variability is dependent on pressure variability is a matter of debate in healthy 
subjects and yet unknown in patients after cardiac arrest [10].
Blood pressure variability is a well known risk factor for end organ damage in patients with chronic 
conditions such as hypertension [11, 12]. In acute ischemic stroke, beat to beat blood pressure 
variability was associated with death and dependency at 30 days [13]. In contrast, in acute brain 
injury patients no differences in blood pressure variability between survivors and non-survivors 
were detected[14]. The impact of blood pressure variability in the time and frequency domains in 
acute brain damage such as after cardiac arrest, is unknown.
The main objective of our study was to determine the spontaneous variability in the time and 
frequency domain in mean flow velocity (MFV) and mean arterial pressure (MAP) in comatose 
patients during the ﬁrst 72 hours after cardiac arrest. In addition, possible differences in spontaneous 
variability between survivors and non-survivors were determined.  
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Materials and methods
Study
A prospective observational study was performed at the ICU of a tertiary care university hospital 
the Netherlands. The local Institutional Review Board approved the study and waived the need for 
informed consent.
Population
We studied 11 comatose patients successfully resuscitated from a cardiac arrest and treated with 
mild therapeutic hypothermia.  Inclusion criteria were age ≥18 years and a Glasgow Coma Score ≤ 6 
after return of spontaneous circulation. We also studied 10 normal control subjects. Seven controls 
were patients admitted to the ICU for pre-operative haemodynamic optimization one day before 
elective esophagectomy with reconstructive surgery because of cancer. Three control patients were 
healthy volunteers that participated in an experimental human endotoxemia study. These controls 
were included after written informed consent and approval of the protocol by the local Institutional 
Review Board (document number 2015-2079, NCT02675868).
Exclusion criteria for all groups were an irregular heart rhythm, absent transtemporal bone window, 
pregnancy, thrombolytic therapy, refractory cardiogenic shock and life expectancy less than 24 
hours.
Patient management
The post-cardiac arrest patients were treated with hypothermia by rapid infusion of 30 mL/kg 
bodyweight of cold Ringer’s lactate at 4 °C followed by external cooling using water-circulating 
blankets (Blanketroll II, Cincinnati Subzero, The Surgical Company, Amersfoort, The Netherlands). 
Temperature was maintained at 32-34 °C for 24 hours, followed by passive rewarming to 
normothermia (deﬁned as 37 °C). All patients were sedated with midazolam and/or propofol and 
sufentanil. Sedation was stopped as soon as the body temperature was ≥36 °C. In case of shivering, 
patients were paralysed using intravenous bolus injections of rocuronium. All patients were 
intubated and mechanically ventilated to obtain a PaO2 >75 mmHg and a PaCO2 between 34 and 
41 mmHg. The radial or femoral artery was cannulated for monitoring of arterial blood pressure 
(ABP) and sampling of arterial blood. According to our local protocol, MAP was maintained between 
80-100 mmHg. If necessary, patients were treated with volume infusion and dobutamine and/or 
milrinone and/or noradrenaline (norepinephrine).
All measurements in the control group were performed while subjects were awake, without 
mechanical ventilation and before fluid resuscitation or other pre-operative or research 
interventions were initiated. 
Data collection
Demographic, pre-hospital and clinical data were collected upon and during admission. An arterial 
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catheter was used for monitoring of blood pressure and sampling of arterial blood in all patients. 
The MFV in the middle cerebral artery (MCA) was measured by transcranial Doppler (TCD) through 
the temporal window with a 2-Mhz probe (Multi-Dop T Digital, Compumedics DWL, Singen, 
Germany). The probe was positioned over the temporal bone window above the zygomatic arch and 
ﬁxed with a frame. This procedure ensured that the angle and the individual depth of insonation 
remained constant during the investigation. The temporal acoustic window and Doppler depth 
giving the highest velocities were determined and used for all measurements. Two investigators 
performed all measurements (J.B. and C.H.). Recordings were made with subjects in the supine 
position with the head elevated to 30°.
A minimum of 10-12 minute windows of MFV, heart rate and MAP were simultaneously recorded on 
a laptop computer and stored on a hard disk with a sample rate of 200 Hz by an A/D converter (NI 
USB-6211, National Instrument, Austin, TX, USA). During the measurements, PaO2 and PaCO2 were 
within normal ranges and stable. 
In the patients after cardiac arrest measurements were performed on admission to the ICU and 
at 6, 12, 24, 36, 48, 60 and 72 hours. One single measurement was performed in the control group. 
Data analysis
MAP and MFV data were analysed using custom-written MATLAB scripts (Matlab R2014b, The 
MathWorks Inc. Massachusetts, USA). MAP and MFV were acquired using a third order zero phase-
lag Butterworth ﬁlter with a cut-off frequency of 0.5 Hz.
From these MAP and MFV signals, 5-minute windows were automatically selected based on the 
least amount of artefacts. By averaging these 5-minute windows of the MAP and MFV signals, mean 
values of MAP and MFV were acquired. 
Coefﬁcient of variation (CV) was used as a standardized measure of dispersion for both MAP and 
MFV in the time domain. CV was deﬁned as the standard deviation of the signal divided by the 
mean of the signal and was calculated from all ﬁltered signals. This way, the variation is expressed 
in percentage of the mean. 
In the frequency domain, the average spectral power of MAP and MFV were calculated in the very 
low (VLF, 0.02–0.07 Hz), low (LF, 0.07–0.15 Hz), and high (HF, 0.15–0.40 Hz) frequency bands. This in 
order to see whether the variation can be designated to a certain frequency band and whether this 
origin of variation changes over time in the patients[15]. 
Statistical analysis 
Statistical analysis was performed using GraphPad Prism version 5.0 (GraphPad Software, La Jolla, 
CA). Data are presented as median with 25th and 75th percentile. Figures also show minimum and 
maximum (whiskers) values. Changes over time were analyzed with the repeated-measures test for 
nonparametric data. Differences between survivors and non-survivors were analyzed with two-way 
analysis of variance. The Mann Whitney test was used for comparison between groups. A p-value of 
<0.05 was considered to indicate signiﬁcance.  
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Results
Demographic and clinical data 
We included 9 male and 2 female (n=11) comatose patients after cardiac arrest. The demographic 
data of the patients are shown in Table 1. Eight patients had ventricular ﬁbrillation or ventricular 
tachycardia as initial rhythm, 3 patients initially had a pulseless electrical activity or asystole. Four 
patients died in the ICU, all as a result of severe postanoxic brain damage. The demographic data of 
the control group are also summarized in Table 1. 
The clinical data on admission are summarized in Table 2. Cardiac arrest patients had a signiﬁcantly 
higher hemoglobin concentration on admission (p=0.03). The pH was lower (p=0.002) and the 
PaCO2 was signiﬁcantly higher (p=0.02) immediately after cardiac arrest compared to the normal 
control patients, but normalized rapidly after admission. Nine percent of the cardiac arrest patients 
received noradrenaline on admission to maintain the MAP within the target range. The normal 
controls were awake and breathing spontaneously on room air. 
MAP was measured continuously in the patients after cardiac arrest and changed signiﬁcantly 
(p=0.04) during the study period according to a U-shaped pattern (electronic supplement Figure 
1). MFV was low (28.00 [25.00-39.00] cm/sec) upon admission after cardiac arrest and increased 
signiﬁcantly to 78.00 [65.00-123.00] cm/sec at 72 hours (p=0.008, electronic supplement Figure 2). 
There were no differences in MAP at any measuring point between survivors and non-survivors 
(p=0.09, data not shown). MFV increased more in non-survivors (from 33.00 [25.00-40.00] to 71.50 
[61.25-96.75] cm/sec) compared to survivors (from 23.50 [20.25-28.25] to 136.00 [136.00-136.00] cm/
sec) in the cardiac arrest group (p<0.001).
Variability in the time domain 
MFV
The CV of MFV after cardiac arrest remained stable with 5.37 [3.38-7.74] on t=0 and 7.49 [4.09-14.97] 
% at 72 hours after admission (p=0.44, data not shown). In survivors the CV of MFV increased from 
4.66 [3.92-6.28] to 7.52 [5.52-15.23] %. In contrast, in non-survivors the CV of MFV decreased from 
9.02 [1.70-9.36] to 1.97 [1.97-1.97] % (Figure 1). The CV of MFV was 7.40 [4.95-12.98] in normal controls 
(Figure 1), and did not differ signiﬁcantly compared to the cardiac arrest group (p=0.14).
MAP
The CV of MAP in the cardiac arrest group was low immediately after admission to the ICU (1.46 
[1.09-2.25]) and remained low at 72 hours (3.05 [1.87-3.63]) (p=0.13, Figure 1). There were no 
differences in CV of MAP between survivors and non-survivors in the cardiac arrest group (p=0.30, 
Figure 1). Normal controls had a signiﬁcantly higher CV of MAP (4.10 [3.23-6.43]) compared to the 
cardiac arrest group on admission (p=0.004, Figure 1). 
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Variability in the frequency domain 
MFV
In the frequency domain, the average spectral power of MFV increased from 0.28 [0.06-0.69] 
to 11.38 [1.58-30.86] (cm/sec)2 between admission and 72 hours after the arrest in the VLF band 
(p=0.008, Figure 2). This increase in spectral power of MFV in the VLF band was due to an increase 
in the favourable outcome group during admission from 0.38 [0.10-0.59] to 15.54 [2.67-31.31] (cm/
sec)2 (p=0.001), whereas VLF spectral power remained low in the patients with an unfavourable 
outcome (0.19 [0.06-1.00] to 1.58 [1.58-1.58] (cm/sec)2 (p=0.23) (Figure 3). There were no changes in 
average spectral power of MFV in the LF and HF bands after admission (respectively p=0.55 and 0.65, 
Figure 2).
The average spectral power of MFV in the VLF band was signiﬁcantly lower in the cardiac arrest 
group on admission compared to the control group (0.28 [0.10-0.69] to 9.01 [4.53-19.71]) (cm/sec)2, 
p=0.002, Figure 3). The average spectral power of MFV did not differ signiﬁcantly between cardiac 
arrest patients on admission and controls in the LF (0.17 [0.11-2.38] to 1.99 [0.47-2.45] (cm/sec)2, 
p=0.21) and HF (0.11 [0.07-0.37] to 0.05 [0.03-0.12] (cm/sec)2, p=0.13) bands. In addition, no differences 
between survivors and non-survivors were found in the LF and HF bands (electronic supplement 
Figure 3). 
MAP
The average spectral power of MAP did not change in the ﬁrst 72 hours after cardiac arrest in the 
VLF (p=0.76), LF (p=0.91), and HF (p=0.14) frequency bands (data not shown). 
The average spectral power of MAP in the VLF frequency band increased in survivors from 0.70 
[0.50-1.93] to 2.10 [1.03-5.54] mmHg2 during admission, while remaining low in non-survivors 0.34 
[0.01-0.47] to 0.68 [0.68-0.68] mmHg2 (p=0.03, Figure 4). 
There were no signiﬁcant differences for average spectral power of MAP en MFV between survivors 
and non-survivors in the LF and HF bands (data not shown).
The average spectral power of MAP was signiﬁcantly lower in the cardiac arrest group on admission 
compared to the control group in the VLF (0.57 [0.27-1.02] to 5.79 [3.59-10.02] mmHg2, p=0.001, Figure 
5), LF (0.37 [0.13-0.67] to 2.6 [1.99-4.68] mmHg2, p<0.001) and HF (0.08 [0.01-0.40] to 0.91 [0.26-2.24] 
mmHg2, p=0.02) bands. 
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Discussion
The spontaneous variability of MFVMCA was low after cardiac arrest. MFV variability returned to 
normal values in survivors whereas variability decreased further in non-survivors after cardiac 
arrest. The variability of the MAP remained low during the entire study period after cardiac arrest. 
The average power in the VLF spectrum of the MFVMCA was low after cardiac arrest and restored 
towards normal values in survivors. The persistently low power in the VLF domain in non-survivors 
suggest perturbations in the intrinsic myogenic vascular function [8]. In normal subjects, the 
correlation between cerebral blood flow velocity and MAP fluctuations is low for frequencies below 
0.1Hz, suggesting that in this frequency range other factors may lead to fluctuations in cerebral 
blood flow velocity [16]. Indeed, in normal volunteers, changes in MFVMCA oscillations in a frequency 
of 0.03-0.15Hz can precede those in blood pressure and heart rate [17]. This suggests that these low 
frequency oscillations have a more central cerebral origin and are transmitted “upstream” to the 
larger cerebral arteries. Probably, these low frequency oscillations arise in the cerebral circulation 
as a result of autonomic (sympathetic) stimulation.  
Cerebral blood flow is tightly regulated at the level of the neurovascular unit through a myriad of 
metabolic, myogenic and autonomic pathways [18]. Cerebral blood flow is decreased after cardiac 
arrest and restores towards normal values in survivors [19]. Non-survivors have a signiﬁcantly 
stronger increase in MFVMCA in the ﬁrst 72 hours after the arrest [20]. Apparently, vasoactive tone 
is lost in patients with poor outcome, resulting in a decrease in cerebral vascular resistance and 
subsequent increase in cerebral blood flow. These observations are in accordance with our current 
study that intrinsic myogenic vascular function and sympathetic autonomic regulation may be 
impaired in non-survivors after cardiac arrest. The importance of the autonomic nervous system in 
regulation of the cerebral blood flow is well documented in humans. Upper thoracic sympathectomy 
in patients with palmar hyperhidrosis resulted in increased blood volume and blood flow velocities in 
the MCA [21]. Trimetaphan (a so-called ganglion blocker, because it blocks the cholinergic synaptic 
transmission in sympathetic and parasympathetic pathways) changes static and dynamic cerebral 
autoregulation in humans, indicating that removal of autonomic neural activity plays an important 
role in the regulation of cerebral blood flow [22].  
Beat to beat changes in cerebral blood flow are under the control of myogenic and autonomic 
mechanisms under normal conditions. Cardiac arrest induces a strong inflammatory response, 
accompanied by changes in NO production and production of reactive oxygen species resulting 
in endothelium-dependent relaxation [23, 24]. An imbalance between local vasoconstrictors and 
vasodilators, characterized by high endothelin levels and initially low but gradually increasing cGMP 
levels is suggested to underlie the cerebral perfusion changes after cardiac arrest [25]. Other factors 
that contribute to this reduced blood flow include a reduction in neuronal activity, vasospasm, 
edema, platelet and leukocyte adhesion and changes in viscosity [25-30]. We hypothesize that these 
pathophysiological changes can contribute to the changes in MFVMCA variability after cardiac arrest 
and influence the state of dynamic autoregulation in these patients. 
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The spontaneous variability in MAP in post- cardiac arrest patients was signiﬁcantly lower compared 
to age- and sex-matched control patients. Similarly, heart rate variability is reduced in both low 
and high frequency power spectra in survivors and non-survivors after cardiac arrest, suggesting 
a decrease in autonomic cardiovascular function, that affects MAP variability in a similar manner 
[31, 32]. The relatively low average spectral power of MAP in the VLF frequency band supports this 
hypothesis of autonomic failure. 
This study has a number of limitations. We performed an observational study in a relatively small 
population. We cannot exclude that in our patients use of medication may have influenced these 
results. In the ﬁrst hours after cardiac arrest, use of sedatives and vasopressive agents were 
common, whereas β-blockers were frequently used after rewarming to normothermia. All patients 
were treated with hypothermia. Hypothermia by itself results in increased heart rate variability in 
both the lower and higher frequency spectra, most likely as a result of the hypothermia induced 
bradycardia [33]. The use of sedatives, vasoactive agents and hypothermia was similar in survivors 
and non-survivors after cardiac arrest. In addition, differences in systemic parameters such as MAP, 
pH or PaCO2 did not account for these differences in MFVMCA and MAP variability (data not shown). 
We cannot exclude other unmeasured effects on cerebral blood flow and the individual patient’s 
autoregulatory threshold is unknown. Although the observational nature of this study did not allow 
modiﬁcation of these possible confounders, the observed pathophysiological differences in cerebral 
blood flow velocity and arterial blood pressure strongly suggest a disease speciﬁc pathophysiologic 
process. 
The changes in spontaneous fluctuations in MFVMCA and MAP suggest changes in dynamic 
autoregulation after cardiac arrest. We did not quantify the strength of the dynamic autoregulation 
in this population. Transfer function analysis is considered the gold standard for the estimation 
of dynamic cerebral autoregulation. Since this technique relies on spontaneous (or induced) 
fluctuations in MFVMCA and MAP, reduced variability in one of both input signals will strongly reduce 
the reliability of the resulting output signal [15]. 
 
Conclusions
Cerebral blood flow is altered after cardiac arrest, with decreased spontaneous fluctuations in 
patients with a poor outcome. Most likely, these changes are the consequence of the associated 
severe brain damage, resulting in impaired intrinsic myogenic vascular function and autonomic 
dysregulation. These perturbations in cerebrovascular regulation may account for the loss of 
vasoactive tone and the increased cerebral blood flow velocity in non-survivors after cardiac arrest. 
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Tables and figures 
table 1      demographic data of cardiac arrest patients and normal controls
characteristics cardiac arrest normal controls p value
Number of patients, n 11 10
Male (n, %) 9 (81%) 8 (80%)
Age (yrs) 57[55-61] 65[31-67] 0.75
Number of survivors, n (%) 7 (64%) 10 (100%) 0.36
table 2      clinical and laboratory data of cardiac arrest patients and normal controls on admission
characteristics cardiac arrest normal controls p value
Mechanical ventilation 11 (100%) 0 (0%)
MAP (mmHg) 91.0[84.5-114.5] 91.1[86.3-105.1] 0.92
Heart rate (bpm) 85.0[80.0-92.0] 69.5[62.5-76.5] 0.09
Temperature (°C) 35.5[34.3-35.9] 37.0[36.8-37.1] 0.006
Norepinephrine
   Dose (µg/kg/min) 
(9.1%)
   0.12
0 (0%)
Milrinone 0 (0%) 0 (0%)
Dobutamine 0 (0%) 0 (0%)
Hemoglobin (g/dL) 14.7[12.9-14.7] 11.6[10.8-12.6] 0.03
pH 7.31[7.26-7.37] 7.45[7.43-7.46] 0.002
PaO2 (mmHg) 102[81-168] 87[78-105] 0.28
PaCO2 (mmHg) 42.0[39.0-43.5] 35.6[34.5-36.8] 0.01
*data represent values upon admission to the ICU
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figure 1a CV of MFV in survivors and non-survivors successfully resuscitated from a cardiac arrest and 
   treated with mild therapeutic hypothermia, during 72 hours of ICU admission and CV of MFV in 
   normal controls
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figure 1b CV of MAP in survivors and non-survivors successfully resuscitated from a cardiac arrest and 
   treated with mild therapeutic hypothermia, during 72 hours of ICU admission and CV of MAP in 
   normal controls
CV MAP  coefficient of variation of mean arterial pressure
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figure  2 the average spectral power of MFV increased, in the whole cardiac arrest group, between admission 
   and 72 hours after the arrest in the VLF band. there was no increase or decrease in the LF and 
  HF bands
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figure 3 spectral power of MFV in the VLF band in survivors and non-survivors successfully resuscitated 
   from a cardiac arrest and treated with mild therapeutic hypothermia, during 72 hours of ICU 
   admission and spectral power of MFV in the VLF band in normal controls
MFV  mean flow velocity
VLF  very low frequency
figure 4 spectral power of MAP in the VLF band in survivors and non-survivors successfully resuscitated 
   from a cardiac arrest and treated with mild therapeutic hypothermia, during 72 hours of ICU 
   admission and spectral power of MAP in the VLF band in normal controls
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Electronic supplement
figure 1  MAP of comatose patients successfully resuscitated from a cardiac arrest and treated with mild 
   therapeutic hypothermia, during 72 hours of ICU admission
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figure 2  MFV of comatose patients successfully resuscitated from a cardiac arrest and treated with 
   mild therapeutic hypothermia, during 72 hours of ICU admission
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figure 3  spectral power of MFV in the LF and HF band in survivors and non-survivors successfully resuscitated 
   from a cardiac arrest and treated with mild therapeutic hypothermia, during 72 hours of ICU 
   admission and spectral power of MFV in the LF and HF band in normal controls
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chapter 5
Influence of induced blood pressure 
variability on the assessment of cerebral 
autoregulation in patients after cardiac 
arrest
Judith M.D. van den Brule
Christiaan R. van Kaam
Johannes G. van der Hoeven
Jurgen A.H.R. Claassen
Cornelia W.E. Hoedemaekers
BioMed Research International, 2018 
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Abstract
Objective
To determine if increasing variability of blood pressure influences determination of cerebral 
autoregulation.
Methods
A prospective observational study was performed at the ICU of an university hospital in the 
Netherlands. 13 comatose patients after cardiac arrest, underwent baseline and intervention (tilting 
of bed) measurements. Mean flow velocity (MFV) in the middle cerebral artery and mean arterial 
pressure (MAP) were measured. Coefﬁcient of variation (CV) was used as a standardized measure of 
dispersion in the time domain. In the frequency domain, coherence, gain and phase were calculated 
in the very low and low frequency bands. 
Results
The CV of MAP was signiﬁcantly higher during intervention compared to baseline. On individual 
level, coherence in the VLF band changed in 5 of 21 measurements from unreliable to reliable and 
in 6 of 21 measurements from reliable to unreliable. In the LF band 1 of 21 measurements changed 
from unreliable to reliable and 3 of 21 measurements from reliable to unreliable. Gain in the VLF and 
LF band was lower during intervention compared to baseline. 
Conclusions
For the ICU setting, more attention should be paid to the exact experimental protocol, since changes 
in experimental settings strongly influence results of estimation of cerebral autoregulation. 
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Introduction
Post-anoxic encephalopathy is a common phenomenon after cardiac arrest and causes high 
mortality and morbidity [1]. Adapting the cerebral blood flow (CBF) to the cerebral metabolic 
demand improves cerebral recovery after cardiac arrest. 
Cerebral autoregulation (CA) describes the process of cerebral vasodilation and vasoconstriction to 
maintain a stable CBF over a wide range of perfusion pressures. This adjustment of CBF to changes 
in cerebral perfusion pressure is directed by central regulation-mechanisms [2, 3] and by a local 
adaptation using myogenic vasoconstriction [4, 5]. In the low frequency band (LF, 0.07-0.2Hz) blood 
pressure variations are provoked by sympathetic modulation of vascular tone [6]. Local vascular 
myogenic changes in blood pressure occur in the LF and very low frequency bands (VLF, 0.02-
0.07Hz) [7]. In the high frequency band (HF, 0.2-0.5Hz) nitric oxide (NO) affects cardiovascular 
variability in animals [8]. Cerebral autoregulation is disturbed in a large proportion of patients after 
cardiac arrest [9, 10]. Disturbed autoregulation in the early phase after cardiac arrest is strongly 
associated with unfavourable outcome [9]. 
After cardiac arrest, the spontaneous variability of arterial pressure is signiﬁcantly lower compared 
to age- and sex-matched control patients [11]. In addition, spontaneous variability in the mean flow 
velocity (MFV) in the middle cerebral artery as measured by transcranial Doppler (TCD) is also 
reduced. MFV variability restores towards normal values in survivors after cardiac arrest, while 
variability continues to decline in patients who do not survive [11]. 
For the estimation of dynamic CA, transfer function analysis (TFA) is considered the gold standard. TFA 
describes the dynamic relationship between blood pressure (input signal) and CBF (output signal). 
This technique relies on spontaneous or induced fluctuations in MFV and mean arterial pressure 
(MAP). Reduced variability in the input signal will strongly reduce the reliability of the resulting 
output signal [12]. Recently, a white paper was published by the Cerebral Autoregulation Research 
Network (CARNet – www.car-net.org) with recommendations to improve the standardization and 
settings for TFA applications in studies of dynamic autoregulation [12]. Because of a lack of evidence 
in this matter, this paper could not formulate a recommendation regarding the minimum variability 
of the input signal that is required for reliable estimation of dynamic autoregulation. As a result, low 
variability may not be regarded as a criterion to reject or at least critically appraise CA data. 
The main objective of our study was to determine if an increase in variability of the blood pressure 
signal influences determination of the state of autoregulation both in the time and frequency 
domain. 
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Materials and methods
Study
A prospective observational study was performed at the intensive care unit (ICU) of a tertiary care 
university hospital in Nijmegen, the Netherlands. 
Population
We studied 13 comatose patients admitted to the ICU after an out-of-hospital cardiac arrest. 
Inclusion criteria were age ≥18 years and a Glasgow Coma Score ≤ 8 after return of spontaneous 
circulation.  Patients were included after written informed consent and approval of the protocol by 
the local Institutional Review Board (document number 2015-1567, 52259.091.15). 
Exclusion criteria were an irregular heart rhythm, no transtemporal bone window, pregnancy, 
thrombolytic therapy, refractory cardiogenic shock, intra aortic balloonpump, a life expectancy ≤ 24 
hours and known carotid artery stenosis, or signs of carotid artery stenosis on physical examination 
or ultrasound.
Patient management
The patients were treated, according to the local protocol as described in a previous manuscript 
[11]. In short, this included mild therapeutic hypothermia 32-34 °C for 24 hours, followed by passive 
rewarming to 37 °C. All patients were sedated and sedation was stopped as soon as the temperature 
reached 36 °C [11]. All patients were intubated and mechanically ventilated to obtain a PaO2 >75 
mmHg and a PaCO2 34-41 mmHg [11]. An arterial catheter was used for monitoring of arterial blood 
pressure (ABP) and sampling of blood. According to this local protocol, MAP was maintained 80-100 
mmHg [11]. 
Data collection
Demographic, pre-hospital and clinical data were collected. MFV in the middle cerebral artery 
was measured by TCD through the temporal window with a 2-Mhz probe (Multi-Dop T Digital, 
Compumedics DWL, Singen, Germany) as described in a previous manuscript [11]. All measurements 
were performed by two investigators (J.B. and C.H.). A 30-minute window of cerebral blood flow 
velocity (CBFV) and ABP was simultaneously recorded on a laptop computer and stored on a hard 
disk with a sample rate of 200 Hz by an A/D converter (NI USB-6211, National Instrument, Austin, 
TX, USA). 
Intervention:
Baseline recordings of continuous ABP and CBFV were performed with the patient at rest, and the 
head of bed elevated at 30 degrees. The intervention consisted of repeated changes in the position of 
the bed from horizontal to maximum 30 degrees Trendelenburg and 30 degrees anti-Trendelenburg 
(period 6 minutes), thereby inducing low frequency blood pressure fluctuations. The blood pressure 
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transducer was attached to the bed at right atrium level and its position changed simultaneously 
with the position of the patient. The patient was moved during 15 seconds from Trendelenburg to 
non-Trendelenburg and remained in this position during 45 seconds. A total of 3 Trendelenburg and 
3 non-Trendelenburg positions were measured during the 6 minutes of testing. Changes were timed 
and recorded. During the measurements, PaO2 and PaCO2 were within normal ranges and stable. 
Measurements were performed on admission to the ICU and at 24, 48 and 72 hours.
Data analysis
CBFV and ABP data were analysed using custom-written MATLAB scripts (Matlab R2014b, The 
MathWorks Inc. Massachusetts, USA), as described in a previous manuscript [11]. From these ABP 
and CBFV signals, 5-minute segments of baseline and intervention data were selected based on the 
least amount of artefacts [11]. MAP and MFV were acquired by ﬁltering ABP and CBFV with a third 
order zero phase-lag Butterworth ﬁlter with a cut-off frequency of 0.5 Hz [11]. By averaging these 
5-minute windows of the MAP and MFV signals, mean values of MAP and MFV were acquired [11]. 
For transfer function analysis, the CARNet TFA MATLAB script was used (available on www.car-net.
org).
To validate our analysis, an external expert (J.C.) went through the analysis step by step to check 
whether this analysis had been performed in agreement with the recommendations in the white 
paper on transfer function analysis of the International Cerebral Autoregulation Research Network 
[12].
Blood pressure variation
Coefﬁcient of variation (CV) was used as a standardized measure of dispersion for both MAP and 
MFV in the time domain. CV was deﬁned as the standard deviation of the signal divided by the 
mean of the signal and was calculated from all ﬁltered signals. This way, the variation is expressed 
in percentage of the mean. 
In the frequency domain, the average spectral power of MAP and MFV were calculated as a measure 
of variation in the very low (VLF, 0.02–0.07 Hz) and low (LF, 0.07–0.2 Hz) frequency bands. 
Cerebral autoregulation
CA was calculated in the time domain and frequency domain. In the time domain, CA was calculated 
by the mean flow velocity index (Mx) as a Pearson’s correlation coefﬁcient between 10-second 
averages of ABP and CBFV over the 5 minute time window [13]. A cut-off value of  0.3 was chosen to 
indicate absence or presence of autoregulation [14].
In the frequency domain, TFA was performed according to the recommendations by the international 
Cerebral Autoregulation Research Network (CARNet) [12]. In short, the 5 minute segments of MFV 
and MAP signals were resampled to 10 Hz. Both auto- and cross-spectra were estimated based on 
Welch’s method using a sliding Hanning window of 100 seconds window length with 50% overlap. 
Spectral smoothing was applied by using a triangular moving average window. Gain and phase 
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were only calculated when coherence was above the critical coherence threshold based on the 95% 
conﬁdence interval. The cut-off value was 0.34. The TFA coherence, gain and phase were calculated 
for the very low (VLF, 0.02-0.07 Hz) and low (LF, 0.07-0.2 Hz) frequency bands.
Statistical analysis 
Statistical analysis was performed using GraphPad Prism version 5.0 (GraphPad Software, La Jolla, 
CA). Data were checked for Gaussian distribution by a Kolmogorov-Smirnov test. Paired, normal 
distributed data were analyzed with a paired t-test and presented as mean with standard deviation. 
Paired, non-Gaussian distributed data were analyzed with a Wilcoxon matched-pairs signed rank 
test and presented as median with 25th and 75th percentile. 
A p-value of <0.05 was considered to indicate signiﬁcance.  
Results
Demographic and clinical data 
We included 13 comatose patients successfully resuscitated after cardiac arrest and treated with 
mild therapeutic hypothermia. The median age was 61 [50-65] years. Twelve patients had ventricular 
ﬁbrillation (VF) or ventricular tachycardia (VT) as initial rhythm, 1 patient initially had a pulseless 
electrical activity (PEA). Four patients died in the ICU, all because of severe post-anoxic brain 
damage. The clinical and laboratory data on admission are summarized in Table 1.
Mean arterial blood pressure variation and mean flow velocity variation in the time domain
Tilting of the bed induced a signiﬁcant increase in CV of MAP from 3.056 ± 1.464 at baseline to 
8.238 ± 2.646 during intervention (p<0.0001) (Figure 1). The CV of MFV after cardiac arrest was also 
signiﬁcantly higher during the intervention (7.571 [6.124-9.176]) compared to baseline (6.090 ± 3.613) 
(p=0.0028) (Figure 1).
Cerebral autoregulation
time domain
On group level, Mx did not change during intervention (0.5669 [0.0132-0.7712]) compared to 
baseline (0.3757 ± 0.4473) (p=0.6776) (Figure 2). On individual level, in 9 of the 21 measurements 
(43%) interpretation of the CA changed during intervention. Five measurements changed from 
intact to impaired CA and 4 measurements changed from impaired to intact CA.
frequency domain
There were no signiﬁcant changes on a group level in coherence between baseline (0.4449 ± 
0.2692) and intervention (0.4313 ± 0.2702) in the VLF band (p=0.8281) (Figure 3). There were also no 
changes in coherence in the LF band between baseline (0.3476 [0.2655-0.6949]) and intervention 
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(0.3043 [0.2361-0.6444]) (p=0.3265) (Figure 4). On an individual level, in the VLF band, 5 of the 21 
measurements changed from unreliable to reliable and 6 of the 21 measurements changed from 
reliable to unreliable. In the LF band 1 of the 21 measurements changed from unreliable to reliable 
and 3 of the 21 measurements changed from reliable to unreliable. 
The gain in the VLF band during intervention (0.5578 ± 0.3046) was lower compared to the gain in 
the VLF baseline (0.7746 ± 0.2579) (p=0.0058) (Figure 5). The gain in the LF band during intervention 
(0.9817 ± 0.4007) was lower compared to the gain in the LF band baseline (1.075 [0.7757-1.405]) 
(p=0.0523) (Figure 6).
There were no changes in phase in the VLF and LF band during intervention (21.29 [11.73-38.64] and 
14.96 [-3.546-27.16] respectively) compared to the phase in baseline position (36.12 ± 31.01 and 12.00 
[0.1032-22.62] respectively) (p=0.4548 and 0.570 respectively) (Figure 7).  
 
Discussion
Ampliﬁcation of blood pressure variability changed the interpretation of CA as measured by Mx and 
TFA. This difference in test results is not related to physiological changes in CA, as both baseline 
and intervention were performed at the same time-point after cardiac arrest. This difference in test 
results is most likely related to bias induced by very low variability in the blood pressure and MFV 
signal at baseline, which renders estimation of CA with these methods unreliable. 
For the estimation of dynamic CA, TFA is considered the gold standard. The white paper on TFA 
methodology provides recommendations on the optimal cut-off values of coherence and parameter 
settings [12]. No recommendations are available for the optimal experimental or clinical protocol. 
High quality of both the ABP and MFV signal are essential for reliable estimation of CA [15]. Poor 
quality of the temporal bone insonation conditions or poor quality of the arterial or MFV signal can 
result in considerable bias of the TFA results. Quality of both signals was adequate in our study, and 
did not explain the intervention induced changes in TFA and Mx in our population. 
The optimal recording time of signals for autoregulation to stabilize is largely unknown. Recording 
time for the autoregulatory index Mx signiﬁcantly influences validity of the measurements. Mx 
calculated on intervals shorter than 6 minutes is at risk for changes due to insufﬁcient stabilization 
of the signal [16] . The Mx data were determined from a 5 minute time window, possibly influencing 
the validity of the Mx. 
The white paper recommends a minimum window length for TFA analysis of at least 100 seconds 
[12]. This is based on the fact that window lengths shorter than 75 seconds resulted in increased 
bias [12]. Recording time of the TFA signals at baseline and during intervention in our study was 
sufﬁciently long to avoid bias related to time restriction.
The extent to which TFA outcomes are influenced by quality of the signals, differs between different 
parameters. In our study, increased variability of signals resulted in decrease in gain in both the 
LF and VLF bands, whereas phase remained stable. This is most likely related to the fact that gain 
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reflects the strength of the autoregulation, which may be changed by increased amplitude of 
the signal. In contrast, phase is related to velocity of dynamic changes in autoregulation. Since 
augmentation of the variability is unlikely to change the timing of the arterial and cerebral pulses, 
phase may remain unchanged during the intervention. 
The use of the coherence function is recommended to identify conditions where estimates of gain 
and phase may not be reliable. The intervention changed the level of coherence from unreliable 
to reliable in a substantial portion of patients, but the reverse (change from reliable to unreliable) 
occurred in a similar proportion of patients. Since the variability was extremely low, the input signal 
may have been too low for adequate determination of TFA coherence at baseline. 
This was supported by visual inspection of the raw data and linking this with individual outcomes of 
TFA. Visual inspection of the raw signals can easily identify whether oscillations in MAP and CBFV 
are present, and whether these oscillations are temporally related. In the few patients who showed 
variability in both MAP and CBFV, the results of TFA appeared reliable, with higher phase values 
in VLF than in LF, and lower gain values in VLF than in LF. In contrast, when TFA was performed in 
patients with low MAP variability, these normal patterns were not observed, even if coherence was 
above the threshold.   
In an earlier study we proved that the spontaneous variability of the MAP remained low during 
the entire study period after cardiac arrest [11]. In the current study we demonstrated a signiﬁcant 
increase in CV of MAP during tilting of the bed compared to the resting position. Previous literature 
showed an improvement of reproducibility of the autoregulation coefﬁcients by inducing blood 
pressure variability due to a sit-to-stand manoeuvre [17, 18]. However, those manoeuvres lead to 
consistent oscillatory changes that enhance reliability, in contrast with bed tilting. 
This study has a number of limitations. We performed an observational study in a relatively small 
population. Tilting of the bed may result in changes in quality of the recorded signal, such as loss 
of signal, motion artefacts, and baseline drifts. Re-analysis of the raw signals however was carefully 
performed by an independent expert (J.C.), using only good quality signals and verifying correct TFA 
settings, but this did not alter the outcome. Changes in the bed position may influence the pressure 
in the veins draining the cerebral venous blood. These changes in venous outflow pressure may 
influence cerebral perfusion and thus the validity of the autoregulation measurements. 
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Conclusions
The white paper on TFA methodology currently provides no recommendations about minimal 
necessary blood pressure variation to perform a reliable TFA. Given the results of this study, 
addition of minimal necessary variation of input signals to the white paper on TFA methodology may 
improve the validity of TFA measurements. For the ICU setting, more attention should be paid to 
the exact experimental protocol, since changes in experimental settings strongly influence results 
of estimation of CA. The optimal level of variation of the signals will be difﬁcult to establish because 
of the lack of golden standards of autoregulation for comparison of the results. Computer modelling 
may be helpful to establish the effects of changes in different parameters on the measurements of 
autoregulation. 
proefschrift_Judith_Brule_final.indd   73 09/11/2018   13:36
526134-L-bw-Brule
Processed on: 12-11-2018 PDF page: 74
74
se
ct
io
n
 i 
ce
re
br
al
 h
em
o
dy
n
am
ic
s 
in
 p
at
ie
n
ts
 a
ft
er
 c
ar
di
ac
 a
rr
es
t
References
1. Neumar, R.W., et al., Post-cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication. 
  A consensus statement from the International Liaison Committee on Resuscitation (American Heart Association, 
 Australian and New Zealand Council on Resuscitation, European Resuscitation Council, Heart and Stroke 
  Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Council of Asia, and the Resuscitation 
  Council of Southern Africa); the American Heart Association Emergency Cardiovascular Care Committee; the 
 Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical 
 Care; the Council on Clinical Cardiology; and the Stroke Council. Circulation, 2008. 118(23): p. 2452-83.
2. Fujii, K., D.D. Heistad, and F.M. Faraci, Vasomotion of basilar arteries in vivo. Am J Physiol, 1990. 258(6 Pt 2): p. 
  H1829-34.
3. Hudetz, A.G., R.J. Roman, and D.R. Harder, Spontaneous flow oscillations in the cerebral cortex during acute 
  changes in mean arterial pressure. J Cereb Blood Flow Metab, 1992. 12(3): p. 491-9.
4. Newell, D.W., et al., The relationship of blood flow velocity fluctuations to intracranial pressure B waves. J 
  Neurosurg, 1992. 76(3): p. 415-21.
5. Zernikow, B., et al., Cerebral autoregulation of preterm neonates--a non-linear control system? Arch Dis Child 
 Fetal Neonatal Ed, 1994. 70(3): p. F166-73.
6. Tzeng, Y.C., et al., Respiratory modulation of cardiovagal baroreflex sensitivity. J Appl Physiol (1985), 2009. 107(3): 
 p. 718-24.
7. Stauss, H.M., Identification of blood pressure control mechanisms by power spectral analysis. Clin Exp Pharmacol 
 Physiol, 2007. 34(4): p. 362-8.
8. Nafz, B., et al., Blood-pressure variability is buffered by nitric oxide. J Auton Nerv Syst, 1996. 57(3): p. 181-3.
9. Ameloot, K., et al., An observational near-infrared spectroscopy study on cerebral autoregulation in post-cardiac 
 arrest patients: time to drop 'one-size-fits-all' hemodynamic targets? Resuscitation, 2015. 90: p. 121-6.
10. Sundgreen, C., et al., Autoregulation of cerebral blood flow in patients resuscitated from cardiac arrest. Stroke, 
 2001. 32(1): p. 128-32.
11. van den Brule, J.M., et al., Low spontaneous variability in cerebral blood flow velocity in non-survivors after cardiac 
  arrest. Resuscitation, 2017. 111: p. 110-115.
12. Claassen, J.A., et al., Transfer function analysis of dynamic cerebral autoregulation: A white paper from the 
  International Cerebral Autoregulation Research Network. J Cereb Blood Flow Metab, 2016. 36(4): p. 665-80.
13. Czosnyka, M., et al., Monitoring of cerebral autoregulation in head-injured patients. Stroke, 1996. 27(10): p. 1829-34.
14. Sorrentino, E., et al., Critical thresholds for transcranial Doppler indices of cerebral autoregulation in traumatic 
  brain injury. Neurocrit Care, 2011. 14(2): p. 188-93.
15. Meel-van den Abeelen, A.S., et al., How measurement artifacts affect cerebral autoregulation outcomes: A 
  technical note on transfer function analysis. Med Eng Phys, 2016. 38(5): p. 490-7.
16. Mahdi, A., et al., At what data length do cerebral autoregulation measures stabilise? Physiol Meas, 2017. 38(7): p. 
 1396-1404.
17. Mahdi, A., et al., Increased blood pressure variability upon standing up improves reproducibility of cerebral 
 autoregulation indices. Med Eng Phys, 2017. 47: p. 151-158.
proefschrift_Judith_Brule_final.indd   74 09/11/2018   13:36
526134-L-bw-Brule
Processed on: 12-11-2018 PDF page: 75
75
in
fl
u
en
ce o
f in
du
ced blo
o
d pressu
re variability o
n
 th
e assessm
en
t o
f cerebral au
to
reg
u
latio
n
 
in
 patien
ts after cardiac arrest
5
18. Smirl, J.D., et al., Methodological comparison of active- and passive-driven oscillations in blood pressure; 
 implications for the assessment of cerebral pressure-flow relationships. J Appl Physiol (1985), 2015. 119(5): p. 487-501.
proefschrift_Judith_Brule_final.indd   75 09/11/2018   13:36
526134-L-bw-Brule
Processed on: 12-11-2018 PDF page: 76
76
se
ct
io
n
 i 
ce
re
br
al
 h
em
o
dy
n
am
ic
s 
in
 p
at
ie
n
ts
 a
ft
er
 c
ar
di
ac
 a
rr
es
t
Tables and figures 
table 1      clinical and laboratory data of cardiac arrest patients on admission
characteristics
Age (years) 61[50-65]
Male (n, %) 12/13 (92%)
Initial rhythm VT/VF (n, %) 12/13 (92%)
Initial rhythm PEA (n, %) 1/13 (8%)
SAPS II 58[42-77]
APACHE II 27[18-30]
pH 7.01[6.94-7.27]
Lactate (mmol/L) 8.5[7.0-13.3]
PaCO2 (mmHg) 7.0[6.2-9.5]
PEA            pulseless electrical activity
VF              ventricular fibrillation
VT              ventricular tachycardia
SAPS II      simplified acute physiology score ii
APACHE II acute physiology and chronic health evaluation ii
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figure 1  CV of MAP and MVF after cardiac arrest in baseline position and during intervention
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CV   coefficient of variation
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MAP mean arterial pressure
MVF mean flow velocity
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figure 2  Mx after cardiac arrest in baseline position and during intervention. 5 of the 21 measurements 
   changed from intact to affected CA and 4 of the 21 measurements changed from affected to intact  
  CA
Mx  mean flow velocity index
M
x
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0.0
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figure 3  coherence in the VLF band. 5 of the 21 measurements changed from unreliable to reliable and 6 of 
   the 21 measurements changed from reliable to unreliable
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figure 4  coherence in the LF band. 1 of the 21 measurements changed from unreliable to reliable and 3 of the 
   21 measurements changed from reliable to unreliable
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figure 5  the gain in the VLF band during intervention was lower compared to the gain in the VLF baseline 
   (p=0.0058)
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figure 6  the gain in the LF band during intervention was lower compared to the gain in the LF band baseline 
   (p=0.0523)
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figure 7  there were no changes in phase in the VLF and LF band during intervention compared to the phase in 
   baseline position (p=0.4548 and 0.570 respectively)
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chapter 6
Cerebral perfusion and cerebral 
autoregulation in sepsis and in  
the human endotoxemia model
Judith M.D. van den Brule
Johannes G. van der Hoeven
Cornelia W.E. Hoedemaekers
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Introduction
Sepsis-associated encephalopathy (SAE) is the most frequent type of encephalopathy in the 
ICU occurring in 30-70% of septic patients [1-3]. It is characterized by diffuse brain dysfunction 
secondary to systemic infection with sterile circulating inflammatory mediators. Recently, Singer et 
al. suggested that also viable bacteria play a role in the pathogenesis of brain dysfunction[4]. The 
sepsis associated inflammatory response induces microglial activation, mitochondrial dysfunction, 
oxidative stress, neuroinflammation, and neuronal apoptosis, resulting in axonal degeneration 
and diffuse brain dysfunction [5-7]. Metabolic disturbances that occur in septic patients such as 
hyperglycemia, hemodynamic failure, hypoxemia, hypercapnia, use of medications and iatrogenic 
and environmental factors may further aggravate the SAE [8]. Clinical presentation of SAE in 
the acute phase may range from mild symptoms such as malaise and concentration deﬁcits to 
disturbances of the sleep–wake cycle, impaired consciousness, cognitive dysfunction, delirium, and 
coma [3]. SAE is associated with increased mortality, higher use of ICU resources, longer hospital 
stay and increased morbidity with long-term cognitive decline [9].
Pathophysiology
Dysregulation of cerebral blood flow (CBF) is a key component in the development of SAE. 
Under normal circumstances, CBF is controlled by pressure autoregulation, flow-metabolism 
coupling and neurogenic regulation [10]. The endothelial cells of the brain microvasculature, 
together with pericytes, the basement membrane, and astrocytes, as well as neurons, microglia 
and oligodendrocytes form the neurovascular unit. The interaction between the components of 
the neurovascular unit is essential for the tight regulation of CBF [11]. This so-called neurovascular 
coupling adapts the local CBF to the metabolic needs of the brain. 
Dysregulation of CBF in SAE is mediated through a combination of mechanisms. In sepsis, cerebral 
endothelial cells are activated by pathogens and inflammatory mediators, resulting in increased 
production of nitric oxide (NO). NO is a key mediator in the vasodilation and hypotension in 
the systemic circulation in sepsis [12]. NO is also a potent cerebral vasodilator that can mediate 
cerebral vasodilation during sepsis [13]. Upregulation of adhesion molecules promotes the adhesion 
of leukocytes to the endothelium, resulting in blood-brain barrier disruption and increased 
permeability leading to perivascular cerebral edema [14, 15]. The increased diapedesis of leukocytes 
and the perivascular edema further decrease the microcirculatory blood flow in the brain capillaries 
in an animal model of sepsis [16]. A MRI study in humans with sepsis and brain dysfunction indicated 
white matter lesions, suggestive of blood-brain barrier breakdown [17]. In contrast, no edema was 
demonstrated in a pathologic study in sepsis patients [18]. Reactive oxygen species reduce the 
deformability of erythrocyte cell membranes. Poorly deformable erytrocytes may be unable to 
enter the brain microcirculation, thus aggravating the cerebral hypoperfusion. 
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Cerebral perfusion and autoregulation in sepsis and the 
human endotoxemia model
Derangements in cerebral perfusion contribute to the pathophysiology of SAE. The experimental 
human endotoxemia model, with administration of  lipopolysaccharide (LPS) is a safe and 
reproducible model of systemic inflammation in humans in vivo, capturing many (hemodynamic) 
hallmarks of early sepsis. Administration of LPS allows for evaluating the consequences of 
endotoxemia on physiological variables[19]. 
We performed a literature search to summarize the current knowledge on cerebral perfusion 
and autoregulation in sepsis and on cerebral autoregulation in the human endotoxemia model. 
We searched the PUBMED database for studies that evaluated cerebral hemodynamic changes in 
patients with sepsis, using the search terms “sepsis” or “lipopolysaccharide” or “human endotoxemia” 
and “cerebral blood flow” or “cerebral perfusion”. In addition, we used the search terms “sepsis” or 
“lipopolysaccharide” or “human endotoxemia” and “autoregulation”. The bibliographical references 
of the retrieved articles were also analyzed and included if relevant. We included: (1) prospective 
studies in which cerebral hemodynamics were evaluated, regardless of the technique; (2) studies 
that included at least 5 patients with sepsis or septic shock according to international standardized 
diagnostic criteria or sublects who received LPS; and (3) studies that were approved by an 
institutional ethics committee. Studies were excluded  in case of: (1) inclusion of patients under 
18 years of age; (2) inclusion of patients with a previous neurological impairment; (3) non-human 
studies; and (4) non-English publications. 
Cerebral perfusion in sepsis
We identiﬁed 14 studies describing cerebral perfusion in sepsis, summarized in table 1 [20-33]. 
Cerebral perfusion was measured using indicator techniques [20, 21, 24], transcranial Doppler (TCD) 
[23-28, 30-33], near infrared spectroscopy (NIRS) [23, 25] and magnetic resonance imaging (MRI) 
[29]. Control groups were included in 7 studies [21, 22, 28-32]. Severity of the sepsis, presence of 
encephalopthy and timing of the perfusion measurements varied between the studies. In addition, 
sedation protocols, mechanical ventilation strategies and PaO2 and PaCO2 targets were inconsistent 
between studies. 
Perfusion measurements based on the 133Xe clearance technique or Kethy Schmidt technique 
indicated a decrease in CBF in 2 studies, whereas no changes in CBF were measured by the 
transcerebral double indicator dilution technique [20, 21, 24]. Most studies (6 of 10 studies) 
using TCD described no changes in cerebral blood flow velocity (CBFV) between septic and non-
septic patients [23-25, 28, 30, 32]. An increase in the pulsatility index (PI) and resistive index (RI) 
characterized 4 of 10 studies using TCD [27, 28, 30, 31]. In general, PI and RI were increased in the 
(early) phases of sepsis, with lower CBFV in patients with higher PI and RI. This suggests that in the 
early phases of sepsis, vasoconstrictive properties of the arterioles may be activated, possibly as a 
result of the autoregulatory response to maintain adequate brain perfusion despite systemic blood 
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pressure changes. One MRI study measured an increase in CBF in sepsis compared to controls [29]. 
Vasoreactivity, induced by changes in mechanical ventilator settings or by infusion of acetazolamide, 
resulted in unchanged, increased and decreased vasoreactivity between studies [20, 24, 26, 30-
32]. Taken together, CBF is heterogeneous in sepsis. Apart from the apparent methodological 
differences, these heterogeneities in flow may also be related to individual differences between 
patients. The level of autoregulation, compensatory adaptations of the microcirculation, changes 
in the inflammatory response or differences in cardiac output may explain the heterogeneities 
between studies.  
Cerebral autoregulation in sepsis
The PUBMED search identiﬁed 12 studies describing cerebral autoregulation in sepsis (table 2) [23, 
25, 29, 34-42]. Cerebral autoregulation has been studied in sepsis with varying results. Cerebral 
perfusion was measured using TCD [23, 25, 34-36, 38-40, 42], NIRS [25, 37, 40, 41] and MRI [29]. 
Studies using TCD determined dynamic cerebral autoregulation by transfer function analysis (TFA), 
cerebral autoregulation index (CAI) or mean flow index (Mx). Studies using NIRS determined 
dynamic cerebral autoregulation by  tissue oxygen reactivity index (TOx). Steiner et al. demonstrated 
good correlation between Mx and TOx (R = 0.81; P < 0.0001) in a group of 23 patients with sepsis, 
severe sepsis, or septic shock [40]. Control groups were included in 3 studies [29, 36, 37]. Severity of 
the sepsis, presence of encephalopthy and timing of the determinination of cerebral autoregulation 
varied between the studies. Besides, sedation protocols, mechanical ventilation strategies and 
PaO2 and PaCO2 targets were inconsistent between studies. 
Static autoregulation describes the relative blood flow changes in response to a steady-state 
change in the blood pressure. Static testing provides a quantitative assessment of autoregulation. 
In contrast, dynamic autoregulation yields information about the latency, as well as the magnitude, 
of the CBF to rapid changes in perfusion pressure. Impairment of dynamic cerebral autoregulation 
renders the brain at risk for intermittent hypo- and hyperperfusion during acute changes in blood 
pressure and contributes to development of SAE. 
Static autoregulation was tested by inducing a blood pressure change of 15-30 mmHg [29, 34, 36]. 
Within this range, static autoregulation was preserved in patients with sepsis. In contrast, dynamic 
cerebral autoregulation was impaired in most studies, especially in the earlier phases of sepsis 
[23, 25, 35, 36, 40-42]. The impairment of dynamic cerebral autoregulation was associated with 
the development of SAE and mortality. Berg et al. determined that static and dynamic cerebral 
autoregulatory performance may dissociate in sepsis; static autoregulation was maintained, whereas 
dynamic autoregulation was impaired with a prolonged response time [36]. 
PaCO2 is one of the main regulators of cerebral hemodynamic function [43] and hyperventilation 
is associated with a reduction in CBF. Several studies have shown that hypercapnia impaires 
dynamic cerebral autoregulation [23, 36, 40, 44-46]. On the other hand, Brassard et al. reported 
a signiﬁcant correlation between dynamic autoregulation and the hyperventilatory response after 
lipopolysaccharide infusion [47]. However, whether changes in PaCO2 act, directly or indirectly, 
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on dynamic cerebral autoregulation remains debated, because ventilation and related changes 
in intrathoracic pressure, rather than PaCO2 per se, could be responsible for changes in dynamic 
cerebral autoregulation [48]. Furthermore, hyperthermia may play a role in changes in dynamic 
autoregulation during inflammation [49].  So, cerebral hemodynamic changes in inflammation can 
be caused by various factors, acting individually, together or in synergy. It is also important to realize 
that all studies do have different measurement methods, patients with various disease severity and 
at a different time in the course of the disease, varying carbon dioxide levels and the duration of 
hypo- or hypercapnia and different ways to induce blood pressure variations.
Cerebral perfusion in the human endotoxemia model
We identiﬁed six studies describing cerebral perfusion in the human endotoxemia model, 
summarized in table 3 [36, 39, 47, 50-52]. Five studies used a model with infusion of 2 ng kg-1 LPS 
and one study [51] used a model with infusion of 4 ng kg-1 LPS. In studies which determined arterial 
blood gasses PaCO2 decreased after LPS infusion [36, 47, 50, 52]
Cerebral perfusion was measured using TCD [36, 39, 47, 50] or indicator techniques [51, 52]. CBFV 
remained equal or was lowered in response to LPS (a reduction of up to 21%) [36, 39, 47, 50-52]. 
Cerebral autoregulation in the human endotoxemia model
The PUBMED search identiﬁed four studies describing cerebral autoregulation in the human 
endotoxemia model, summarized in table 4 [36, 39, 47, 50]. All these studies used the model with 
infusion of 2 ng kg-1 LPS. In studies which determined arterial blood gasses PaCO2 decreased 
after LPS infusion [36, 47, 50]. Cerebral perfusion was measured using TCD and dynamic cerebral 
autoregulation was determined by TFA or by the rate of regulation [36, 39, 47, 50]. These four studies 
determined an enhanced dynamic autoregulation after LPS infusion. More in detail, Berg et al. 
determined that static autoregulation was maintained after LPS (and also in patients with sepsis), 
whereas dynamic autoregulation was enhanced after LPS (and impaired with a prolonged response 
time in patients) [36]. The other three studies only investigated dynamic cerebral autoregulation, 
which was enhanced in all studies [39, 47, 50]. TFA, which was used to determine dynamic cerebral 
autoregulation in three studies showed an increased phase in the low frequency band in all three 
studies [36, 47, 50]. Gain was reduced in two of three studies and was unaffected in one study [36, 47, 
50]. Berg et al. showed an enhanced dynamic autoregulation after LPS during thigh-cuff deflation-
induced changes in MAP for the determination of a modiﬁed rate of regulation [39].
The differences in dynamic cerebral autoregulation between sepsis patients and volunteers 
(enhanced autoregulation in healthy volunteers) may be the result of the difference in duration 
and seriousness of systemic inflammatory response, to the different levels of ventilation and to 
different levels of hyperthermia. 
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Conclusion
Derangements in cerebral perfusion, vasoreactivity and cerebral autoregulation occur frequently 
in sepsis. The exact effects of sepsis on the macro- and microcirculation in humans are difﬁcult to 
establish, due to the large heterogeneity of the disease. Insight in the effects of sepsis on cerebral 
autoregulation is important for the development of brain-protective strategies. 
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Tables 
table 1       summary of 14 studies about cerebral perfusion in sepsis
study
number of 
patients
measurement of 
CBF
timing main results sedation PaCO2
Bowton [20] 9 septic patients 
with SAE, 
no controls
133Xe clearance 
technique
- Decreased CBF; 
Intact CO2 
reactivity
No sedation <24h;
Mathematic 
correction of 
CBF results to 
PaCO2 40 torr
Maekawa [21] 6 septic patients 
with MOF, 
13 historical 
control patients
Kety-Schmidt 2-10 days after 
initial diagnosis
Decreased CBF 
and CMRO2
MV to 
normocapnia;
No sedation <24h
Smith [22] 15 patients with 
septic shock,
9 control patients 
with  hypovolemic 
or cardiogenic 
shock
Doppler 
ultrasound 
common carotid 
artery
12-48h after 
onset shock
Decreased CBF 
sepsis (not 
signiﬁcant);
Carotid flow 
proportional to 
cardiac index
No association 
between MAP, 
PaCO2, PaO2 
and mean 
carotid blood 
flow
Pﬁster [23] 16 septic patients 
with/without 
delirium
TCD and NIRS 6-48h after ICU 
admission 
No differences 
between sepsis 
and sepsis with 
SAE
Sedation;
No differences 
in PaCO2 
between groups
Thees [24] 10 septic patients TCD and 
transcerebral  
double-indicator 
dilution methods
>48h after 
diagnosis
Intact CO2 
reactivity, 
normal cerebral 
haemodynamics
Ramsay sedation 
score 3
Terborg [25] 8 patients during 
and outside 
severe sepsis and 
septic shock
TCD and NIRS - Similar CBFV 
(normalized 
for PaCO2 
differences)
Sedation
Bowie [26] 12 septic patients TCD >24h 7 decreased, 
2 increased CO2 
reactivity
Sedation
CBF cerebral blood flow; CBFV cerebral blood flow velocity; MAP mean arterial pressure; MOF multi organ 
failure; MRI magnetic resonance imaging; MV mechanical ventilation; NIRS near infrared spectroscopy; PI 
pulsatility index; RI resistive index; SAE sepsis-associated encephalopathy; TCD transcranial Doppler
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table 1       summary of 14 studies about cerebral perfusion in sepsis
study
number of 
patients
measurement of 
CBF
timing main results sedation PaCO2
Pierrakos [27] 40 septic patients 
with/without 
delirium
TCD Day 1 and 3 after 
sepsis
Increased PI in 
patients with 
encephalopathy; 
Decreased CBFV 
in patients with 
increased PI
Pierrakos [28] 20 septic patients, 
20 ICU patients 
without sepsis
TCD 24-48 hrs after 
admission
No differences in 
CBFV between 
sepsis and non-
sepsis;
Increased PI and 
RI in sepsis
Septic patients 
higher PaCO2 
compared to 
control;
Sedation
Masse [29] 10 septic patients 
(2 different blood 
pressure targets), 
12 control patients 
(sedated and non-
sedated)
MRI 0-3 days after 
ICU admission
Increase in 
CBF in sepsis 
compared to 
controls
All sepsis 
patients under 
sedation
Fulesdi [30] 16 patients with 
sepsis and severe 
sepsis, 
16 non-septic 
controls
TCD <24h No difference in 
CBFV between 
sepsis and non-
sepsis;
PI higher in 
sepsis;
Similar reaction 
to acetazolamide
Lower PaCO2 in 
sepsis compared 
to controls
CBF cerebral blood flow; CBFV cerebral blood flow velocity; MAP mean arterial pressure; MOF multi organ 
failure; MRI magnetic resonance imaging; MV mechanical ventilation; NIRS near infrared spectroscopy; PI 
pulsatility index; RI resistive index; SAE sepsis-associated encephalopathy; TCD transcranial Doppler
proefschrift_Judith_Brule_final.indd   95 09/11/2018   13:36
526134-L-bw-Brule
Processed on: 12-11-2018 PDF page: 96
96 
se
ct
io
n
 ii
 c
er
eb
ra
l 
h
em
o
dy
n
am
ic
s 
in
 p
at
ie
n
ts
 w
it
h
 s
ep
si
s 
an
d 
in
 t
h
e 
h
um
an
 e
n
do
to
xe
m
ia
 m
o
de
l
table 1       summary of 14 studies about cerebral perfusion in sepsis
study
number of 
patients
measurement of 
CBF
timing main results sedation PaCO2
Szatmari [31] 14 patients with 
sepsis and SAE,
20 controls
TCD - Lower CBFV in 
sepsis;
Increased PI in 
sepsis; 
Impaired 
cerebrovascular 
reactivity to 
acetazolamide in 
sepsis
No mechanical 
ventilation;
(No 
hemodynamic 
instability, 
hemodynamic 
support or 
hypoperfusion)
Kadoi [32] 20 patients with 
septic shock,
20 control 
patients
TCD <72h after 
diagnosis shock
CBFV similar;
PI similar in 
sepsis and 
controls;
Reduced CO2 
reactivity in 
sepsis
Both controls 
and sepsis 
randomized 
to dexmed or 
propofol
Straver [33] 20 patients with 
septic shock
TCD Increased CBFV 
with increasing 
systemic 
vasoparalysis
CBF cerebral blood flow; CBFV cerebral blood flow velocity; MAP mean arterial pressure; MOF multi organ 
failure; MRI magnetic resonance imaging; MV mechanical ventilation; NIRS near infrared spectroscopy; PI 
pulsatility index; RI resistive index; SAE sepsis-associated encephalopathy; TCD transcranial Doppler
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table 2      summary of 12 studies about cerebral autoregulation in sepsis
study number of 
patients
measurement of 
CBF 
autoregulation
timing main results sedation PaCO2
Masse [29] 10 septic patients 
(2 different blood 
pressure targets), 
12 control patients 
(sedated and non-
sedated)
MRI
SA
0-3 days after 
ICU admission
No effect 15 
mmHg MAP 
increase on CBF 
All sepsis 
patients under 
sedation
Matta [34] 10 septic patients TCD
SA
<24h after ICU 
admission
No effect 23 
mmHg MAP 
increase on CBF;
Intact vasomotor 
reactivity
All sepsis 
patients under 
sedation;
Stable PaCO2
Schramm [35] 30 patients with 
severe sepsis or 
septic shock
TCD
dAR: Mx
<24h after 
diagnosis
dAR impaired at 
day 1 in 60%, day 
2 in 59%, day 3 in 
41% and day 4 in 
46% of patients; 
Impaired AR was 
associated with 
SAE
Berg [36] 16 patients severe 
sepsis or septic 
shock, 9 healthy 
controls
TCD
SA
dAR: TFA
0-72h after 
diagnosis
No effect 25-30 
mmHg MAP 
increase on CBF; 
Similar gain but 
lower phase
Sedation
Terborg [25] 8 patients during 
and outside 
severe sepsis and 
septic shock
TCD and NIRS - Decreased CO2 
reactivity
Sedation during 
sepsis
Pﬁster [23] 16 septic patients 
with/without 
delirium
TCD 
dAR: Mx
6-48h after ICU 
admission 
Higher Mx in 
patients with 
delirium and 
sepsis
Sedation;
No differences 
in PaCO2 
between groups
AR autoregulation; CAI cerebral autoregulation index; CBF cerebral blood flow; dAR dynamic autoregulation; 
MAP mean arterial pressure; MRI magnetic resonance imaging; Mx mean flow index; NIRS near infrared 
spectroscopy; SA static autoregulation; TCD transcranial Doppler; TFA transfer function analysis; TOx tissue 
oxygen reactivity index
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table 2      summary of 12 studies about cerebral autoregulation in sepsis
study number of 
patients
measurement of 
CBF 
autoregulation
timing main results sedation PaCO2
Vasko [37]
(abstract)
15 patients severe 
sepsis, 10 healthy 
controls
NIRS
Vasoreactivity 
testing with 
acetazolamide
No differences 
between patients 
and controls
Berg [38] 7 patients with 
severe sepsis or 
septic shock
TCD
Vasoreactivity
dAR: TFA
<7h after 
diagnosis
Intact 
vasoreactivity 
to changes in 
PaCO2; dAR no 
change during 
hyperventilation
Berg [39] 6 sepsis patients TCD
dAR: Rate of 
regulation, thigh-
cuff deflation
<72h after 
diagnosis
Results 
inconclusive
Steiner [40] 23 patients sepsis, 
severe sepsis or 
septic shock
TCD: dAR: Mx
NIRS: dAR: TOx
Mx related to 
TOx
Bindra [41]
(abstract)
28 patients with 
septic shock
NIRS
dAR: TOx
<72h after ICU 
admission
TOx higher in 
non-survivors 
compared to 
survivors
Taccone [42] 21 patients with 
septic shock
TCD
dAR: CAI
<72h after 
diagnosis
AR impaired 
in majority of 
patients with 
septic shock, 
especially in 
presence of 
hypercapnia
AR autoregulation; CAI cerebral autoregulation index; CBF cerebral blood flow; dAR dynamic autoregulation; 
MAP mean arterial pressure; MRI magnetic resonance imaging; Mx mean flow index; NIRS near infrared 
spectroscopy; SA static autoregulation; TCD transcranial Doppler; TFA transfer function analysis; TOx tissue 
oxygen reactivity index
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table 3      summary of  six studies about cerebral perfusion in the human endotoxemia model
study number of 
patients
measurement of 
CBF 
timing main results sedation PaCO2
Berg [36] 16 patients severe 
sepsis or septic 
shock, 
9 healthy controls
TCD CBFV decreased PaCO2 
decreased
Brassard [47] 10 healthy 
subjects
TCD CBFV decreased PaCO2 
decreased
Berg [50] 10 healthy 
volunteers
TCD CBFV unchanged PaCO2 lower, no 
hypocapnia
Berg [39] 6 sepsis patients,
9 healthy 
volunteers
TCD CBFV decreased
Moller [52] 8 volunteers Kety-Schmidt CBF decreased Hypocapnia
Pollard [51] 10 volunteers Kety-Schmidt CBF unchanged
CBF cerebral blood flow; CBFV cerebral blood flow velocity; TCD transcranial Doppler
table 4     summary of  four studies about cerebral autoregulation in the human endotoxemia model
study number of 
patients
Measurement 
of CBF/
autoregulation
timing main results sedation PaCO2
Berg [36] 16 patients severe 
sepsis or septic 
shock, 9 healthy 
controls
TCD
SA
dAR: TFA
Decreased gain 
and increased 
phase
PaCO2 
decreased
Brassard [47] 10 healthy 
subjects
TCD
dAR: TFA
Reduced gain 
and increased 
phase
PaCO2 
decreased
Berg [50] 10 healthy 
volunteers
TCD
dAR: TFA
Gain unaffected; 
Increased phase
PaCO2 lower, no 
hypocapnia
Berg [39] 6 sepsis patients,
9 healthy 
volunteers
TCD
dAR: Rate of 
regulation, thigh-
cuff deflation
Faster rate of 
regulation
dAR dynamic autoregulation; SA static auitoregulation; TCD transcranial Doppler; TFA transfer function 
analysis
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Abstract
Objective
To investigate the influence of systemic inflammation on dynamic cerebral autoregulation and 
vascular tone during experimental human endotoxemia and sepsis. 
Methods
Healthy volunteers received 3 hours continuous infusion of LPS (c-LPS, 4 ng/kg, n=11) or a bolus of 
LPS (b-LPS, 2 ng/kg, n=8) and 10 sepsis patients were studied. Mean arterial pressure (MAP) and 
cerebral blood flow velocity (CBFV) were monitored simultaneously. Cerebral autoregulation was 
analysed by transfer function analysis (TFA). Critical closing pressure (CrCP) was estimated as a 
measure of cerebral vascular tone.
Results
c-LPS resulted in a more pronounced and prolonged plasma cytokine response compared with 
b-LPS. MAP decreased from 89±3 to 75±2 mmHg (p<0.05) and from 91±2 to 77±3 mmHg (p<0.001) 
in the c-LPS and b-LPS groups, respectively. MAP in sepsis patients was 65±4 mmHg. TFA in both 
LPS groups showed no signiﬁcant changes over time in coherence, gain and phase. Phase in sepsis 
patients was lower compared with both LPS groups (7 [2-33] in sepsis versus 57 [36-74] degrees in 
the c-LPS group (p=0.02) and 53 [43-64] degrees in the b-LPS group (p=0.01)). CrCP decreased from 
49±2 to 41±2 mmHg (p=0.16) in the c-LPS group and from 50±2 to 42±2 mmHg in the b-LPS group 
(p<0.01), and was 36±2 mmHg in sepsis patients. 
Conclusions
Dynamic cerebral autoregulation is impaired in sepsis patients, but remains intact during 
experimental human endotoxemia. CrCP decreased during endotoxemia and was low in sepsis 
patients, reflecting decreased vascular tone. This indicates the activation of a cerebrovascular 
adaptive process, also during experimental endotoxemia with intact cerebral autoregulation. 
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Introduction
Sepsis is deﬁned as life-threatening organ dysfunction caused by a dysregulated host response to 
infection [1]. The brain is frequently affected in sepsis and sepsis-associated encephalopathy (SAE) 
is associated with increased mortality, prolonged hospital stay and long-term cognitive decline [2]. 
The pathophysiology of SAE is multifactorial, and includes diffuse neuroinflammation, abnormalities 
in cerebral perfusion, and excitotoxicity [2]. 
Cerebral autoregulation is the mechanism that ensures a constant cerebral blood flow (CBF) despite 
alterations in arterial blood pressure (ABP). Under healthy circumstances, CBF is characterized by 
rapid spontaneous fluctuations, in order to maintain cerebrovascular homeostasis. However, this 
so-called dynamic cerebral autoregulation is frequently impaired in sepsis, especially in the earlier 
phases [3, 4]. A disturbed cerebral autoregulation may represent an important mechanism in the 
pathophysiology of SAE, rendering the brain more vulnerable to changes in perfusion pressure [4]. 
The most frequently used method to quantify dynamic cerebral autoregulation is transfer function 
analysis (TFA), with the calculation of coherence, gain and phase [5]. TFA uses beat-to-beat blood 
pressure variation as input signal [5]. The coherence function tests the linearity of the relation 
between input and output. The gain quantiﬁes the damping effect between the input and output of 
the transfer function. The phase shift of a waveform represents the displacement of this waveform 
relative to another waveform with the same period. Gain and phase are the parameters from which 
dynamic cerebral autoregulation can be determined [5].
In addition to dynamic autoregulation, the critical closing pressure (CrCP) is another frequently 
used tool in cerebral vascular research. CrCP is deﬁned as the lower limit of ABP below which 
vessels collapse and flow ceases [6]. CrCP allows estimation of changes in cerebrovascular tone and 
minimal cerebral perfusion pressure to prevent collapse of vessels and ischemia [6].
The experimental human endotoxemia model is a highly standardized and controlled model of 
systemic inflammation induced by intravenous administration of lipopolysaccharide (LPS) in 
healthy volunteers that captures many hallmarks of sepsis [7]. Previous work has demonstrated 
that administration of 2 ng/kg LPS results in an improved dynamic autoregulation [3, 8-10]. These 
effects differ from those observed in sepsis patients, in whom dynamic autoregulation is impaired 
in the early phase and restores later on [3, 4, 11-17]. The observed differences between the human 
endotoxemia model and sepsis may be related to the use of a relatively low LPS dose or the fact 
that LPS is administrated as a single bolus, whereas sepsis patients are exposed to micro-organisms 
and their toxins for a more sustained period. We previously showed that  endotoxemia induced by 
continuous infusion of LPS at a total dose of 4 ng/kg results in a signiﬁcantly more pronounced and 
prolonged inflammatory response compared to bolus administration of 2 ng/kg LPS, which may 
better recapitulate the response observed in septic patients [18]. Therefore, continuous infusion of 
LPS may also result in a cerebrovascular proﬁle that better resembles the situation in sepsis. This 
would enable the use of such a “continuous human endotoxemia model” for investigation of new 
therapies aimed at maintaining cerebrovascular homeostasis in sepsis.
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In the present study, we investigated dynamic cerebral autoregulation and CrCP in healthy 
volunteers following continuous or bolus administration of LPS, and compared these responses to 
those observed in sepsis patients. 
 
Methods
Study design, setting, subjects and patients
We performed a prospective observational study in healthy male volunteers during experimental 
endotoxemia induced by 2 different dosing regimens, and an observational study in sepsis 
patients. Data were obtained from a total of 19 healthy, non-smoking, male volunteers, aged 18 to 
35 years, 11 of whom were included in a human endotoxemia study employing continuous infusion 
of LPS (Clinicaltrials.gov NCT02922673), and 8 of whom were included in a human endotoxemia 
study employing single bolus administration of LPS (Clinicaltrials.gov NCT02675868). All subjects 
provided written informed consent and experiments were in accordance with the Declaration 
of Helsinki and Good Clinical Practice guidelines, and approved by the local ethics committee 
(document numbers NL57410.091.16 and NL53411.091.15). Subjects were screened prior to inclusion, 
and had a normal physical examination, electrocardiography and routine laboratory values. Also, 
10 patients with septic shock, older than 18 years, were included. The local Institutional Review 
Board waived the need for informed consent for these sepsis patients. Septic shock was deﬁned 
by the international sepsis deﬁnition conference [19]. Sepsis patients were treated according to 
international management guidelines [20]. All sepsis patients were sedated and mechanically 
ventilated to normocapnia. Patients with an irregular heart rhythm or an insufﬁcient transtemporal 
bone window were not included.
Experimental human endotoxemia
Puriﬁed LPS (continuous infusion study: Escherichia coli O:113, Lot no. 94332B4, List Biological 
Laboratories, Campbell, USA; bolus administration study: US Standard Reference Endotoxin 
Escherichia coli O:113, Pharmaceutical Development Section of the National Institutes of Health, 
Bethesda, USA) was supplied as a lyophilized powder and dissolved in normal saline 0.9% as 
described previously [21, 22]. For the continuous infusion study (c-LPS), a total of 4 ng/kg LPS 
was administered as a intravenous loading bolus of 1 ng/kg body weight at T=0, followed by an 
intravenous infusion of 1 ng/kg/h for a period of 3 hours [22]. For the bolus administration study 
(b-LPS), LPS was administered as an intravenous bolus injection at a dose of 2 ng/kg body weight 
in 1 min at T=0 [21].
All subjects received 1.5 L of 2.5% glucose/0.45% saline solution in the hour before initiation of LPS 
administration, followed by 150 mL/h during the ﬁrst 6 hours after LPS administration and 75 mL/h 
until the end of the experiment. 
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Data collection
ABP, heart rate and temperature were monitored during the entire experiment. ABP was measured 
using a 20 gauge arterial catheter (Angiomat, Deseret Medical, Becton Dickinson, Sandy UT, 
U.S.A.) connected to an arterial pressure monitoring line (Edwards Lifesciences LLC, Irvine CA, 
USA connected to a Philips Intellivue MP70 monitor). For determination of plasma levels of IL-
6, IL-8, IL-10 and TNFα, ethylenediaminetetraacetic (EDTA)-anticoagulated blood was centrifuged 
immediately after withdrawal (2000g, 10 min, 4 oC) after which plasma was stored at -80 oC 
until analysis by a multiplex Luminex assay (Milliplex, Billerica, USA). Heart rate was continuously 
monitored using a 3-lead ECG. The temperature was determined every 30 minutes using an infrared 
tympanic thermometer (Sherwood Medical, ’s-Hertogenbosch, the Netherlands).
Cerebral blood flow velocity (CBFV) in the middle cerebral artery (MCA) was measured using 
transcranial Doppler (TCD) through the temporal window with a 2-Mhz probe (Multi-Dop T Digital, 
Compumedics DWL, Singen, Germany) according to the method developed by Aaslid et al. [23]. All 
recordings were made in supine position with the head elevated 30°.
A minimum of 10-12 minute windows of ABP and CBFV were simultaneously recorded on a laptop 
computer and stored on a hard disk with a sample rate of 200 Hz by an A/D converter (NI USB-6211, 
National Instrument, Austin, TX, USA). Recordings were performed at 60 minutes before (baseline, 
T=BL), and at 150, 300 and 420 minutes after initiation of LPS administration in the c-LPS group 
and at 90 minutes before (baseline, T=BL), and at 90, 210 and 270 minutes after LPS administration 
in the b-LPS group. Data from sepsis patients were obtained once, under stable hemodynamic 
(normotensive) and respiratory (normocapnic) conditions. 
Some clinical data (ABP, heart rate, temperature), CBFV and CrCP of the 8 endotoxemia subjects 
who received a bolus administration of LPS and of the 10 sepsis patients were previously reported 
[24].
Data analysis
Analysis of ABP and CBFV was performed using a custom-written MATLAB script (Matlab R2014b, 
The MathWorks Inc. Massachusetts, USA). Mean ABP (MAP) and mean flow velocity (MFV) were 
obtained ﬁltering ABP and CBFV with a 3th order low-pass Butterworth ﬁlter. Raw and mean data 
underwent visual inspection and artifact free segments of 5 minutes were selected for subsequent 
analysis.
Cerebral autoregulation
Dynamic autoregulation was determined by transfer function analysis (TFA) and performed 
according to the recommendations of the international Cerebral Autoregulation Research Network 
(CARNet) to asses cerebral autoregulation in the frequency domain using artifact free segments of 
5 minutes [5]. The 5 minute segments were resampled to 10 Hz after which auto- and cross-spectra 
were estimated based on Welch’s method using a sliding Hanning window of 100 seconds window 
length with 50% overlap. Spectral smoothing was applied by using a triangular moving average 
proefschrift_Judith_Brule_final.indd   105 09/11/2018   13:36
526134-L-bw-Brule
Processed on: 12-11-2018 PDF page: 106
106 
se
ct
io
n
 ii
 c
er
eb
ra
l 
h
em
o
dy
n
am
ic
s 
in
 p
at
ie
n
ts
 w
it
h
 s
ep
si
s 
an
d 
in
 t
h
e 
h
um
an
 e
n
do
to
xe
m
ia
 m
o
de
l
window. Gain and phase were only calculated when coherence was above the critical coherence 
threshold based on the 95% conﬁdence interval. The cut-off value was 0.34. The TFA coherence, gain 
and phase were calculated for the very low (VLF, 0.02-0.07 Hz) and low (LF, 0.07-0.2 Hz) frequency 
bands. In addition, the average spectral power of MAP and MFV were calculated in the VLF and LF 
frequency bands in order to see whether the variation can be designated to a certain frequency 
band and whether this origin of variation changes over time in the patients [5]. 
Critical Closing Pressure 
CrCP was estimated according to the method by Varsos et al. [25, 26]. 
CrCP = ABP -
With CVR cerebrovascular resistance, Ca compliance of the cerebral vascular bed and HR heart 
rate. Cerebral perfusion pressure (CPP) is deﬁned as ABP – ICP, however in this study ICP was not 
measured. Therefore mean ABP was used as an approximation of CPP, as previously described [26]. 
CVR was calculated by dividing ABPmean by mean flow velocity (MFV). To determine Ca, cerebral 
arterial blood volume (CABV) was calculated by integrating the MFV signal over time. Then Ca was 
calculated by dividing the amplitude of the ﬁrst harmonic of CABV by the amplitude of the ﬁrst 
harmonic of ABP. HR was deﬁned as the ﬁrst harmonic frequency of ABP.
Calculations and statistical analysis
Statistical analysis was performed using GraphPad Prism version 5.0 (GraphPad Software, La Jolla, 
CA). Data are presented as mean±SD, mean±SEM, or median [interquartile range], according to 
their distribution (determined by Kolmogorov-Smirnov tests). According to the distribution of the 
data, within-group changes over time were analyzed with repeated measures ANOVA or Friedman 
tests followed by Dunnet’s or Dunn’s post-hoc tests. Mann Whitney U-tests were used for between-
group comparisons. A p-value of <0.05 was considered statistically signiﬁcant. 
 
Results
Baseline characteristics and LPS-induced inflammatory response parameters
Baseline characteristics of the healthy volunteers participating in the experimental human 
endotoxemia studies and sepsis patients are presented in Table 1. SAPS 2 score in sepsis patients 
was 55 [49-77], and the APACHE 2 score was 25 [18-29]. All patients in the sepsis population received 
norepinephrine (median dose 0.3 [0.2-0.5] µg/kg/min). 
Subjects of the c-LPS group displayed a more pronounced and prolonged plasma cytokine response 
CPP
√(CVR·Ca·HR·2π)²+1
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compared to subjects of the b-LPS group, with higher peak levels of IL-6, IL-8, IL-10, and TNFα (Figure 1). 
Hemodynamic data
MAP in the c-LPS group was 89±3 mmHg before initiation of LPS infusion (baseline, T=BL) and 
decreased to 75±2 mmHg at T=420min (p<0.05, Figure 2A). MAP in the b-LPS group was 91±2 mmHg 
before LPS administration (T=BL) and decreased to 77±3 mmHg at T=210min (p<0.001, Figure 2A). 
MAP in sepsis patients was lower than the lowest MAPs observed in both LPS groups (65±4 mmHg, 
p<0.05, Figure 2A). CBFV before LPS infusion was 60±4 cm/s in the c-LPS group and 72±4 cm/s in 
the b-LPS group (Figure 2B). In both LPS groups, CBFV did not change signiﬁcantly following LPS 
administration (Figure 2B). Furthermore, CBFV in sepsis patients was comparable to that observed 
in healthy volunteers (57±6 cm/s, Figure 2B). 
In the frequency domain, neither continuous infusion nor bolus administration of LPS resulted in 
changes in coherence, gain and phase in the VLF and LF bands over time (Figure 3A-C, LF band data 
not shown). VLF coherence in sepsis patients was comparable to the coherence observed in healthy 
volunteers (0.5±0.1 in sepsis patients compared to 0.4±0.04 in the c-LPS group at baseline and 
0.4±0.1 in the b-LPS group at baseline, Figure 3A). VLF gain in sepsis patients was higher compared 
to VLF gain at baseline and T=150 in the c-LPS group (1.0±0.1 cm.s-1.mmHg-1 compared to 0.7±0.1 
[p=0.04] and 0.7±0.1 [p=0.04], respectively, Figure 3B), but not signiﬁcantly different from VLF gain 
measured at any of the time points in the b-LPS group (Figure 3B). VLF phase in sepsis patients was 
signiﬁcantly lower compared to both LPS groups at all timepoints (7 [2-33] degrees, p<0.05, Figure 
3C). 
No statistical differences were observed in VLF spectral power of MAP of the c-LPS or b-LPS group 
over time (data not shown). 
CrCP decreased in the c-LPS group from 49±2 at baseline to 41±2 mmHg at T=420 (p=0.16) and in 
the b-LPS group from 50±2 at baseline to 42±2 mmHg at T=210 (p<0.01, Figure 4A). Sepsis patients 
displayed a lower CrCP compared to both LPS groups at all timepoints (36±2 mmHg, p<0.05, Figure 
4A).
No differences in CVR were observed in the c-LPS group over time (Figure 4B). In the b-LPS group, 
CVR decreased from 1.3±0.1 mmHg.sec/cm at baseline to 1.1±0.1 mmHg.sec/cm at T=210 (p<0.05, 
Figure 4B). CVR in sepsis was 1.2±0.1 mmHg.sec/cm (Figure 4B), comparable to that observed in 
healthy volunteers after bolus administration of LPS.
There were no correlations between plasma cytokine levels and phase in the VLF band or CrCP (data 
not shown). 
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Discussion
Herein, we demonstrate that, although lower blood pressure is observed both during human 
endotoxemia and sepsis, dynamic cerebral autoregulation remains unchanged during endotoxemia, 
but is impaired in sepsis. Furthermore, CrCP decreases upon administration of LPS and is low in 
sepsis, indicating changes in cerebrovascular tone with a decreased lower limit of ABP below which 
vessels collapse and flow ceases. 
Dynamic cerebral autoregulation serves to maintain a stable CBF by dampening the effects of 
changes in perfusion pressure through cerebral arteriolar vasodilatation and vasoconstriction. 
Dynamic cerebral autoregulation is disturbed in sepsis and associated with the development of 
SAE and mortality [3, 4]. In our sepsis patients this was exempliﬁed by a lower VLF phase than 
found in any of our LPS groups. In our experiments however, continuous LPS infusion or bolus 
LPS administration did not change dynamic cerebral autoregulation. CrCP did decrease during 
experimental endotoxemia, indicating a decreased vascular tone. Taken together, these results 
indicate that despite a lower blood pressure and decreased vascular tone as signs of a vasodilatory 
status, cerebral autoregulation remains intact in the human endotoxemia model. In constrast, in 
septic shock patients, cerebral autoregulation is impaired, likely due to an exhausted compensatory 
cardiovascular mechanism. 
Human endotoxemia is frequently used as a model to study the cerebrovascular effects of sepsis. 
Previously, administration of 2 ng/kg of LPS was shown to result in an increased phase difference 
as determined by TFA [3, 8, 9]. Two studies infused 2 ng/kg LPS over a 4 hr period  [3, 8]. The third 
study  administered the same dose as a bolus [9]. The increased phase implies a more swift response 
of the cerebrovascular bed to perfusion changes. This enhanced dynamic cerebral autoregulation is 
considered to reflect the hemodynamic changes in the earlier phases of sepsis [3, 27, 28]. We propose 
that administration of 2 ng/kg LPS (as bolus or continuous infusion) is an inadequate stimulus to 
induce the sepsis-related cerebrovascular changes, because dynamic cerebral autoregulation does 
not deteriorate as in sepsis patients.
Continuous infusion of 4 ng/kg LPS over three hours resulted in a signiﬁcant decrease in MAP and 
induced a more pronounced inflammatory response compared to 2 ng/kg LPS bolus administration, 
as also previously described [18]. Still, dynamic cerebral autoregulation remained unaffected. This 
stable cerebral autoregulatory response in our experiment may be related to the liberal infusion 
strategy with considerable volumes of fluid infused as prehydration prior to LPS administration 
and relatively high infusion rates during the endotoxemia experiment, thus preventing extensive 
fluctuations of perfusion pressure and cardiac output. This volume infusion is part of our standard 
endotoxemia protocol to prevent vasovagal reactions [22]. Studies reporting enhanced dynamic 
cerebral autoregulation used a more conservative infusion regimen, with no additional fluid 
infusion prior to and during the entire experiment, versus approximately 2.5 L fluid infusion in our 
experiments (Berg, personal communication). 
In our sepsis patients, the VLF phase was signiﬁcantly lower, but the gain was not different compared 
proefschrift_Judith_Brule_final.indd   108 09/11/2018   13:36
526134-L-bw-Brule
Processed on: 12-11-2018 PDF page: 109
109
dyn
am
ic cerebral au
to
reg
u
latio
n
 an
d critical clo
sin
g
 pressu
re 
in
 experim
en
tal h
um
an
 en
do
to
xem
ia an
d sepsis patien
ts
7
to healthy volunteers before and during endotoxemia. This is consistent with previous reports that 
the response of the cerebrovascular bed is slower in sepsis, but the magnitude of change is not 
affected [3, 4, 14, 16, 17, 29, 30]. A disturbed autoregulation could potentially, expose the brain to 
hypo- and hyperperfusion during acute changes in arterial blood pressure and contribute to the 
development of SAE. Perfusion as measured by the CBFV was highly variable in our sepsis patients 
and in line with the current literature that describes cerebral perfusion as increased, unchanged 
or decreased after sepsis [12-15, 31] Comparison between these studies is hampered by the large 
variability in severity of the disease, timing of the measurements and techniques used to measure 
CBF. 
The CrCP decreased during human endotoxemia and was low in sepsis, reflecting a decreased 
vascular tone in these patients. This indicates that a cerebrovascular adaptation process has been 
switched on, also during experimental endotoxemia with intact cerebral autoregulation. These 
results are analogous to our previous observations of a decreased CrCP in human endotoxemia (2 
ng/kg bolus) and sepsis [24]. This decreased CrCP serves as a mechanism to protect the brain against 
ischemia, and is mainly caused by a decrease in Tau. Tau is the time constant of the cerebral arterial 
bed and is the product of brain arterial compliance and resistance. These data are in agreement with 
earlier studies where an increased pulsatility index was demonstrated in sepsis and associated with 
the development of SAE [31-33].
This study has a number of limitations. The ﬁrst limitation pertains the relatively small number of 
subjects enrolled and the fact that the population in the endotoxemia group markedly differed from 
the sepsis group in terms of sex and age. As described in a previous study, we included only young 
healthy men in the endotoxemia study to limit intersubject variability [24]. Second, we measured 
MAP through a catheter in the radial artery, at the heart level. Measuring of MAP in the MCA, at 
brain level, would be more accurate to estimate cerebral perfusion pressure but is not feasible. Third, 
CrCP is estimated using a mathematical model, with its inherent risks of bias. Intracranial pressure 
is required for the most accurate determination of CrCP, but clearly intracranial pressure was not 
obtained in this study. Because intracranial pressure is low in sepsis, the absence of intracranial 
pressure data is assumed not to signiﬁcantly influence the estimation of CrCP [34]. Fourth, cerebral 
perfusion changes may be heterogeneously distributed through the brain, with some regions 
more affected than others. As CrCP is derived from the CBFV MCA, this heterogeneity cannot be 
assessed using this technique. Finally, as respiratory rate and body temperature increase after LPS 
administration [24], we cannot exclude an influence of altered levels of carbon dioxide on CBFV 
MCA and cerebrovascular adaptation.
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Conclusions 
Continuous LPS infusion (4 ng/kg over 3 hours) results in similar vasodilation and decrease in blood 
pressure, and also does not affect the cerebrovascular proﬁle to a greater extent compared to bolus 
LPS administration (2 ng/kg). Dynamic cerebral autoregulation remains intact during experimental 
human endotoxemia. In sepsis, a low phase with normal gain suggests a delayed cerebrovascular 
response to changes in blood pressure. CrCP decreases during endotoxemia and is low in sepsis 
patients, reflecting a decreased vascular tone. These results indicate an intact cerebral autoregulation 
in the human endotoxemia model with an active cardiovascular compensatory mechanism, whereas 
cerebral autoregulation is disturbed in sepsis patients, plausibly because the compensatory 
cardiovascular mechanism is exhausted. According to these data the human endotoxemia model 
cannot be used as a proxy for sepsis-related cerebrovascular research. 
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Tables and figures
table 1   demographic and clinical data at baseline of endotoxemia subjects and sepsis patients. data are 
      expressed as mean±SD
healthy volunteers 
c-LPS (n=11)
healthy volunteers 
b-LPS (n=8)
sepsis
patients (n=10)
Age (y) 22.4±1.6 23.1±3.6 63.1±12.8
BMI (kg/m2) 24.4±2.7 20.5±1.8 26.2±3.3
HR (min-1) 68.5±8.7 62.3±11.3 105.2±13.3
MAP (mmHg) 96.8±5.1 90.8±5.2 68.1±10.2 
Temperature (ºC) 36.4±0.6 36.9±0.5 37.4±1.3
BMI           body mass index
HR             heart rate
MAP          mean arterial pressure
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figure 1  plasma levels of IL-6, IL-8, IL-10 and TNFα of endotoxemia subjects. for reasons of clarity, only mean 
   values are depicted to illustrate the differences in kinetics and magnitude of the cytokine response 
   between continuous and bolus LPS infusion/administration. LPS infusion/administration was 
   initiated/performed at T=0
IL-6  interleukin 6  TNFα tumor necrosis factor α
IL-8  interleukin 8  c-LPS continuous LPS infusion
IL-10 interleukin 10  b-LPS bolus LPS administration
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figure 2  arterial blood pressure (a) and cerebral blood flow (b) of endotoxemia subjects and sepsis patients. 
   data are expressed as mean±SEM (arterial blood pressure). * indicates p<0.05. * depicted above the 
   sepsis patients data indicates p<0.05 compared to c-LPS and b-LPS at all timepoints. white bars reflect 
   c-LPS, light grey bars b-LPS and dark grey bars sepsis patients
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figure 3  coherence (a), gain (b) and phase (c) in the VLF band of endoxemia subjects and sepsis patients. data 
   are expressed as mean±SEM. * indicates p<0.05. * depicted above the sepsis patients data in panel 
  c indicates p<0.05 compared to c-LPS and b-LPS at all timepoints. white bars reflect c-LPS, light grey 
   bars b-LPS and dark grey bars sepsis patients
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figure 4  critical closing pressure (a) and cerebrovascular resistance  (b) of endoxemia subjects and sepsis 
   patients. data are expressed as mean±SEM. * indicates p<0.05. * depicted above the sepsis patients data 
   indicates p<0.05 compared to c-LPS and b-LPS at all timepoints. white bars reflect c-LPS, light grey 
   bars b-LPS and dark grey bars sepsis patients
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chapter 8
Vasopressors do not influence cerebral 
critical closing pressure during systemic 
inflammation evoked by experimental 
endotoxemia and sepsis in humans
Judith M.D. van den Brule
Roeland Stolk
Elisabeth J. Vinke
Lex M. van Loon
Peter Pickkers
Johannes G. van der Hoeven
Matthijs Kox
Cornelia W.E. Hoedemaekers
Shock, 2018; 49(5); 529-535 
https://dx.doi.org/10.1097/SHK.0000000000001003
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Abstract
Objective
The aim of this study was to investigate the effects of different vasopressors on the cerebral 
vasculature during experimental human endotoxemia and sepsis. We used the critical closing 
pressure (CrCP) as a measure of cerebral vascular tone. 
Methods
We performed a prospective pilot study, at the intensive care department (ICU) of a tertiary care 
university hospital in the Netherlands, in 40 healthy male subjects during experimental human 
endotoxemia (administration of bacterial lipopolysaccharide [LPS]) and in 10 patients with severe 
sepsis or septic shock. 
Subjects in the endotoxemia study were randomized to receive a 5 hour infusion of either 0.05µg/
kg/min noradrenaline (n=10, “LPS-nor”), 0.5 µg/kg/min phenylephrine (n=10, “LPS-phenyl”), 0.04 IU/
min vasopressin (n=10, “LPS-AVP”) or saline (n=10, “LPS-placebo”) starting 1 hour before intravenous 
administration of 2 ng/kg LPS. In patients with sepsis, fluid resuscitation and vasopressor use was 
at the discretion of the medical team, aiming at normovolemia and a mean arterial pressure (MAP) 
>65mmHg, using noradrenaline. 
The mean flow velocity in the middle cerebral artery (MFVMCA) was measured by transcranial 
Doppler (TCD) with simultaneously recording of heart rate, arterial blood pressure, respiratory rate 
and oxygen saturation. CrCP was estimated using the cerebrovascular impedance model.
Results
The CrCP decreased in the LPS-placebo group from 52.6 [46.6-55.5] mmHg at baseline to 44.1 
[41.2-51.3] mmHg at 270 min post-LPS (P=0.03). Infusion of phenylephrine increased the CrCP in 
the period before LPS administration from 46.9 [38.8-53.4] to 53.8 [52.9-60.2] mmHg (P=0.02), but 
after LPS administration, a similar decrease was observed compared with the LPS-placebo group. 
Noradrenaline or vasopressin prior to LPS did not affect the CrCP. The decrease in CrCP after LPS 
bolus was similar in all treatment groups. The CrCP in the sepsis patients equaled 35.7 [34.4-42.0] 
mmHg, and was lower compared to that in the LPS-placebo subjects from baseline until 90 min after 
LPS (P<0.01).
Conclusions
Experimental human endotoxemia results in a decreased CrCP due to a loss of vascular resistance of 
the arterial bed. Vasopressors did not prevent this decrease in CrCP. Findings in patients with sepsis 
are comparable to those found in subjects after LPS administration. 
Patients with sepsis, despite treatment with vasopressors, have a risk for low cerebral blood flow 
and ischemia.
 
proefschrift_Judith_Brule_final.indd   120 09/11/2018   13:36
526134-L-bw-Brule
Processed on: 12-11-2018 PDF page: 121
121
vaso
presso
rs do
 n
o
t in
fl
u
en
ce cerebral critical clo
sin
g
 pressu
re du
rin
g
 
system
ic in
fl
am
m
atio
n
 evo
ked by experim
en
tal en
do
to
xem
ia an
d sepsis in
 h
um
an
s
8
Introduction
Sepsis-associated encephalopathy (SAE) is a common complication of sepsis and septic shock and 
associated with increased mortality and long-term cognitive impairment [1]. Reduced cerebral blood 
flow (CBF) is one of the major features in the pathophysiology of SAE. In addition, autoregulation 
is frequently disturbed in patients with severe sepsis and SAE, and may further increase the risk of 
ischemia if blood pressure decreases below the lower limit of autoregulation [2]. 
The critical closing pressure (CrCP) is a method to describe and quantify characteristics of the 
cerebrovascular bed and is deﬁned as the lower limit of arterial blood pressure below which vessels 
collapse and flow ceases [3, 4]. CrCP is a valuable and clinically relevant tool in cerebrovascular 
research, as it allows for estimation of the minimal cerebral perfusion pressure required to prevent 
collapse of vessels and ischemia [5-7]. The CrCP is mainly a feature of the arteriolar bed and the 
difference between the arterial (inflow) pressure and the CrCP is regarded as the driving pressure 
for cerebral perfusion [8]. Because CrCP cannot be measured directly, several models have been 
developed to estimate CrCP indirectly from other physiological parameters or their derivatives. 
Varsos et al. proposed a model using cerebrovascular impedance to determine the CrCP. This model 
can accurately detect changes in vascular properties induced by changes in intracranial pressure 
(ICP), PaCO2 and blood pressure [9].
Vasopressors are frequently applied to counteract hypotension and subsequent decreased 
cerebral perfusion in sepsis and septic shock [10]. The effects of different vasopressors on cerebral 
hemodynamics in sepsis are however unknown. Directly studying the effects of different vasopressors 
on cerebral perfusion in sepsis patients is hampered by the heterogeneity of the patient population, 
encompassing large variability in hemodynamic compromise and vasopressor requirements. 
In addition, current sepsis resuscitation protocols dictate a central role for noradrenaline, with 
vasopressin only used as an additional drug in ‘catecholamine-resistant’ shock. The experimental 
human endotoxemia model is a safe and reproducible model of systemic inflammation in humans 
in vivo, capturing many (hemodynamic) hallmarks of early sepsis, including a reduced MAP and 
increased heart rate. As such, this model allows for a head-to-head comparison of the effects of 
different vasopressors on cerebral hemodynamics in sepsis-like conditions [11].
Taken together, microvascular and macrovascular alterations play a key role in the pathogenesis 
of SAE. The effects of vasopressors on the cerebrovascular tone in SAE are unknown, despite the 
widespread use these agents in daily clinical practice. The effects of vasopression on CBF may be 
mediated by a change in systemic MAP. Alternatively, different vasopressors may induce changes in 
cerebrovascular resistance through direct effects on the cerebral vasculature. 
The aim of this study was to investigate the effects of different vasopressors on the cerebral 
vasculature during experimental human endotoxemia and to compare these to data obtained in 
sepsis patients. We focused on the parameter CrCP as a measure of cerebral vascular tone. 
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Methods
Study design, setting, and subjects
We performed a randomized controlled experimental endotoxemia pilot study in healthy subjects. 
Furthermore, we performed a prospective observational pilot study in patients with severe sepsis or 
septic shock. Both studies were performed at the intensive care department (ICU) of a tertiary care 
university hospital in the Netherlands.
Forty healthy, non-smoking, male volunteers, aged 18 to 35 years, were included in the human 
endotoxemia study that was registered at Clinicaltrials.gov under NCT02675868. All subjects 
provided written informed consent and experiments were in accordance with the Declaration 
of Helsinki and Good Clinical Practice guidelines, and approved by the local ethics committee 
(document number 2015-2079). Subjects were screened before start of the experiment and had 
a normal physical examination, electrocardiography and routine laboratory values. Subjects were 
excluded from participation in the endotoxemia trial in case of febrile illness in the two weeks 
preceding the experiment, use of any medication or nicotine, signs and symptoms of cardiovascular 
disease, renal or liver impairment, or in case they previously participated in an endotoxemia 
experiment. Subjects refrained from alcohol or caffeine intake 24 hours before the experiment and 
refrained from food 12 hours before the start of the endotoxemia experiment. 
Ten patients with severe sepsis or septic shock were included. The local Institutional Review Board 
waived the need for informed consent. Severe sepsis or septic shock was deﬁned by the international 
sepsis deﬁnition conference [12], requiring the use of vasopressors. Sepsis patients were treated 
according to international guidelines for management of severe sepsis and septic shock [13]. All 
sepsis patients were sedated and mechanically ventilated. Sedation was performed using propofol 
and/or midazolam and sufentanil to achieve a target Richmond Agitation and Sedation Scale (RASS) 
score of -3 to 0. 
General exclusion criteria for all participants were an irregular heart rhythm, insufﬁcient 
transtemporal bone window, age <18 years, pregnancy, thrombolytic therapy, refractory cardiogenic 
shock or life expectancy less than 24 hours.
Experimental human endotoxemia
Puriﬁed lipopolysaccharide (LPS, US Standard Reference Endotoxin Escherichia coli O:113) obtained 
from the Pharmaceutical Development Section of the National Institutes of Health, supplied as a 
lyophilized powder, was reconstituted in 5 mL saline 0.9% for injection and vortex mixed for at least 
20 minutes. The LPS solution was administered as an intravenous bolus injection at a dose of 2 ng/
kg body weight in 1 min at T= 0 min as described previously [14]. All subjects received 1.5 L of 2.5% 
glucose/0.45% saline solution in the hour before the administration of LPS, followed by 150 mL/h 
2.5% glucose/0.45% saline solution during the ﬁrst 6 hours after the LPS administration and 75 mL/h 
until the end of the experiment. LPS-induced symptoms, including headache, nausea, shivering, 
muscle and back pain, were scored every 30 min on a six-point Likert scale (0 = no symptoms, 5 = 
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worst ever experienced), resulting in a total score of 0–25.
Vasopressors
Subjects in the LPS trial were randomized using the sealed envelope method to receive either a 
5 hour infusion of 0.05µg/kg/min noradrenaline (n=10, “LPS-nor”), 0.5 µg/kg/min phenylephrine 
(n=10, “LPS-phenyl”), 0.04 IU/min vasopressin (n=10, “LPS-AVP”) or saline (NaCl 0,9%) (n=10, “LPS-
placebo”). Continuous infusion of the vasopressors started at one hour before LPS administration 
until 4 hours afterwards. A visual outline of the study is depicted in Figure 1. 
In sepsis patients, fluid resuscitation and vasopressor use was at the discretion of the medical team, 
aiming at normovolemia and a mean arterial pressure (MAP) >65mmHg, using noradrenaline. 
Data collection
In subjects participating in the endotoxemia study, the radial artery was cannulated using a 20 
gauge arterial catheter (Angiocath; Becton Dickinson) which was connected to an arterial pressure 
monitoring set (Edwards Lifesciences). Heart rate, blood pressure, respiratory rate and oxygen 
saturation were recorded continuously, starting 2 hours before administration of LPS until discharge 
from the ICU 8 hours after LPS administration. In sepsis patients the radial artery was cannulated 
using a 20 gauge arterial catheter (Angiocath; Becton Dickinson) which was connected to an arterial 
pressure monitoring set (Edwards Lifesciences). Heart rate, blood pressure, respiratory rate and 
oxygen saturation were recorded continuously during 30 minutes.
The mean flow velocity in the middle cerebral artery (MFVMCA) in both healthy volunteers and 
patients was measured using transcranial Doppler (TCD) through the temporal window with a 
2-Mhz probe (Multi-Dop T Digital, Compumedics DWL, Singen, Germany) according to the method 
developed by Aaslid et al [15]. The probe was positioned over the temporal bone window above 
the zygomatic arch and ﬁxed. This procedure ensured that the angle and the individual depth of 
insonation remained constant during the investigation. The TCD was measured on both sides. For 
the recordings, the bone window with the most optimal signal was chosen. All recordings were 
made with subjects/patients in the supine position with the head elevated to 30°.
A minimum of 10-12 minute windows of MFV, heart rate (ECG) and arterial blood pressure (ABP) 
were simultaneously recorded on a laptop computer and stored on a hard disk with a sample rate 
of 200 Hz by an A/D converter (NI USB-6211, National Instrument, Austin, TX, USA). In subjects 
participating in the endotoxemia study, recordings were performed at 90 and 30 minutes before, 
and at 90, 210 and 270 minutes after LPS administration. Sepsis patients were measured once, under 
stable hemodynamic (normotensive) and respiratory conditions (normocapnic). 
Data analysis
ABP and MFV data were analysed using custom-written MATLAB scripts (Matlab R2014b, The 
MathWorks Inc. Massachusetts, USA). First, the time series were ﬁltered with an 5th-order low-pass 
Butterworth ﬁlter (25 Hz), to ascertain signal stationarity. Second, periods of 5 minutes of artefact- 
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and calibration-free data were selected by visual inspection for subsequent analysis. Finally,mean 
blood pressure and cerebral blood flow velocity were obtained simultaneously using a 4th order 
low-pass Butterworth ﬁlter.
Critical Closing Pressure (CrCP)
CrCP was determined according to the method suggested by Varsos et al. [9, 16]. 
CrCP = ABP -
With CVR the cerebrovascular resistance, Ca the compliance of the vascular bed of the brain and 
HR the heart rate. The multiplication of CVR and Ca is also called the timeconstant Tau (t). Cerebral 
perfusion pressure (CPP) is deﬁned as ABP – ICP, however in this study the ICP was not measured. 
Therefore the mean ABP was used as an approach of CPP, as described by Varsos et al. [9]. CVR 
was calculated by dividing ABPmean by MFVmean. To determine the Ca, the cerebral arterial blood 
volume (CABV) was calculated by integrating the MFV signal over time. Then Ca was calculated by 
dividing the amplitude of the ﬁrst harmonic of the CABV by the amplitude of the ﬁrst harmonic of 
the ABP. Heart rate (HR) was deﬁned as the ﬁrst harmonic frequency of ABP.
Calculations and statistical analysis
Statistical analysis was performed using GraphPad Prism version 5.0 (GraphPad Software, La 
Jolla, CA). All baseline characteristics data are presented as means +/- SD, as they were normally 
distributed (determined by Shapiro-Wilk tests). 
All other results are presented as median with 25th and 75th percentile (interquartile range [IQR]), 
as they were not normally distributed (determined by Shapiro-Wilk tests). Changes over time were 
analyzed with Friedman tests.
A P-value of <0.05 was considered to indicate signiﬁcance. 
 
Results
Population
Baseline characteristics of the healthy volunteers participating in the experimental human 
endotoxemia study are presented in Table 1. There were no differences in baseline characteristics 
between the 4 treatment groups. All subjects developed the typical flulike symptoms, starting 
approximately 75 minutes after LPS administration. As expected, symptoms completely subsided 
after 5-6 hours. 
CPP
√(CVR·Ca·HR·2π)²+1
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The 10 sepsis patients had a SAPS 2 score of 55.0 [48.5-76.8] and an APACHE 2 score of 24.5 [18.3-
28.8]; 6 sepsis patients died in the ICU due to refractory shock and multi-organ failure. All patients in 
the sepsis population received noradrenaline (0.30 [0.24-0.45] µg/kg/min). Baseline characteristics 
of sepsis patients are presented in Table 2.
Hemodynamic and clinical data
The MAP in the LPS-placebo group was 91.0 [78.8-92.4] mmHg at the start of the experiment 
and decreased to 78.9 [71.3-88.5] mmHg after LPS administration (P<0.01) (Figure 2). Infusion of 
noradrenaline and phenylephrine signiﬁcantly increased MAP by 12.6 [11.5-15.2] and 22.2 [9.4-37.1] % 
in the period before LPS administration (P=0.01), whereas vasopressin had no effects on MAP. LPS 
administration decreased MAP in all treatment groups, with no signiﬁcant differences between 
groups. MAP in sepsis patients was lower than in healthy volunteers at all time-points (69.7 [66.4-
73.5] mmHg, P<0.01). 
The temperature increased from 36.8 [36.6-37.2] °C at baseline to 38.4 [37.5-38.6] °C after LPS 
administration in the LPS-placebo group (P<0.01) and a similar temperature response was observed 
in endotoxemic subjects receiving vasopressors (data not shown). 
The respiratory rate in the LPS-placebo group increased from 16.8 [14.0-20.0] resp/min to 19.4 
[18.0-21.9] resp/min at 210 min post-LPS and 20.4 [19.7-21.5] resp/min at 270 min post-LPS (P<0.01). 
Administration of vasopressors neither affected respiratory rates before LPS administration, nor 
the LPS-induced increase in respiratory rate. Septic patients were ventilated aiming at normocarbia. 
MFV and CrCP
The MFVMCA in the LPS-placebo group decreased signiﬁcantly during human endotoxemia from 69.9 
[64.2-85.3] cm/sec at baseline to 59.0 [54.3-63.1] cm/sec at 270 min post-LPS (P=0.01) (Figure 3). None 
of the vasopressors increased the MFVMCA in the period before LPS administration. Despite infusion 
of the vasopressors, the MFVMCA decreased upon LPS injection to values similar to that observed in 
the LPS-placebo group. The MFVMCA in sepsis patients was 69.8 [54.6-83.3 cm/sec]. 
The CrCP decreased signiﬁcantly in the LPS-placebo group from 52.6 [46.6-55.5] mmHg at baseline 
to 44.1 [41.2-51.3] mmHg at 270 min after LPS administration (P=0.03) (Figure 4). Infusion of 
phenylephrine before LPS injection increased the CrCP signiﬁcantly from 46.9 [38.8-53.4] to 53.8 
[52.9-60.2] mmHg (P=0.02). Noradrenaline or vasopressin had no effect on the CrCP prior to LPS 
administration. The decrease in CrCP after LPS bolus was similar in all treatment groups. The CrCP 
in the sepsis patients was 35.7 [34.4-42.0] mmHg, which was signiﬁcantly lower compared to values 
in the LPS-placebo subjects from baseline until 90 min post-LPS (P<0.01). 
The cerebrovascular arterial compliance (Ca) represents the change of arterial blood volume in 
response to change in arterial pressure and is estimated as a ratio of pulse amplitude of cerebral 
arterial blood volume and pulse amplitude of the arterial blood pressure. In the LPS-placebo group, 
Ca decreased from 0.16 [0.12-0.26] mmHg/cm3 before LPS admission to 0.11 [0.10-0.14] mmHg/cm3 
at 270 min post-LPS (P=0.03) (Figure 5a). None of the vasopressors changed the Ca signiﬁcantly 
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before LPS administration. Furthermore, no signiﬁcant changes compared to the placebo group 
were observed in subjects treated with vasopressors after LPS administration. Ca values in sepsis 
patients were lower compared to values in healthy volunteers before LPS administration (0.10 [0.07-
0.13] mmHg/cm3, P<0.01). 
The CVR represents the resistance of small cerebral arteries and arterioles, which was estimated 
from the MAP and MFV. The initial CVR in endotoxemia subjects was 1.37 [1.01-1.45] mmHg*sec/
cm and did not change signiﬁcantly after LPS administration (P=0.63) (Figure 5b). Phenylephrine 
increased the CVR from 1.32[1.07-1.54] to 1.71[1.52-1.87] mmHg*sec/cm (P=0.02). No changes in 
CVR occurred in any of the other treatment groups. The CVR in sepsis patients was 1.11 [0.87-1.56] 
mmHg*sec/cm, and did not differ from the LPS subjects (P=0.50). 
Tau (t) is the time constant of the cerebral arterial bed and is the product of brain arterial compliance 
Ca and resistance CVR. It provides an estimation as to how quickly cerebral blood arrives in the 
cerebral arterial bed during each cardiac cycle. Tau decreased from 0.21 [0.17-0.25] sec to 0.15 [0.15-
0.18] sec in the LPS-placebo group (P<0.01) (Figure 5c). None of the vasopressors changed Tau 
signiﬁcantly in the period before LPS injection. Furthermore, no signiﬁcant changes compared to 
the placebo group were found in the subjects treated with vasopressors after LPS administration. 
Tau in the sepsis group was 0.12 [0.08-0.15] sec, and signiﬁcantly lower compared to values before 
LPS administration (P<0.01). 
 
Discussion
Endothelial dysfunction and disturbed NO production play a key role in the pathogenesis of 
SAE [17, 18]. After LPS administration, cerebral blood flow velocity decreases [19] most likely as a 
result of decreased outflow from the circle of Willis to the middle and anterior cerebral arteries 
[20]. The decrease in cerebral blood flow velocities was accompanied by a decrease in CrCP. This 
decrease in CrCP probably maintains adequate cerebral driving pressure and thereby serves as a 
mechanism to protect the brain against ischemia. The decrease in cerebrovascular compliance in 
our study is consistent with previous work indicating that systemic vasoparalysis does not affect 
the brain circulation in sepsis [21]. In contrast to the systemic vasodilation in sepsis, decreased 
blood flow velocities together with higher pulsatility indices in patients with SAE strongly suggest 
vasoconstriction of the resistance arterioles in the brain [22]. 
Remarkably, CVR was unmodiﬁed during endotoxemia . Ideally, CVR is calculated by dividing pressure 
in the resistance arterioles by MFVmean. In this study, the CVR was estimated from the MAP and 
MFV in the MCA and thus not measured in the cerebral resistance arterioles. This may explain 
the fact that CVR did not change in endotoxemic subjects. Ca decreased in our study, reflecting 
a reduced ability of arteries to expand and contract with changes in blood pressure. Generally, Ca 
and CVR are inversely correlated, but the correlation between these parameters may change in 
pathological states, such as SAE [23].
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Infusion of noradrenaline and phenylephrine before LPS bolus injection increased MAP, whereas 
vasopressin had no effect on blood pressure. The latter ﬁnding was not unexpected, because the 
hemodynamic effect of vasopressin in septic shock is based on the relative vasopressin deﬁciency 
in these patients [24, 25]. Therefore, exogenous vasopressin infusion will not change the vascular 
tone in healthy subjects with adequate endogenous vasopressin levels. The increased MAP after 
initiation of noradrenaline and phenylephrine infusion did not result in a change of the MFVMCA. 
Probably, the simultaneous increase in CrCP ensured a constant cerebral driving pressure despite 
the increase in MAP, suggestive of cerebrovascular adaptation in these subjects.
suggesting cerebrovascular adaptation in these subjects.
None of the vasopressors used in this study prevented the decrease in MFVMCA after LPS 
administration. In addition, the decrease in CrCP in the subjects receiving vasopressors was similar 
to that in the placebo group. So far, few studies have compared the effectiveness of commonly used 
agents to augment cerebral perfusion, and the available literature is restricted patients suffering 
from traumatic brain injury [26-30]. None of these studies found signiﬁcant differences in cerebral 
hemodynamic responses or oxygenation between different vasopressors. However, several animal 
studies have examined the effects of different vasopressors on cerebral perfusion. For instance, 
augmentation of cerebral perfusion with noradrenaline resulted in a more pronounced increase 
in brain tissue oxygenation compared to phenylephrine in a large animal model of pediatric 
closed head injury [31]. The lack of effect of the α-agonist phenylephrine and the combined α-β-
agonist noradrenaline in our study may reflect the low density of α and β receptors in the human 
cerebral vasculature. Alternatively, the dose of phenylephrine (0.5 µg/kg/min) and noradrenaline 
(0.05µg/kg/min) may have been too low to induce an effect on CBF, either directly by influencing 
cerebrovascular tone or indirectly by augmentation of MAP. The fact that CrCP decreased 
simultaneously with decreasing MAP, indicates that cerebrovascular adaptation was not affected by 
the use of phenylephrine and noradrenaline. 
The reported effects of vasopressin on the cerebral vasculature are heterogeneous, with cerebral 
vasoconstriction or dilation depending on the species, artery size and vasopressin dose [32-35]. The 
relevance of these studies for the treatment of patients with septic shock remains to be established. 
In our population of healthy subjects during endotoxemia, no effects of vasopressin (administered 
in a clinically relevant dose) on CBF were observed. 
The cerebrovascular effects in the human endotoxemia model strongly resembled the ﬁndings in 
septic patients. In both endotoxemia and sepsis the MFVMCA decreased, together with a lowered CrCP. 
Previously, dynamic cerebral autoregulation was believed to be enhanced in human endotoxemia 
and impaired in sepsis [19, 36]. More recently it was suggested that dynamic cerebral autoregulation 
is also enhanced in the earlier stages of sepsis, indicating that in early sepsis cerebrovascular 
adaptation to changes in cerebral perfusion are similar to those observed in human endotoxemia 
[37]. This suggests that the human endotoxemia model is a relevant model to study the efﬁciency of 
therapeutic approaches in SAE. 
This study has a number of limitations. First, CrCP cannot be measured directly but is estimated 
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using a mathematical model, with its inherent risks of bias. Most importantly, ICP is required for 
the most accurate calculation of CrCP, but this parameter was not obtained in the current study. 
Nevertheless, since ICP is low under septic conditions, it is unlikely that the absence of ICP data 
signiﬁcantly influenced the estimation of CrCP [38]. Second, we measured MAP through a catheter 
in the radial artery, at heart level instead of brain level. Measurement of the MAP in the MCA 
would have resulted in a more accurate estimation of cerebral perfusion pressure but is not feasible. 
Thirdly, cerebral perfusion changes after a LPS bolus or in sepsis may be heterogeneously distributed 
through the brain, with some areas more affected than others. As CrCP is derived from the MFVMCA, 
this heterogeneity in flow cannot be assessed using this technique. 
Fourth, as mentioned before, because healthy subjects were studied in the endotoxemia study, only 
low-dose vasopressors were administered. We cannot exclude a possible effect on cerebrovascular 
adaptation with higher dosing.
A ﬁfth limitation of this study is the small number of subjects and that the population in the 
endotoxemia group differed from the sepsis group in terms of sex and age. We included only men 
in the endotoxemia study to limit subject variability, because we know from earlier experimental 
human endotoxemia studies that females show a more pronounced proinflammatory innate 
immune response associated with less attenuation of norepinephrine sensitivity [39]. We included 
only young volunteers in the endotoxemia study to limit subject variability and for reasons of safety 
(comorbidity). Injection of E. coli endotoxin in elderly patients (median age 66yrs) is associated 
with a more pronounced reduction in blood pressure compared to younger control subjects [40]. 
Aging is associated with decreasing cerebral blood flow velocities. However this occurs mainly in 
the posterior cerebral circulation and at signiﬁcantly older ages than those of our sepsis population. 
A study measuring cerebral blood flow velocity and pulsatility index by transcranial Doppler in 
303 healthy elderly subjects indicated a slight but non-signiﬁcant decrease in cerebral blood flow 
velocities in the middle cerebral artery (33.8±0.9 to 32.2±1.1 and 34.8±0.9 to 32.8±1.1 cm/s) between 
patient groups 70-74 yrs to > 85 yrs. The pulsatility index (reflecting cerebrovascular resistance) 
increased from 1.55±0.04 to 1.66±0.04 and from 1.59±0.04 to 1.64±0.04 in these age groups [41]. 
In our study, the CrCP in the (older) septic population was signiﬁcantly lower compared to the 
(younger) endotoxemia group. In addition, the CVR was similar in both populations. This strongly 
suggests that in our population, changes in CrCP and CVR were mainly influenced by sepsis, rather 
than the age per se.
A sixth limitation of the study is that data obtained in healthy volunteers were not controlled 
for carbon dioxide tension: as the respiratory rate and body temperature increased after LPS 
administration, we cannot exclude an influence of altered levels of CO2 on reduced MFV and 
cerebrovascular adaptation.
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Conclusions
Cerebral blood flow velocity decreases during human endotoxemia and vasopressors do not 
prevent this decrease. In addition, vasopressors do not influence the change in CrCP during human 
endotoxemia. These results have important clinical implications as they indicate that titration of 
the systemic circulation to a speciﬁc minimal MAP with vasopressors will not automatically restore 
cerebral perfusion in patients with septic shock. Monitoring of cerebral perfusion parameters such 
as CrCP may assist in titration of the optimal systemic MAP to prevent cerebral hypoperfusion and 
brain ischemia.
 
proefschrift_Judith_Brule_final.indd   129 09/11/2018   13:36
526134-L-bw-Brule
Processed on: 12-11-2018 PDF page: 130
130 
se
ct
io
n
 ii
 c
er
eb
ra
l 
h
em
o
dy
n
am
ic
s 
in
 p
at
ie
n
ts
 w
it
h
 s
ep
si
s 
an
d 
in
 t
h
e 
h
um
an
 e
n
do
to
xe
m
ia
 m
o
de
l
References
1. Goodson, C.M., et al., Cerebral Blood Flow Autoregulation in Sepsis for the Intensivist: Why Its Monitoring May Be
  the Future of Individualized Care. J Intensive Care Med, 2016.
2. Taccone, F.S., et al., Brain perfusion in sepsis. Curr Vasc Pharmacol, 2013. 11(2): p. 170-86.
3. Burton, A.C., On the physical equilibrium of small blood vessels. Am J Physiol, 1951. 164(2): p. 319-29.
4. Dewey, R.C., H.P. Pieper, and W.E. Hunt, Experimental cerebral hemodynamics. Vasomotor tone, critical closing 
  pressure, and vascular bed resistance. J Neurosurg, 1974. 41(5): p. 597-606.
5. Varsos, G.V., et al., Cerebral vasospasm affects arterial critical closing pressure. J Cereb Blood Flow Metab, 2015. 
  35(2): p. 285-91.
6. Varsos, G.V., et al., Cerebral critical closing pressure in hydrocephalus patients undertaking infusion tests. Neurol 
  Res, 2015. 37(8): p. 674-82.
7. Varsos, G.V., et al., Critical closing pressure during intracranial pressure plateau waves. Neurocrit Care, 2013. 
 18(3): p. 341-8.
8. Weyland, A., et al., Cerebrovascular tone rather than intracranial pressure determines the effective downstream 
  pressure of the cerebral circulation in the absence of intracranial hypertension. J Neurosurg Anesthesiol, 2000. 
  12(3): p. 210-6.
9. Varsos, G.V., et al., Critical closing pressure determined with a model of cerebrovascular impedance. J Cereb Blood 
 Flow Metab, 2013. 33(2): p. 235-43.
10. Gamper, G., et al., Vasopressors for hypotensive shock. Cochrane Database Syst Rev, 2016. 2: p. CD003709.
11. Lowry, S.F., Human endotoxemia: a model for mechanistic insight and therapeutic targeting. Shock, 2005. 
 24 Suppl 1: p. 94-100.
12. Levy, M.M., et al., 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care 
  Med, 2003. 29(4): p. 530-8.
13. Dellinger, R.P., et al., Surviving Sepsis Campaign: international guidelines for management of severe sepsis and 
 septic shock: 2008. Intensive Care Med, 2008. 34(1): p. 17-60.
14. Dorresteijn, M.J., et al., Iso-osmolar prehydration shifts the cytokine response towards a more anti-inflammatory 
  balance in human endotoxemia. J Endotoxin Res, 2005. 11(5): p. 287-93.
15. Aaslid, R., T.M. Markwalder, and H. Nornes, Noninvasive transcranial Doppler ultrasound recording of flow 
 velocity in basal cerebral arteries. J Neurosurg, 1982. 57(6): p. 769-74.
16. Varsos, G.V., et al., Model-based indices describing cerebrovascular dynamics. Neurocrit Care, 2014. 20(1): 
 p. 142-57.
17. Ait-Oufella, H., et al., The endothelium: physiological functions and role in microcirculatory failure during severe 
  sepsis. Intensive Care Med, 2010. 36(8): p. 1286-98.
18. Hughes, C.G., et al., Association between endothelial dysfunction and acute brain dysfunction during critical 
 illness. Anesthesiology, 2013. 118(3): p. 631-9.
19. Brassard, P., et al., Endotoxemia reduces cerebral perfusion but enhances dynamic cerebrovascular autoregulation 
  at reduced arterial carbon dioxide tension. Crit Care Med, 2012. 40(6): p. 1873-8.
20. Villega, F., et al., Circulating bacterial lipopolysaccharide-induced inflammation reduces flow in brain-irrigating 
proefschrift_Judith_Brule_final.indd   130 09/11/2018   13:36
526134-L-bw-Brule
Processed on: 12-11-2018 PDF page: 131
131
vaso
presso
rs do
 n
o
t in
fl
u
en
ce cerebral critical clo
sin
g
 pressu
re du
rin
g
 
system
ic in
fl
am
m
atio
n
 evo
ked by experim
en
tal en
do
to
xem
ia an
d sepsis in
 h
um
an
s
8
 arteries independently from cerebrovascular prostaglandin production. Neuroscience, 2017. 346: p. 160-172.
21. Matta, B.F. and P.J. Stow, Sepsis-induced vasoparalysis does not involve the cerebral vasculature: indirect evidence 
  from autoregulation and carbon dioxide reactivity studies. Br J Anaesth, 1996. 76(6): p. 790-4.
22. Szatmari, S., et al., Impaired cerebrovascular reactivity in sepsis-associated encephalopathy studied by acetazolamide 
 test. Crit Care, 2010. 14(2): p. R50.
23. Carrera, E., et al., Effect of hyper- and hypocapnia on cerebral arterial compliance in normal subjects. 
 J Neuroimaging, 2011. 21(2): p. 121-5.
24. Holmes, C.L., et al., Physiology of vasopressin relevant to management of septic shock. Chest, 2001. 120(3): 
 p. 989-1002.
25. Landry, D.W. and J.A. Oliver, The pathogenesis of vasodilatory shock. N Engl J Med, 2001. 345(8): p. 588-95.
26. Friess, S.H., et al., Neurocritical care monitoring correlates with neuropathology in a swine model of pediatric 
 traumatic brain injury. Neurosurgery, 2011. 69(5): p. 1139-47; discussion 1147.
27. Johnston, A.J., et al., Effect of cerebral perfusion pressure augmentation with dopamine and norepinephrine on 
 global and focal brain oxygenation after traumatic brain injury. Intensive Care Med, 2004. 30(5): p. 791-7.
28. Ract, C. and B. Vigue, Comparison of the cerebral effects of dopamine and norepinephrine in severely head-injured 
 patients. Intensive Care Med, 2001. 27(1): p. 101-6.
29. Sookplung, P., et al., Vasopressor use and effect on blood pressure after severe adult traumatic brain injury. 
 Neurocrit Care, 2011. 15(1): p. 46-54.
30. Steiner, L.A., et al., Direct comparison of cerebrovascular effects of norepinephrine and dopamine in head-injured 
  patients. Crit Care Med, 2004. 32(4): p. 1049-54.
31. Friess, S.H., et al., Differing effects when using phenylephrine and norepinephrine to augment cerebral blood flow 
 after traumatic brain injury in the immature brain. J Neurotrauma, 2015. 32(4): p. 237-43.
32. Faraci, F.M., Effects of endothelin and vasopressin on cerebral blood vessels. Am J Physiol, 1989. 257(3 Pt 2): 
 p. H799-803.
33. Fernandez, N., et al., Cerebral vasoconstriction produced by vasopressin in conscious goats: role of vasopressin V(1) 
 and V(2) receptors and nitric oxide. Br J Pharmacol, 2001. 132(8): p. 1837-44.
34. Suzuki, Y., et al., Regional differences in the vasodilator response to vasopressin in canine cerebral arteries in vivo. 
  Stroke, 1993. 24(7): p. 1049-53; discussion 1053-4.
35. Takayasu, M., et al., Triphasic response of rat intracerebral arterioles to increasing concentrations of vasopressin in 
  vitro. J Cereb Blood Flow Metab, 1993. 13(2): p. 304-9.
36. Berg, R.M., et al., Disassociation of static and dynamic cerebral autoregulatory performance in healthy volunteers 
  after lipopolysaccharide infusion and in patients with sepsis. Am J Physiol Regul Integr Comp Physiol, 2012. 
 303(11): p. R1127-35.
37. Berg, R.M., et al., Dynamic cerebral autoregulation to induced blood pressure changes in human experimental and 
  clinical sepsis. Clin Physiol Funct Imaging, 2016. 36(6): p. 490-496.
38. Pﬁster, D., et al., Intracranial pressure in patients with sepsis. Acta Neurochir Suppl, 2008. 102: p. 71-5.
39. van Eijk, L.T., et al., Gender differences in the innate immune response and vascular reactivity following the 
  administration of endotoxin to human volunteers. Crit Care Med, 2007. 35(6): p. 1464-9.
40. Krabbe, K.S., et al., Hypotension during endotoxemia in aged humans. Eur J Anaesthesiol, 2001. 18(9): p. 572-5.
proefschrift_Judith_Brule_final.indd   131 09/11/2018   13:36
526134-L-bw-Brule
Processed on: 12-11-2018 PDF page: 132
132 
se
ct
io
n
 ii
 c
er
eb
ra
l 
h
em
o
dy
n
am
ic
s 
in
 p
at
ie
n
ts
 w
it
h
 s
ep
si
s 
an
d 
in
 t
h
e 
h
um
an
 e
n
do
to
xe
m
ia
 m
o
de
l
41. Yang, D., et al., Cerebral Hemodynamics in the Elderly: A Transcranial Doppler Study in the Einstein Aging Study 
  Cohort. J Ultrasound Med, 2016. 35(9): p. 1907-14.
proefschrift_Judith_Brule_final.indd   132 09/11/2018   13:36
526134-L-bw-Brule
Processed on: 12-11-2018 PDF page: 133
133
vaso
presso
rs do
 n
o
t in
fl
u
en
ce cerebral critical clo
sin
g
 pressu
re du
rin
g
 
system
ic in
fl
am
m
atio
n
 evo
ked by experim
en
tal en
do
to
xem
ia an
d sepsis in
 h
um
an
s
8
Tables and figures 
table 1      demographic and clinical data at baseline of LPS subjects
all subjects 
(n=40)
LPS-nor
(n=10)
LPS-phenyl 
(n=10)
LPS-AVP 
(n=10)
LPS-placebo 
(n=10)
p value
Age (years) 22.4 (±2.6) 20.9 (±1.6) 22.4 (±2.8) 22.9 (±2.2) 23.3 (±3.2) P = 0.09
BMI (kg/m²) 22.6 (±2.7) 20.90 (±2.2) 22.61 (±2.7) 23.5 (±2.3) 20.9 (±2.9) P = 0.34
HR (BPM) 66.6 (±10.5) 64.5 (±8.5) 67.8 (±10.8) 71.6 (±11.8) 62.50 (±10.0) P = 0.41
MAP (mmHg) 89.0 (±7.4) 86.44 (±6.2) 87.6 (±10.3) 92.9 (±6.0) 91.5 (±5.2) P = 0.27
Temperature (°C) 36.9 (±0.3) 36.9 (±0.4) 36.9 (±0.3) 36.9 (±0.4) 36.8 (±0.3) P = 0.98
Hb (mmol/L) 8.9 [8.5 – 9.1] 8.9 [8.525 – 9.375] 8.8 [8.5 – 9.125] 8.8 [8.5 – 9.2] 8.9 [8.5 – 9.15] P = 0.93
BMI           body mass index
HR             heart rate
MAP          mean arterial pressure
table 2      demographic and clinical data at baseline of sepsis patients
sepsis (n=10)
Age (years) 63.1 (±12.8)
BMI (kg/m²) 26.2 (±3.3)
HR (BPM) 105.2 (±13.3)
MAP (mmHg) 68.1 (±10.2)
Temperature (°C) 37.4 (±1.3)
Hb (mmol/L) 6.0 (±1.1)
BMI           body mass index
HR             heart rate
MAP          mean arterial pressure
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figure 1  outline of the human endotoxemia trial 
HD  hemodynamic
LPS  lipopolysaccharide
TCD transcranial doppler
NIRS near infrared spectroscopy
figure 2  MAP after LPS injection in LPS-placebo, LPS-nor, LPS-phenyl and LPS-AVP, Time 0 = time of LPS bolus
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figure 3  MFVMCA in sepsis patients and after LPS injection in LPS-placebo, LPS-nor, LPS-phenyl and LPS-AVP, 
   time 0 = time of LPS bolus
LPS  lipopolysaccharide 
MFVMCA  mean flow velocity in the middle cerebral artery 
figure 4  CrCP in sepsis patients after LPS injection in LPS-placebo, LPS-nor, LPS-phenyl and LPS-AVP, 
  Time 0 = time of LPS bolus
CrCP critical closing pressure
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figure 5 Ca, CVR and Tau in sepsis patients after LPS injection in LPS-placebo, LPS-nor, LPS-phenyl and 
   LPS-AVP, time 0 = time of LPS bolus
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chapter 9
Summary, conclusions, future perspectives 
and clinical implications
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In this thesis we studied cerebral hemodynamics in patients with an inflammatory status, more 
speciﬁcally patients after cardiac arrest (Section I) and patients with sepsis (Section II). 
Mean arterial pressure (MAP) and cerebral autoregulation are major determinants in cerebral 
hemodynamics. Cerebral autoregulation is the mechanism that keeps blood flow at a constant level 
within certain blood pressure limits. Cerebral autoregulation can be evaluated by measuring relative 
blood flow changes in response to a steady-state change in blood pressure (static method) or during 
the response to a rapid change in blood pressure (dynamic method). The static method evaluates 
mainly the efﬁciency of the autoregulatory response, while the dynamic method evaluates how fast 
the cerebral blood flow (CBF) can adapt to changes in perfusion pressure. 
To quantify characteristics of the cerebrovascular bed, the critical closing pressure (CrCP) is a 
frequently used method. The CrCP is deﬁned as the lower limit of arterial blood pressure below 
which vessels collapse and flow ceases [1, 2]. CrCP cannot be measured directly, so several models 
have been developed to estimate CrCP indirectly from other measurable physiological parameters 
or their derivatives. The most frequently used model is the multiparameter mathematical model 
proposed by Varsos et al. [3]. Using the concept of impedance to CBF, CrCP can be expressed with 
brain-monitoring parameters: cerebral perfusion pressure, arterial blood pressure, blood flow 
velocity (MFVMCA), and heart rate [3].  
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Summary
Section I Cerebral hemodynamics in patients after cardiac arrest
Out of hospital cardiac arrest is the leading cause of death in industrialized countries. Chapter 2 
reviews the current literature regarding cerebral perfusion and cerebral autoregulation after 
cardiac arrest. Cerebral perfusion after resuscitation shows a temporal course from early hyperemia 
followed by hypoperfusion and, ﬁnally, to restoration of normal blood flow. 
Static and dynamic cerebral autoregulation may remain intact in comatose patients after cardiac 
arrest, but with a narrowed and upward shifted zone [4]. Frequently, static and dynamic cerebral 
autoregulation are disturbed after resuscitation. Disturbed autoregulation and a MAP below the 
optimal autoregulatory range in the early phase after cardiac arrest are associated with unfavorable 
outcome [5-7].
CrCP is a reliable parameter to quantify characteristics of the cerebrovascular bed and is deﬁned as 
the lower limit of arterial blood pressure below which vessels collapse and flow ceases [1, 2]  
The aim of chapter 3 was to estimate the CrCP of the cerebrovascular circulation during the post-
cardiac arrest syndrome and to determine if CrCP differs between survivors and non-survivors. CrCP 
was determined according to the method suggested by Varsos [3, 8]. As expected, MFVMCA increased 
signiﬁcantly from intensive care unit (ICU) admission to 72 hrs after cardiac arrest. The MFVMCA 
was similar in survivors and non-survivors upon admission to the ICU, but the MFVMCA increased 
stronger (overshoot) in non-survivors compared to survivors throughout the observation period. 
Immediately after cardiac arrest the CrCP was signiﬁcantly higher compared to healthy controls. 
The CrCP decreased signiﬁcantly from admission until 48 hrs after cardiac arrest, after which it 
remained stable. The CrCP was signiﬁcantly higher in survivors compared to non-survivors. We 
concluded that CrCP is high immediately after cardiac arrest with high cerebrovascular resistance 
and low cerebral blood flow velocities. This suggests that cerebral perfusion pressure should be 
maintained at a sufﬁcient high level to avoid secondary brain injury. We also concluded that failure 
to normalize the cerebrovascular proﬁle may be a parameter of poor outcome.
In chapter 4, we investigated spontaneous variability in the time and frequency domain in MFVMCA 
and MAP in comatose patients during the ﬁrst 72 hrs after cardiac arrest to determine other possible 
differences between survivors and non-survivors. The spontaneous variability of MFVMCA was low 
after cardiac arrest. MFVMCA variability returned to normal values in survivors whereas variability 
decreased further in non-survivors after cardiac arrest. The variability of the MAP remained low 
during the entire study period after cardiac arrest. There were no differences in variability of MAP 
between survivors and non-survivors. The average power in the very low frequency (VLF) spectrum 
of the MFVMCA was low after cardiac arrest and restored towards normal values in survivors, whereas 
this average power remained low in non-survivors. Apparently, intrinsic myogenic vascular function 
and sympathetic autonomic regulation may be impaired in non-survivors after cardiac arrest.
The differences in spontaneous fluctuations in MFVMCA described in chapter 4 suggested changes 
in dynamic autoregulation after cardiac arrest. Transfer function analysis (TFA) is considered the 
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gold standard for the estimation of dynamic cerebral autoregulation and this technique relies on 
spontaneous (or induced) fluctuations in the input signal. The variability in MAP is low after cardiac 
arrest. Since low variability in MAP as the input signal could strongly reduce the reliability of the 
resulting output signal, we did not quantify the strength of the dynamic autoregulation in this 
population [9]. 
Subsequently, the aim of chapter 5 was to determine if an artiﬁcial increase in blood pressure 
variability would improve determination of cerebral autoregulation. Tilting of the bed induced a 
signiﬁcant increase in variability of MAP and MFVMCA in patients after cardiac arrest. Ampliﬁcation 
of the blood pressure variability by tilting of the bed changed the interpretation of cerebral 
autoregulation (from intact to impaired and vice versa), as measured by TFA and by the mean flow 
velocity index (Mx). This difference in interpretation of cerebral autoregulation is most likely related 
to bias induced by very low variability (as previously described in chapter 4) in the blood pressure 
and MFVMCA signal at baseline. We concluded that increasing blood pressure variability is useful 
in determination of dynamic cerebral autoregulation by TFA. The necessary minimal amount of 
variability has not yet been determined.
 
Section II Cerebral hemodynamics in patients with sepsis and in the human endotoxemia 
model
Dysregulation of cerebral hemodynamics plays a crucial role in the development of sepsis-associated 
encephalopathy (SAE) [10]. SAE is associated with increased mortality, higher use of ICU resources, 
longer hospital stay and increased morbidity with long-term cognitive decline [11]. To gain more 
insight into the effects of sepsis on cerebral hemodynamics, we used the human endotoxemia 
model. The experimental human endotoxemia model, with administration of  lipopolysaccharide 
(LPS) is a safe and reproducible model of systemic inflammation in humans in vivo, capturing 
many (hemodynamic) hallmarks of early sepsis [12]. Chapter 6 reviewed the current literature 
regarding cerebral perfusion and cerebral autoregulation in patients with sepsis and also in the 
human endotoxemia model. CBF is heterogeneous (increased, decreased, unchanged) in sepsis. This 
heterogeneity is probably caused by methodological differences (e.g. study protocols used different 
time moments for inclusion) and individual differences (e.g. changes in the inflammatory response 
or differences in cardiac output) between patients [13-25]. Static autoregulation was preserved in 
patients with sepsis [25-27]. In contrast, dynamic cerebral autoregulation was impaired in most 
studies, especially in the earlier phases of sepsis [16, 17, 27-31]. The impairment of dynamic cerebral 
autoregulation was associated with the development of SAE and mortality. Cerebral perfusion 
remained equal or was decreased after LPS infusion [27, 32-36]. Static autoregulation was maintained 
after LPS and dynamic autoregulation was enhanced [27, 32-34]. 
The differences in dynamic cerebral autoregulation between patients with sepsis and healthy 
volunteers to whom LPS was administered (impaired dynamic cerebral autoregulation in patients 
with sepsis versus enhanced dynamic autoregulation in healthy volunteers after LPS infusion) may 
be the result of the difference in duration and severity of the systemic inflammatory response. 
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Chapter 7 described the effect of high dose LPS continuous infusion (4 ng/kg LPS), compared to 2 ng/
kg bolus LPS and compared this to patients with sepsis. We hypothesized  that a higher dose of LPS 
would create a more pronounced systemic inflammatory response, that would more closely mimic 
the cerebrovascular changes of clinical sepsis. The results showed an impaired dynamic cerebral 
autoregulation as measured by TFA in patients with sepsis and an intact dynamic autoregulation 
during human endotoxemia after 2 and 4 ng/kg LPS. CrCP decreased in both LPS groups and was 
low in patients with sepsis. This reflects an exhausted compensatory cardiovascular mechanism 
in sepsis. The stable cerebral autoregulatory response in our human endotoxemia experiment, in 
contrast to enhanced dynamic cerebral autoregulation in previously published literature, may be 
related to the larger amount of fluids (2.5 L) administered in our study thus preventing extensive 
fluctuations of perfusion pressure and cardiac output. Studies reporting enhanced dynamic 
cerebral autoregulation did not infuse additional fluids prior to and during the human endotoxemia 
experiment. We concluded that the human endotoxemia model cannot be used as a proxy for sepsis-
related cerebrovascular research.
To counteract hypotension and subsequent decreased cerebral perfusion in sepsis and septic 
shock, vasopressors are frequently applied [37]. In chapter 8 we described the effects of different 
vasopressors on the cerebral vasculature during experimental human endotoxemia. We used CrCP 
as a measure of cerebral vascular tone during experimental human endotoxemia and sepsis. Both 
experimental human endotoxemia and sepsis resulted in a decreased CrCP due to a loss of vascular 
resistance of the arterial bed. Vasopressors (noradrenaline, phenylephrine and vasopressin) did 
not prevent the decrease in CrCP after LPS administration. An important clinical implication 
is that titration of the systemic circulation to a speciﬁc minimal MAP with vasopressors will not 
automatically restore cerebral perfusion in patients with septic shock.
 
Conclusions, future perspectives and clinical implications
Section I Cerebral hemodynamics in patients after cardiac arrest
Cerebral perfusion after return of spontaneous circulation (ROSC) is characterized by early hyperemia 
(0-20min) followed by a period of hypoperfusion (20min-12h). During the delayed hypoperfusion 
phase CBF decreases to about 50% or less [38, 39]. Subsequently (12-72h), older literature showed 
a persistently low, an increased or normal CBF, while more recent literature described a normal or 
increased MFVMCA, as a parameter of CBF during this period [38-42]. It is important to note that 
MFVMCA is not equivalent to CBF, but changes in CBF can be extrapolated from changes in MFVMCA. 
CBF and MFVMCA do have a linear relationship if the diameter of the insonated vessel (MCA) and the 
angle of insonation remain constant while using transcranial Doppler.
As also described in previous literature, we found a low MFVMCA  in the early phase after cardiac 
arrest. Thereafter (12-72h after ROSC), MFVMCA returns towards normal values in patients that 
ultimately survive. MFVMCA increases stronger (overshoot) in non-survivors compared to survivors. 
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Recently, Hoedemaekers et al. concluded that low CBF after ROSC is not associated with anaerobic 
metabolism and that hypoperfusion appears to be the result of a decrease in neuronal functioning 
and metabolic needs [43]. Alternatively, hypoperfusion may decrease cerebral metabolism, 
because reduced energy supply leads to a sudden discontinuation of multiple neuronal functions, 
mainly synaptic neurotransmission [44]. This reduction in neurotransmission is regarded to be 
a compensatory mechanism [45]. Subsequently, they concluded that metabolism increases in 
survivors associated with restoration of neuronal activity, whereas in non-survivors persistent low 
metabolism reflects irreversible neuronal injury [43]. 
The CrCP immediately after cardiac arrest is signiﬁcantly higher compared to healthy controls. The 
CrCP decreases signiﬁcantly from admission until 48 hrs after cardiac arrest, after which it remains 
stable. This CrCP is signiﬁcantly higher in survivors compared to non-survivors. This suggests that 
cerebral perfusion pressure should be maintained at a sufﬁcient high level to avoid secondary brain 
damage. No other studies used the CrCP to quantify the characteristics of the cerebrovascular bed. 
CrCP is the sum of intracranial pressure and cerebral artery smooth muscle tone [1]. Most likely, 
the increased CrCP in the ﬁrst hours after ROSC is the result of cerebral vasoconstriction. In our 
population cerebral vascular resistance (CVR), reflecting the resistance of small cerebral arteries 
and arterioles, was high and gradually decreased. Transcranial Doppler pulsatility index (PI) has 
traditionally been interpreted as a descriptor of distal CVR [46]. The PI describes the pulsatility 
of TCD waveforms. It is calculated as the difference between systolic and diastolic flow velocities 
divided by the mean velocity [47]. The transcranial Doppler PI of the MCA is high in the early 
phase after cardiac arrest and decreases towards normal values after 24-48 hours [42, 48, 49], 
implicating increased cerebral arterial resistance. An imbalance between local vasoconstrictors and 
vasodilators is the most likely underlying mechanism for these cerebral perfusion changes after 
cardiac arrest [48]. These different parameters all point in the direction of vasoconstriction in the 
early phase after cardiac arrest. Whether this is pathological remains the subject of debate and 
requires further research. It may also imply a protective mechanism. Hypoperfusion may decrease 
cerebral metabolism. Alternatively, hypoperfusion may be the consequence of a decrease of 
neuronal functioning and metabolic needs. 
The jugular venous-to-arterial CO2/arterial to-jugular venous O2 content difference ratio (Cjb-
aCO2/Ca-jbO2) is a useful clinical parameter for the detection of anaerobic cerebral metabolism, 
similar to mixed venous-arterial CO2 to arterial-venous O2 content difference ratio for the 
detection of anaerobic metabolism in sepsis [50]. Hoedemaekers et al. showed, that cerebral 
metabolism after cardiac arrest is mainly aerobic. In this study supply of oxygen was not a limiting 
factor. The conclusion of this study was that it is unlikely that increasing CBF in the ﬁrst hours 
after ROSC will improve neurological activity and outcome [43]. Loss of neural tissue after ROSC 
is secondary to multiple mechanisms, including excitotoxicity, disrupted calcium homeostasis, free 
radical formation, pathological protease cascades, and activation of cell-death signaling pathways 
[43]. Intervention in one or more of these pathways may be more effective than increasing CBF 
after cardiac arrest.
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In case of anaerobic cerebral metabolism, increase of cerebral perfusion by mitigating cerebral 
vasoconstriction may be a proﬁtable therapeutic option. In this way, metabolic supply and demand 
may be better in balance with enhanced opportunity of neurological recovery. It may be important 
to discover the underlying process of vasoconstriction. As mentioned earlier, the mechanism of 
vasoconstriction may include an imbalance between local vasoconstrictors and vasodilators [48]. 
Recovery of this imbalance would be a possible treatment option. Preferably, this therapy should 
work locally in the cerebral vasculature, to prevent further peripheral vasodilatation with systemic 
hypotension and possible hypoperfusion. 
Another technique to determine cerebral perfusion is perfusion computed tomography. Perfusion 
computed tomography is an imaging technique that allows rapid, noninvasive, quantitative 
evaluation of cerebral perfusion by generating maps of CBF, cerebral blood volume and mean 
transit time [51]. With this imaging technique it is possible to determine cerebral perfusion and its 
metabolic consequences. This allows distinguishing a pathological process from an adaptive process, 
by imaging blood vessels, perfusion and, if present, cerebral vasospasm and ischemia [51]. Perfusion 
computed tomography is, in contrast to other techniques, able to show regional heterogeneous 
differences in microvascular perfusion. Perfusion computed tomography is not used routinely in 
brain monitoring in post-cardiac arrest patients for diagnosis, management and prognostication, 
but could be helpful and deserves further research [52].
The spontaneous variability of MFVMCA is low after cardiac arrest and returns to normal values in 
survivors, whereas variability decreased further in non-survivors. The spontaneous variability of 
MAP is low during the ﬁrst 72 hrs after cardiac arrest. To determine the degree of dynamic cerebral 
autoregulation by TFA, sufﬁcient variability in the input signal (e.g. MAP) is necessary [9]. Increasing 
the variability of MAP by tilting of the bed, changes the interpretation of cerebral autoregulation 
(intact or not intact), as determined by TFA. This difference in test results is not related to 
physiological changes in dynamic cerebral autoregulation, as both baseline and intervention were 
performed at the same time-point after cardiac arrest. This difference in test results is most likely 
related to bias induced by the very low variability in the input signal (e.g. the blood pressure) at 
baseline. As the necessary amount of variability of the input signal is unknown and published 
articles do not mention the variability of MAP with TFA, we are unable to assess whether the results 
are reliable. Other methods to determine the presence and degree of dynamic autoregulation 
should therefore be investigated.
Lee et al., Ameloot et al. and Pham et al. used near infrared spectroscopy and MAP to determine 
dynamic cerebral autoregulation and showed that disturbed autoregulation was associated with 
unfavorable outcome and that MAP below the optimal autoregulatory range during the ﬁrst 48 
hours after cardiac arrest was associated with worse outcomes compared to patients with higher 
blood pressures  [5-7].
To recapitulate, these ﬁndings in cerebrovascular hemodynamics suggest that failure to normalize 
the cerebrovascular proﬁle after cardiac arrest may be a parameter of poor outcome. Further 
understanding of cerebral autoregulation after cardiac arrest may unravel the complex interplay 
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between MAP, CBF, characteristics of the cerebrovascular bed and metabolism. It is of great 
importance that dynamic cerebral autoregulation can be measured reliably. TFA is considered the 
gold standard to measure dynamic cerebral autoregulation as described in the white paper from 
the International Cerebral Autoregulation Research Network [9]. However, caution is required 
in interpretation of dynamic cerebral autoregulation determined by TFA if there is low variability 
in the input signal. Reliable measurement of dynamic autoregulation could be extremely useful. 
In patients with an absent dynamic cerebral autoregulation, preservation of adequate perfusion 
pressure is very important. Of course, not only perfusion pressure is important, but also the supply 
of oxygen and nutrients (e.g. glucose) should be sufﬁcient and this applies to both patients with 
intact and impaired dynamic cerebral autoregulation. Both hypoxemia and hyperoxemia are harmful 
for the vulnerable brain in the post-cardiac arrest period [53-60]. Hypocapnia causes cerebral 
vasoconstriction, a decreased CBF and cerebral ischemia, and is associated with a poor neurological 
outcome after cardiac arrest [61-63]. According to the European Resuscitation Council Guidelines 
for Resuscitation 2015, unnecessary arterial hyperoxia should be avoided and the inspired oxygen 
concentration should be titrated to maintain the arterial oxygen saturation in the range of 94-98% 
[64]. Besides, it is reasonable to adjust ventilation to achieve normocarbia [64]. 
Hyperglycemia and hypoglycemia after ROSC have a high association with poor neurological 
outcome [65, 66]. Based on the available literature, it is reasonable to maintain the blood glucose 
level at ≤10 mmol/L (180 mg/dL) and to avoid hypoglycaemia following ROSC [64, 66].
The relation between perfusion pressure and CBF is partly determined by blood viscosity. Hematocrit 
affects blood viscosity and thus the rheological properties of blood [67]. Blood cells increase blood 
viscosity and changes in  blood viscosity are associated with changes in MFVMCA [68]. High viscosity 
early after cardiac arrest may lead to reduced CBF and to secondary brain damage. The optimal 
hematocrit during the different phases after cardiac arrest is still unknown and should be subject 
of future research.
For the patient population with an intact dynamic cerebral autoregulation, the next contributing 
step would be the development of a model to determine the individual lower and upper limits of 
dynamic cerebral autoregulation. The lower limit of autoregulation represents the MAP below which 
the CBF decreases. Whether modulation of the CBF after ROSC, e.g. by maintaining MAP at optimal 
autoregulation ranges, impacts the outcome of these patients remains to be determined. However, 
it seems logical to keep MAP above the lower limit of autoregulation to guarantee an adequate CBF. 
A second argument for this is that a MAP below the optimal autoregulatory range in the early phase 
after cardiac arrest is associated with unfavorable outcome [7]. Future research should lead to an 
individual sufﬁciently high cerebral perfusion pressure, especially in the ﬁrst hours after cardiac 
arrest to avoid secondary brain ischemia. The current data suggest that the widely used MAP range 
of 65-70 mmHg for every patient after cardiac arrest is probably suboptimal [5, 69]. 
Cerebral perfusion pressure is deﬁned as arterial blood pressure minus intracranial pressure (ICP). 
Theoretically, ICP may play a role in cerebral perfusion pressure. The incidence of intracranial 
hypertension after ROSC is unknown, and has been studied in only a small number of highly 
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selected patients [70-73]. In those patients, ICP upon admission to the ICU was low, even in patients 
who developed intracranial hypertension later during the course of admission [71]. We found a high 
CrCP  on admission, which decreased in the ﬁrst hours after ROSC. We speculate that ICP was not 
a major factor determining CrCP in our population, as the gradual increase in ICP would result in a 
high CrCP. This is supported by the fact that CrCP was lower in non-survivors compared to survivors, 
whereas post-cardiac arrest patients with intracranial hypertension (resulting in high CrCP) had an 
invariably poor outcome in all studies [70-73].
 
Section II Cerebral hemodynamics in patients with sepsis and in the human endotoxemia 
model 
Cerebral perfusion, vasoreactivity and cerebral autoregulation are frequently disturbed in patients 
with sepsis and in the human endotoxemia model. The exact effects of sepsis on the macro- and 
microcirculation in humans are difﬁcult to establish, due to the large heterogeneity of the disease, 
varying study protocols and variable results in the studies using LPS to simulate sepsis in healthy 
volunteers. A small number of previous studies in sepsis patients shows an increase in CBF and 
the other studies show a decrease or no change in CBF [13-17, 19-23, 25]. Studies using the human 
endotoxemia model show a decreased or unchanged CBF in response to LPS [27, 32-36]. 
Dynamic cerebral autoregulation is impaired in most sepsis studies, especially in the earlier phases 
of sepsis [16, 17, 27-31]. Studies using the human endotoxemia model show an enhanced dynamic 
autoregulation after LPS infusion [27, 32-34]. All these LPS studies used a model with infusion of 2 
ng/kg LPS. However, it is important to realize that study protocols may vary on several points. 
Impaired dynamic cerebral autoregulation is one of the contributing factors to SAE and consequently 
to morbidity and mortality. To gain more insight in dynamic cerebral autoregulation in sepsis, we 
studied the effect of higher dosage LPS (4 ng/kg) for a longer infusion period. Higher dosage 
LPS infusion accomplishes a more pronounced inflammatory response compared to LPS 2 ng/kg 
administration. Higher dosage LPS 4 ng/kg infusion and LPS 2 ng/kg bolus administration did have 
the same cerebrovascular proﬁle and dynamic cerebral autoregulation. Until now, no other studies 
using higher dosage regimens are performed. It may be interesting and important to investigate 
which experimental model mimics sepsis and the effects of sepsis on the cerebrovascular 
hemodynamics in the most reliable way. More insight in cerebral hemodynamics during sepsis is 
necessary, because dysregulation of CBF is a key component in the development of SAE [74]. SAE 
is the most frequent type of encephalopathy in the ICU occurring in 30-70% of septic patients [75-
77]. SAE is associated with increased mortality, higher use of ICU resources, longer hospital stay 
and increased morbidity with long-term cognitive decline [11]. Three studies showed a reduced CBF 
in sepsis patients with SAE [13, 19, 22]. Pﬁster et al. found no difference in cerebral perfusion in 16 
sepsis patients with and without SAE, however the state of autoregulation differed between the 
two groups [78]. PI is increased in patients with SAE and reduced CBF [19, 22]. This implicates an 
increased cerebral arterial resistance and cerebral vasoconstriction. If the underlying mechanisms 
of this vasoconstriction (triggered by the neurovascular unit that is composed by neurones, 
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astrocytes, endothelial cells of blood-brain barrier, myocytes, pericytes and extracellular matrix 
components) can be unraveled in the future, this could offer possibilities for therapeutic options.
Another important point of interest is the target blood pressure in patients with sepsis. Most 
clinicians, instructed by the Surviving Sepsis Campaign, use a target mean arterial blood pressure 
above 65 mmHg [79]. The effects of different vasopressors on the cerebrovascular perfusion in 
sepsis were not investigated before, despite the widespread use of these agents in daily clinical 
practice. Directly studying the effects of different vasopressors on cerebral hemodynamics in sepsis 
patients is difﬁcult, because of the heterogeneity of the patient population. In addition, current 
sepsis resuscitation protocols dictate a central role for noradrenaline to restore MAP. We used 
the human endotoxemia model to investigate the effect of different vasopressors (noradrenaline, 
phenylephrine and vasopressin) on cerebral hemodynamics in sepsis patients. We determined 
that patients with sepsis will not automatically restore cerebral perfusion, despite treatment with 
vasopressors titrated to a speciﬁc minimal MAP. So, these patients do have a risk for low CBF and 
ischemia, despite an apparently sufﬁcient systemic blood pressure. We cannot compare our results 
with previous literature, because the available literature is restricted to patients suffering from 
traumatic brain damage [80-83]. None of these trauma studies found signiﬁcant differences in 
cerebral hemodynamic changes between different vasopressors. 
Particular in the early stages of resuscitation of septic shock microvascular perfusion is deranged, 
even when the macrocirculation looks normal [84]. Near-infrared spectroscopy is clinically suitable 
to investigate the cerebral microcirculation [85]. Also jugular venous-to-arterial CO2/arterial to-
jugular venous O2 content difference ratio, as described in patients after cardiac arrest, could be 
useful to evaluate and optimize cerebral microvascular perfusion [43]. Of course, future research on 
this topic is necessary to investigate techniques to analyse the cerebral microcirculation in sepsis 
and to investigate the clinical opportunities for diagnosis and intervention. 
The current techniques (e.g. near-infrared spectroscopy) satisfactorily detect global decreases in 
tissue perfusion but not heterogeneity of microvascular perfusion. Cerebral perfusion changes 
are probably heterogeneously distributed throughout the brain in sepsis, with some areas more 
affected than others. Also techniques analyzing macrovascular parameters (e.g. MFVMCA) cannot 
measure these heterogeneities. Perfusion computed tomography allows evaluation of cerebral 
perfusion and determination of cerebral vasospasm and ischemia [51]. This technique could be 
helpful in brain monitoring in sepsis patients for diagnosis, management and prognostication, but 
is not used routinely and needs further research [52].
Future research should focus on increasing insight into the effects of sepsis on cerebral perfusion, 
vasoreactivity, autoregulation and microcirculation, resulting in the development of brain-protective 
strategies to prevent SAE. More research is also necessary to investigate cerebral perfusion 
parameters to effectuate optimal, individual cerebral perfusion (to prevent hyperperfusion and 
hypoperfusion) and not just a certain systemic blood pressure. This requires studies according to 
the same protocol in well-deﬁned populations. 
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hoofdstuk 10
Samenvatting, conclusies, 
toekomstperspectieven en klinische 
implicaties
proefschrift_Judith_Brule_final.indd   155 09/11/2018   13:36
526134-L-bw-Brule
Processed on: 12-11-2018 PDF page: 156
156
In dit proefschrift bestudeerden we de cerebrale bloeddoorstroming bij patiënten met een 
inflammatoire status, meer speciﬁek bij patiënten na een hartstilstand (Sectie I) en bij patiënten 
met sepsis (Sectie II). 
Gemiddelde arteriële bloeddruk (MAP) en cerebrale autoregulatie zijn belangrijke determinanten 
van de cerebrale bloeddoorstroming. Cerebrale autoregulatie is het mechanisme dat zorgt voor een 
constante bloedstroom binnen bepaalde bloeddruk grenzen. Cerebrale autoregulatie kan bepaald 
worden door het meten van relatieve veranderingen in bloedstroom als reactie op een stabiele 
verandering in bloeddruk (statische methode) of gedurende de reactie op een snelle verandering in 
bloeddruk (dynamische methode). De statische methode evalueert met name de efﬁciëntie van de 
autoregulatie, terwijl de dynamische methode evalueert hoe snel de hersendoorbloeding zich kan 
aanpassen aan veranderingen in perfusiedruk. 
De “critical closing pressure” (CrCP) is een methode die frequent wordt toegepast om de 
karakteristieken van het cerebrovasculaire vaatbed te kwantiﬁceren. De CrCP wordt gedeﬁnieerd 
als de ondergrens van arteriële bloeddruk waaronder vaten collaberen en de bloedstroom ophoudt 
[1, 2]. CrCP kan niet direct gemeten worden, zodat verschillende methoden ontwikkeld zijn om de 
CrCP indirect te schatten op basis van meetbare fysiologische parameters en andere afgeleiden. 
Het meest frequent gebruikte model is het multiparameter mathematisch model zoals voorgesteld 
door Varsos et al. [3]. CrCP kan, gebruikmakend van het concept van impedantie voor cerebrale 
bloedstroom, worden uitgedrukt met hersenmonitor parameters: cerebrale perfusiedruk, arteriële 
bloedstroom snelheid (MFVMCA) en hartfrequentie [3].  
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Samenvatting
Sectie I Cerebrale hemodynamiek bij patiënten na een hartstilstand
Een hartstilstand buiten het ziekenhuis is de meest voorkomende doodsoorzaak in 
geïndustrialiseerde landen. Hoofdstuk 2 geeft een overzicht van de huidige literatuur betreffende 
cerebrale perfusie en cerebrale autoregulatie na een hartstilstand. Cerebrale perfusie na reanimatie 
vertoont een beloop in de tijd met vroege hyperemie, gevolgd door hypoperfusie en uiteindelijk 
herstel van normale bloeddoorstroming. 
Statische en dynamische cerebrale autoregulatie kunnen ongeschonden blijven bij comateuze 
patiënten na een hartstilstand, maar met een versmalde en naar boven verschoven plateauzone [4]. 
Frequent zijn de statische en dynamische cerebrale autoregulatie echter gestoord na reanimatie. 
Gestoorde autoregulatie en een MAP onder het optimale autoregulatie bereik in de vroege fase na 
een hartstilstand zijn geassocieerd met een slechte uitkomst [5-7].
CrCP is een betrouwbare parameter om de karakteristieken van het cerebrovasculaire vaatbed te 
kwantiﬁceren en wordt gedeﬁnieerd als de ondergrens van arteriële bloeddruk waaronder vaten 
collaberen en de bloedstroom ophoudt [1, 2].  
Het doel van hoofdstuk 3 was om de CrCP van de cerebrovasculaire circulatie vast te stellen 
gedurende de vroege periode na een hartstilstand en om te bepalen of de CrCP verschillend is 
tussen overlevers en niet-overlevers. CrCP werd bepaald volgens de methode zoals voorgesteld 
door Varsos et al. [3, 8]. Zoals verwacht nam de MFVMCA signiﬁcant toe vanaf opname op de intensive 
care unit (ICU) tot 72 uur na hartstilstand. De MFVMCA was gelijk in overlevers en niet-overlevers 
bij opname op de ICU, maar de MFVMCA nam sterker toe (overshoot) in niet-overlevers vergeleken 
met overlevers gedurende de observatie periode. Meteen na de hartstilstand was de CrCP in alle 
patienten signiﬁcant hoger vergeleken met gezonde controle personen. De CrCP nam signiﬁcant af 
vanaf opname tot 48 uur na hartstilstand en daarna bleef de CrCP stabiel. De CrCP was signiﬁcant 
hoger in overlevers vergeleken met niet-overlevers. Wij concludeerden dat CrCP hoog is meteen na 
hartstilstand met een hoge cerebrovasculaire weerstand en lage cerebrale bloedstroom snelheden. 
Dit impliceert dat cerebrale perfusiedruk op een voldoende hoog niveau gehouden moet worden 
om secundaire hersenschade te vermijden. Wij concludeerden ook dat het uitblijven van herstel 
naar een normaal cerebrovasculair proﬁel een teken van slechte uitkomst kan zijn.
In hoofdstuk 4 onderzochten we de spontane variabiliteit van de MFVMCA en MAP in het 
tijdsdomein en in het frequentiedomein bij comateuze patiënten gedurende de eerste 72 uur na 
een hartstilstand, om mogelijke verschillen vast te stellen tussen overlevers en niet-overlevers. 
De spontane variabiliteit van de MFVMCA was laag na hartstilstand. MFVMCA variabiliteit herstelde 
naar normale waarden in overlevers terwijl de variabiliteit verder afnam in niet-overlevers na een 
hartstilstand. De variabiliteit van de MAP bleef laag gedurende de gehele studie periode na een 
hartstilstand. Er waren geen verschillen in variabiliteit van MAP tussen overlevers en niet-overlevers. 
De gemiddelde power in het “very low frequency” (VLF) spectrum van de MFVMCA was laag na 
hartstilstand en herstelde tot normale waarden in overlevers, terwijl deze gemiddelde power laag 
proefschrift_Judith_Brule_final.indd   157 09/11/2018   13:36
526134-L-bw-Brule
Processed on: 12-11-2018 PDF page: 158
158
bleef in niet-overlevers. Blijkbaar zijn de intrinsieke myogene vasculaire functie en sympathische 
autonome regulatie verstoord bij niet-overlevers na een hartstilstand.
De verschillen in spontane fluctuaties in MFVMCA zoals beschreven in hoofdstuk 4 suggereren 
veranderingen in dynamische autoregulatie na hartstilstand. Transfer functie analyse (TFA) wordt 
beschouwd als de gouden standaard voor het bepalen van dynamische cerebrale autoregulatie en 
deze techniek berust op spontane (of geïnduceerde) fluctuaties in het ingangssignaal. De variabiliteit 
in MAP is laag na een hartstilstand. Aangezien lage variabiliteit in MAP als ingangssignaal de 
betrouwbaarheid van het resulterende uitgangssignaal sterk kan reduceren, hebben we de mate 
van dynamische autoregulatie niet gekwantiﬁceerd in deze populatie [9]. 
Hieropvolgend was het doel van hoofdstuk 5 om vast te stellen of een kunstmatige toename 
van bloeddruk variabiliteit het bepalen van de cerebrale autoregulatie zou verbeteren. Herhaalde 
kanteling van het bed induceerde een signiﬁcante toename in variabiliteit van MAP en MFVMCA bij 
patiënten na een hartstilstand. Verhoging van bloeddruk variabiliteit door kantelen van het bed 
veranderde de interpretatie van cerebrale autoregulatie (van intact naar gestoord en andersom) op 
basis van TFA en op basis van de “mean flow velocity index” (Mx). Dit verschil in interpretatie van 
cerebrale autoregulatie komt meest waarschijnlijk door bias die wordt geïnduceerd door de zeer 
lage variabiliteit (zoals eerder beschreven in hoofdstuk 4) van het bloeddruk- en MFVMCA-signaal bij 
de uitgangsmeting. Wij concludeerden dat een toename in bloeddruk variabiliteit nuttig is voor de 
bepaling van dynamische cerebrale autoregulatie door TFA. De noodzakelijke minimale hoeveelheid 
aan variabiliteit is nog niet vastgesteld.
Sectie II Cerebrale hemodynamiek bij patiënten met sepsis en in het humane endotoxemie 
model
Disregulatie van cerebrale hemodynamiek speelt een cruciale rol in de ontwikkeling van sepsis-
geassocieerde encefalopathie (SAE) [10]. SAE is geassocieerd met toegenomen mortaliteit, meer 
gebruik van intensive care middelen, langer ziekenhuisverblijf en toename in morbiditeit met 
op de lange termijn cognitieve achteruitgang [11]. Wij gebruikten het humane endotoxemie 
model om meer inzicht te verwerven in de effecten van sepsis op de cerebrale hemodynamiek. 
Het humane experimentele endotoxemie model met toediening van lipopolysaccharide (LPS) 
is een veilig en reproduceerbaar model van systemische inflammatie in de mens in vivo. Dit 
model omvat veel (hemodynamische) kenmerken van vroege sepsis [12]. Hoofdstuk 6 geeft een 
overzicht van de huidige literatuur betreffende cerebrale perfusie en cerebrale autoregulatie in 
patiënten met sepsis en in het humane endotoxemie model. Cerebrale bloedstroom is heterogeen 
(toegenomen, afgenomen, onveranderd) in sepsis. Deze heterogeniteit is waarschijnlijk het gevolg 
van methodologische verschillen (bijvoorbeeld studieprotocollen met verschillende tijdstippen van 
inclusie) en individuele verschillen tussen patiënten (bijvoorbeeld veranderingen in inflammatoire 
respons en verschillen in hartminuutvolume) [13-25]. Statische autoregulatie was intact in patiënten 
met sepsis [25-27]. Daarentegen was dynamische cerebrale autoregulatie verminderd in de meeste 
studies, met name in de vroege fase van sepsis [16, 17, 27-31]. De verslechtering van dynamische 
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cerebrale autoregulatie was geassocieerd met de ontwikkeling van SAE en mortaliteit. Cerebrale 
perfusie bleef stabiel of verminderde na LPS infusie [27, 32-36]. Statische autoregulatie bleef intact 
na LPS en dynamische autoregulatie was versterkt [27, 32-34]. 
De verschillen in dynamische cerebrale autoregulatie tussen sepsis en gezonde vrijwilligers aan wie 
LPS werd toegediend (verminderde dynamische cerebrale autoregulatie in patiënten met sepsis 
versus versterkte dynamische autoregulatie in gezonde vrijwilligers na LPS infusie) kan het resultaat 
zijn van verschillen in de duur en ernst van de systemische inflammatoire respons. Hoofdstuk 7 
beschreef het effect van hoge dosis LPS middels continue infusie (4 ng/kg LPS), vergeleken met 
2 ng/kg bolus LPS en vergeleek dit met patiënten met sepsis. Wij veronderstelden dat een hogere 
dosis LPS een meer uitgesproken systemische inflammatoire respons zou creëren en dat deze 
respons de cerebrovasculaire veranderingen van klinische sepsis nauwkeuriger zou nabootsen. De 
resultaten toonden een verminderde dynamische cerebrale autoregulatie, gemeten met behulp van 
TFA, bij patiënten met sepsis en een intacte dynamische cerebrale autoregulatie gedurende humane 
endotoxemie na 2 en 4 ng/kg LPS. CrCP daalde in beide LPS groepen en was laag in patiënten 
met sepsis. Dit weerspiegelt een uitgeput compensatoir cerebrovasculair mechanisme in sepsis. De 
stabiele cerebrale autoregulatie respons in ons humane endotoxemie experiment, in tegenstelling 
tot een versterkte dynamische cerebrale autoregulatie in de eerder verschenen literatuur, kan 
gerelateerd zijn aan het grotere volume vocht (2.5 L) dat werd toegediend in onze studie, waardoor 
grote fluctuaties in perfusiedruk en hartminuutvolume werden voorkomen. Studies die een 
versterkte dynamische cerebrale autoregulatie beschreven dienden geen additionele hoeveelheden 
vocht toe voorafgaand en tijdens het humane endotoxemie experiment. Wij concludeerden 
dat het humane endotoxemie model niet zomaar kan worden gebruikt voor sepsisgerelateerde 
cerebrovasculair onderzoek.
Vasopressoren worden vaak toegepast om hypotensie en dientengevolge verminderde cerebrale 
perfusie tegen te gaan in sepsis en septische shock [37]. In hoofdstuk 8 beschreven wij de effecten 
van verschillende vasopressoren op de cerebrale vasculatuur gedurende experimentele humane 
endotoxemie. Wij gebruikten CrCP als een maat voor cerebrale vasculaire tonus gedurende 
experimentele humane endotoxemie en sepsis. Zowel experimentele humane endotoxemie als 
sepsis resulteerde in een afgenomen CrCP ten gevolge van een afname in vasculaire tonus van 
het arteriële vaatbed. Vasopressoren (noradrenaline, fenylefrine en vasopressine) voorkwamen niet 
dat de CrCP afnam na toediening van LPS. Een belangrijke klinische implicatie is dat titratie van de 
systemische circulatie naar een speciﬁeke minimale MAP met vasopressoren niet automatisch de 
cerebrale perfusie zal herstellen bij patiënten met septische shock.
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Conclusies, toekomstperspectieven en klinische implicaties
Sectie I Cerebrale hemodynamiek bij patiënten na een hartstilstand
Cerebrale perfusie na herstel van spontane circulatie (ROSC) wordt gekenmerkt door vroege 
hyperemie (0-20min), gevolgd door een periode van hypoperfusie (20min-12uur). Gedurende de 
hypoperfusie fase daalt de hersendoorbloeding tot ongeveer 50% of lager [38, 39]. Eerder verschenen 
literatuur toonde aan dat de hersendoorbloeding daarna (12-72uur) persisterend laag, toegenomen 
of normaal is, terwijl meer recente literatuur een normale of toegenomen MFVMCA als parameter 
van hersendoorbloeding gedurende deze periode beschreef [38-42]. Het is belangrijk te vermelden 
dat MFVMCA niet overeenkomt met hersendoorbloeding, maar veranderingen in hersendoorbloeding 
kunnen geëxtrapoleerd worden vanuit veranderingen in MFVMCA. Hersendoorbloeding en MFVMCA 
hebben een lineaire verhouding mits de diameter van het bloedvat (MCA) en de hoek van echo 
hetzelfde blijven wanneer transcraniële Doppler gebruikt wordt.
Wij stelden een lage MFVMCA vast in de vroege fase na een hartstilstand, zoals ook beschreven in 
eerdere literatuur. Daarna (12-72uur na ROSC), herstelt de MFVMCA tot normale waarde bij patiënten 
die uiteindelijk overleven. MFVMCA neemt sterker toe (overshoot) in niet-overlevers vergeleken met 
overlevers. 
Recent concludeerden Hoedemaekers et al. dat een lage hersendoorbloeding na ROSC niet 
geassocieerd is met anaeroob metabolisme en dat hypoperfusie het resultaat lijkt te zijn van 
een afname in neurologische functie en metabole behoeften [43]. Een alternatieve verklaring is 
dat hypoperfusie het cerebraal metabolisme zou kunnen doen afnemen, omdat een verminderd 
energie aanbod leidt tot een plotse onderbreking van multipele neuronale functies en dan met 
name synaptische neurotransmissie [44]. Deze reductie in neurotransmissie wordt beschouwd als 
een compensatie mechanisme [45]. Tevens concludeerden zij dat deze toename in metabolisme 
in overlevers gepaard gaat met herstel van neuronale activiteit, terwijl een persisterend laag 
metabolisme in niet-overlevers een reflectie is van irreversibele neuronale schade [43]. 
De CrCP is signiﬁcant hoger na een hartstilstand vergeleken met gezonde controle personen. 
De CrCP neemt signiﬁcant af vanaf opname tot 48 uur na de hartstilstand en daarna blijft de 
CrCP stabiel. De CrCP is signiﬁcant hoger in overlevers vergeleken met niet-overlevers. Dit 
suggereert dat cerebrale perfusie op een voldoende hoog niveau gehouden moet worden om 
secundaire hersenschade te vermijden. Er zijn geen andere studies die de CrCP gebruikten 
om de karakteristieken van het cerebrovasculaire vaatbed te kwantiﬁceren. CrCP is de som van 
intracraniële druk en de tonus van de gladde spier in de cerebrale arteriën [1]. De toegenomen 
CrCP in de eerste uren na ROSC is meest waarschijnlijk het gevolg van cerebrale vasoconstrictie. 
In onze populatie was de cerebrale vasculaire weerstand (CVR), die de weerstand van de kleine 
cerebrale arteriën en arteriolen weergeeft, hoog waarna deze gradueel afnam. De pulsatiliteit 
index (PI) wordt traditioneel gezien als een weergave van distale CVR [46]. De PI beschrijft de 
pulsatiliteit van transcraniële Doppler (TCD) golfvormen. De index wordt berekend als het verschil 
tussen systolische en diastolische stroomsnelheid gedeeld door de gemiddelde snelheid [47]. De 
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PI van de MCA is hoog in de vroege fase na een hartstilstand en neemt af tot normale waarden 
na 24-48 uur, wat een toegenomen cerebrale arteriële weerstand impliceert [42, 48, 49]. Het 
onderliggende mechanisme voor deze cerebrale perfusie veranderingen na een hartstilstand is 
meest waarschijnlijk een disbalans tussen lokale vasoconstrictoren en vasodilatatoren [48]. Deze 
verschillende parameters wijzen allemaal in de richting van vasoconstrictie in de vroege fase na een 
hartstilstand. Of dit pathologisch is, blijft onderwerp van discussie en vereist verder onderzoek. Het 
zou ook een beschermingsmechanisme kunnen zijn. Hypoperfusie kan het cerebrale metabolisme 
doen afnemen. Een alternatieve benadering is dat hypoperfusie het gevolg kan zijn van een afname 
in neuronale functie en metabole behoeften. 
De hoeveelheid CO2 in de vena jugularis minus de hoeveelheid CO2 arterieel ten opzichte van de 
hoeveelheid O2 arterieel minus de hoeveelheid O2 in de vena jugularis (Cjb-aCO2/Ca-jbO2) is een 
bruikbare klinische parameter voor de detectie van anaeroob cerebraal metabolism, gelijkwaardig 
aan de verhouding van de gemengd veneuze minus arteriële CO2 hoeveelheid ten opzichte de 
arteriële minus de veneuze O2 hoeveelheid voor de detectie van anaeroob metabolisme in sepsis 
[50]. Hoedemaekers et al. toonden aan dat cerebraal metabolisme na een hartstilstand met name 
aeroob is. In deze studie was het aanbod van zuurstof aan de hersenen niet de limiterende factor. 
De conclusie van deze studie was dat het onwaarschijnlijk is dat een toename in hersendoorbloeding 
in de eerste uren na ROSC de neurologische activiteit en uitkomst zal verbeteren [43]. Verlies van 
neuraal weefsel na ROSC is secundair aan multipele mechanismen, zoals excitotoxiciteit, verstoorde 
calcium hemostase, vrije radicaal vorming, pathologische protease cascades en activatie van 
signaleringsroutes voor celdood [43]. Interventie in een of meerdere van deze mechanismen zou 
effectiever kunnen zijn dan het verhogen van hersendoorbloeding na een hartstilstand.
In geval van anaeroob cerebraal metabolisme zou toename van cerebrale perfusie door het 
verminderen van cerebrale vasoconstrictie een bijdragende therapeutische optie kunnen zijn. 
Op deze manier zouden metabole vraag en aanbod beter in balans gebracht kunnen worden met 
een grotere kans op neurologisch herstel. Het is belangrijk om het onderliggende proces van 
vasoconstrictie te analyseren. Zoals eerder vermeld zou het mechanisme van vasoconstrictie kunnen 
berusten op een disbalans tussen lokale vasoconstrictoren en vasodilatatoren [48]. Herstel van deze 
disbalans zou een mogelijke behandeloptie kunnen zijn. Deze therapie moet bij voorkeur lokaal op 
de cerebrale vasculatuur werken om verdere perifere vasodilatatie met systemische hypotensie en 
mogelijke hypoperfusie te voorkomen
Een andere techniek om cerebrale perfusie nader te analyseren is perfusie computer tomograﬁe. 
Perfusie computer tomograﬁe is een beeldvormingstechniek die snelle, niet-invasieve, kwantitatieve 
evaluatie van de cerebrale perfusie mogelijk maakt [51]. Met deze beeldvormingstechniek is het 
mogelijk om de cerebrale perfusie en de metabole gevolgen ervan vast te stellen. Dit maakt het 
mogelijk om pathologische processen te onderscheiden van adaptieve processen door het afbeelden 
van bloedvaten, perfusie en, indien aanwezig, cerebrale vaatspasmen en ischemie [51]. Perfusie 
computer tomograﬁe is, in tegenstelling tot andere technieken, in staat om regionale heterogene 
verschillen in microvasculaire perfusie aan te tonen. Perfusie computer tomograﬁe wordt niet 
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routinematig toegepast voor breinmonitoring na een hartstilstand voor diagnose, behandeling en 
prognosebepaling, maar zou behulpzaam kunnen zijn en verdient verder onderzoek [52].
De spontane variabiliteit van de MFVMCA is laag na een hartstilstand en herstelt naar normale 
waarden in overlevers, terwijl de variabiliteit verder afneemt bij niet-overlevers. De spontane 
variabiliteit van de MAP is laag gedurende de eerste 72 uur na een hartstilstand. Om de mate van 
dynamische cerebrale autoregulatie te bepalen met behulp van TFA is voldoende variabiliteit van 
het ingangssignaal (bijvoorbeeld MAP) noodzakelijk [9]. Toename van de variabiliteit van MAP 
door het kantelen van het bed verandert de interpretatie van cerebrale autoregulatie (intact of niet 
intact), zoals vastgesteld door TFA. Dit verschil in testresultaten is niet gerelateerd aan fysiologische 
veranderingen in dynamische cerebrale autoregulatie, aangezien zowel de basismeting als 
de interventiemeting werd verricht op hetzelfde tijdstip na de hartstilstand. Dit verschil in 
testresultaten is meest waarschijnlijk gerelateerd aan bias die geïnduceerd is door de zeer lage 
variabiliteit van het ingangssignaal (bijvoorbeeld bloeddruk) bij de basismeting. Wij zijn niet in 
staat om te bepalen of de resultaten betrouwbaar zijn aangezien de noodzakelijke hoeveelheid 
variabiliteit van het ingangssignaal onbekend is en gepubliceerde artikelen de variabiliteit van 
de MAP bij TFA niet vermelden. Andere methoden om de aanwezigheid en mate van dynamische 
autoregulatie te bepalen moeten om die reden onderzocht worden.
Lee et al., Ameloot et al. en Pham et al. gebruikten “near infrared spectroscopy” en MAP om 
dynamische cerebrale autoregulatie te bepalen en toonden aan dat gestoorde autoregulatie 
geassocieerd was met ongunstige uitkomst en dat MAP beneden de optimale autoregulatie grenzen 
in de eerste 48 uur na hartstilstand geassocieerd was met slechtere uitkomst vergeleken met 
patiënten met hogere bloeddrukken [5-7].
Samenvattend, suggereren deze bevindingen in cerebrovasculaire hemodynamiek dat het niet 
herstellen van het cerebrovasculaire proﬁel na een hartstilstand een voorspeller is voor een 
slechte uitkomst. Meer inzicht in cerebrale autoregulatie na een hartstilstand kan de complexe 
interactie tussen MAP, hersendoorbloeding, karakteristieken van het cerebrovasculaire vaatbed 
en metabolisme ontrafelen. Het is van groot belang dat dynamische cerebrale autoregulatie 
betrouwbaar gemeten kan worden. TFA wordt beschouwd als de gouden standaard om dynamische 
cerebrale autoregulatie te bepalen zoals is beschreven in “the white paper from the International 
Cerebral Autoregulation Research Network” [9]. Niettemin is voorzichtigheid geboden in de 
interpretatie van dynamische cerebrale autoregulatie zoals bepaald door TFA wanneer er sprake is van 
lage variabiliteit in het ingangssignaal. Betrouwbare meting van dynamische autoregulatie kan zeer 
nuttig zijn. Bij patiënten met afwezige dynamische cerebrale autoregulatie is behoud van adequate 
perfusiedruk uitermate belangrijk. Natuurlijk is niet alleen de perfusiedruk belangrijk, maar ook de 
toevoer van zuurstof en voedingsstoffen (zoals bijvoorbeeld glucose) moet voldoende zijn bij zowel 
patiënten met intacte als voor patiënten met aangedane dynamische cerebrale autoregulatie. Zowel 
hypoxemie als hyperoxie is schadelijk voor het vulnerabele brein in de periode na een hartstilstand 
[53-60]. Hypocapnie veroorzaakt cerebrale vasoconstrictie, een verminderde hersendoorbloeding 
en cerebrale ischemie, en is geassocieerd met slechte neurologische uitkomst na een hartstilstand 
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[61-63]. Overeenkomstig de European Resuscitation Council Guidelines for Resuscitation 2015, dient 
onnodige arteriële hyperoxie vermeden te worden en dient de ingeademde concentratie zuurstof 
zodanig getitreerd te worden dat de arteriële zuurstofsaturatie tussen 94-98% is [64]. Tevens moet 
de ventilatie aangepast worden, zodat normocapnie bereikt wordt [64]. 
Hyperglycemie en hypoglycemie na ROSC zijn sterk geassocieerd met slechte neurologische 
uitkomst [65, 66]. Gebaseerd op de beschikbare literatuur lijkt het redelijk om de glucosewaarde in 
bloed ≤10 mmol/L (180 mg/dL) te houden en hypoglycemie te vermijden na ROSC [64, 66].
De relatie tussen perfusiedruk en hersendoorbloeding wordt deels bepaald door de viscositeit van 
het bloed. Hematocriet beïnvloedt viscositeit en dus de rheologische eigenschappen van het bloed 
[67]. Bloedcellen doen de viscositeit van het bloed toenemen en veranderingen in die viscositeit 
zijn geassocieerd met veranderingen in MFVMCA [68]. Hoge viscositeit vroeg na een hartstilstand 
kan leiden tot verminderde hersendoorbloeding en tot secundaire hersenschade. De optimale 
hematocriet gedurende de verschillende fases na een hartstilstand is nog steeds niet bekend en 
moet onderwerp zijn voor toekomstig onderzoek.
De volgende bijdragende stap voor de patiëntenpopulatie met een intacte dynamische cerebrale 
autoregulatie is het ontwikkelen van een model om de individuele onder- en bovengrens van 
dynamische cerebrale autoregulatie vast te stellen. De ondergrens van autoregulatie weerspiegelt 
de MAP waaronder de hersendoorbloeding afneemt. Of moduleren van de hersendoorbloeding 
na ROSC, bijvoorbeeld door de MAP binnen de grenzen van autoregulatie te houden, de uitkomst 
beïnvloedt, moet nog worden uitgezocht. Echter, het lijkt logisch om de MAP boven de ondergrens 
van autoregulatie te houden om een adequate hersendoorbloeding te garanderen. Een tweede 
argument hiervoor is dat een MAP onder het optimale bereik van autoregulatie in de vroege fase 
na een hartstilstand geassocieerd is met ongunstige uitkomst [7]. Toekomstig onderzoek moet 
leiden tot een individueel voldoende hoge cerebrale perfusiedruk, met name in de eerste uren 
na een hartstilstand, om secundaire hersenschade te voorkomen. De huidige kennis suggereert 
dat de veelgebruikte MAP tussen 65-70 mmHg voor iedere patiënt na een hartstilstand mogelijk 
suboptimaal is [5, 69]. 
Cerebrale perfusiedruk is gedeﬁnieerd als MAP minus intracraniële druk (ICP). Theoretisch speelt 
ICP een belangrijke rol in cerebrale perfusiedruk. De incidentie van intracraniële hypertensie na 
ROSC is onbekend, en is alleen bestudeerd in een klein aantal  streng geselecteerde patiënten 
[70-73]. Bij die patiënten was de ICP bij opname op de ICU laag, zelfs bij patiënten die gedurende 
het latere beloop van opname intracraniële hypertensie ontwikkelden [71]. Wij stelden een hoge 
CrCP vast bij opname en deze CrCP daalde in de eerste uren na ROSC. Wij speculeren dat ICP 
geen belangrijke factor is voor de CrCP in onze populatie aangezien de graduele toename in ICP 
zou resulteren in een hoge CrCP. Dit wordt ondersteund door het feit dat de CrCP lager was in 
niet-overlevers vergeleken met overlevers, terwijl patiënten na een hartstilstand met intracraniële 
hypertensie (resulterend in een hoge CrCP) een slechte uitkomst hadden in alle studies [70-73].
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Sectie II Cerebrale hemodynamiek bij patiënten met sepsis en in het humane endotoxemie 
model 
Cerebrale perfusie, vasoreactiviteit en cerebrale autoregulatie zijn frequent verstoord bij patiënten 
met sepsis en in het humane endotoxemie model. De precieze effecten van sepsis op de macro- en 
microcirculatie bij mensen zijn moeilijk vast te stellen ten gevolge van de grote heterogeniteit  van 
de ziekte, de verschillende studieprotocollen en variabele resultaten in de studies die LPS gebruiken 
om sepsis te simuleren in gezonde vrijwilligers. Een klein aantal eerdere studies bij sepsis patiënten 
toont een toename van hersendoorbloeding en de andere studies tonen een afname of geen 
verandering in hersendoorbloeding [13-17, 19-23, 25]. Studies die het humane endotoxemie model 
gebruiken tonen een afname of onveranderde hersendoorbloeding in reactie op LPS [27, 32-36]. 
Dynamische cerebrale autoregulatie is aangedaan in de meeste sepsis studies, met name in de 
vroege fases van sepsis [16, 17, 27-31]. Studies die het humane endotoxemie model gebruiken tonen 
een toegenomen dynamische autoregulatie na toediening van LPS [27, 32-34]. Al deze LPS studies 
gebruikten een model met infusie van 2 ng/kg LPS. Echter het is belangrijk te realiseren dat deze 
studieprotocollen onderling verschillen op meerdere punten. 
Verminderde dynamische cerebrale autoregulatie is een van de bijdragende factoren aan SAE 
en dientengevolge aan morbiditeit en mortaliteit. Wij bestudeerden het effect van een hogere 
dosis LPS (4 ng/kg) gedurende een langere periode van infusie om meer inzicht te verwerven in 
dynamische cerebrale autoregulatie tijdens sepsis. Hogere dosis LPS infusie bewerkstelligt een meer 
uitgesproken inflammatoire respons vergeleken met LPS 2 ng/kg toediening. Hogere dosis LPS 4 
ng/kg infusie en LPS 2 ng/kg bolus toediening resulteren in hetzelfde cerebrovasculaire proﬁel en 
in dezelfde dynamische cerebrale autoregulatie. Tot nu toe zijn er geen andere studies uitgevoerd 
die hogere dosisregimes gebruiken. Het is interessant en belangrijk om te onderzoeken welk 
experimenteel model sepsis en de effecten van sepsis op de cerebrovasculaire hemodynamiek het 
meest betrouwbaar nabootst. Meer inzicht in cerebrale hemodynamiek tijdens sepsis is noodzakelijk, 
omdat ontregeling van hersendoorbloeding een belangrijke factor is in de ontwikkeling van SAE 
[74]. SAE is het meest frequent voorkomende type van encefalopathie op de ICU en komt voor in 
30-70% van de septische patiënten [75-77]. SAE is geassocieerd met toegenomen mortaliteit, meer 
gebruik van ICU middelen, langer ziekenhuisverblijf en toegenomen morbiditeit met cognitieve 
achteruitgang op de lange termijn [11]. Drie studies laten een verminderde hersendoorbloeding 
zien bij sepsis patiënten met SAE [13, 19, 22]. Pﬁster et al. zien geen verschil in cerebrale perfusie 
bij 16 sepsis patiënten met en zonder SAE, echter de mate van autoregulatie verschilt tussen 
de twee groepen [78]. De PI is toegenomen bij patiënten met SAE en de hersendoorbloeding is 
verminderd [19, 22]. Dit impliceert een toegenomen cerebrale arteriële weerstand en cerebrale 
vasoconstrictie. Indien het onderliggende mechanisme van deze vasoconstrictie (getriggerd door 
de neurovasculaire eenheid die bestaat uit neuronen, astrocyten, endotheel cellen van de bloed-
hersenbarrière, myocyten, pericyten en extracellulaire matrix componenten) ontrafeld kan worden, 
dan biedt dit in de toekomst mogelijkheden voor therapeutische opties.
Een ander belangrijk en interessant punt is de streefbloeddruk bij patiënten met sepsis. De meeste 
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clinici, geïnstrueerd door de Surviving Sepsis Campaign, passen een MAP toe van boven de 65 
mmHg [79]. De effecten van verschillende vasopressoren op de cerebrovasculaire perfusie tijdens 
sepsis zijn niet eerder onderzocht, ondanks het wijdverspreid gebruik van deze middelen in de 
dagelijkse klinische praktijk. Het bestuderen van het effect van de verschillende vasopressoren 
op de cerebrale hemodynamiek tijdens sepsis is moeilijk gezien de heterogeniteit van de 
patiëntenpopulatie. Bovendien dichten de huidige sepsis resuscitatie protocollen een prominente 
rol toe aan noradrenaline om de MAP te herstellen. Wij gebruikten het humane endotoxemie model 
om de effecten van verschillende vasopressoren (noradrenaline, fenylefrine en vasopressine) op 
de cerebrale hemodynamiek bij sepsis patiënten te onderzoeken. Wij stelden vast dat patiënten 
met sepsis geen automatisch herstel hebben van cerebrale perfusie, ondanks behandeling met 
vasopressoren die getitreerd werden tot een speciﬁeke minimale MAP werd bereikt. Deze 
patiënten lopen dus een risico op een lage hersendoorbloeding en ischemie, ondanks een schijnbaar 
toereikende systemische bloeddruk. Wij konden onze resultaten niet vergelijken met eerdere 
literatuur, omdat de beschikbare literatuur beperkt is tot patiënten met traumatisch hersenletsel 
[80-83]. Geen van deze traumastudies vond signiﬁcante verschillen in cerebrale hemodynamiek 
tussen de verschillende vasopressoren. 
De microvasculaire perfusie is met name gedurende de vroege fases van resuscitatie van septische 
shock ontregeld, zelfs wanneer de macrocirculatie normaal lijkt te zijn [84]. “Near-infrared 
spectroscopy” is klinisch geschikt om de cerebrale microcirculatie te onderzoeken [85]. Ook de 
meting van anaeroob metabolisme zoals beschreven bij patiënten na een hartstilstand, kan nuttig 
zijn om de microvasculaire perfusie te evalueren en optimaliseren [43]. Natuurlijk is toekomstig 
onderzoek naar dit onderwerp noodzakelijk om technieken te ontwikkelen die de cerebrale 
microcirculatie kunnen analyseren tijdens sepsis en om klinische mogelijkheden te onderzoeken 
voor diagnose en interventie. 
De huidige technieken (bijvoorbeeld “near-infrared spectroscopy”) detecteren een globale afname 
in weefselperfusie op een betrouwbare manier, maar niet de heterogeniteit van de microvasculaire 
perfusie. Veranderingen in cerebrale perfusie zijn waarschijnlijk heterogeen verspreid door de 
hersenen tijdens sepsis, waarbij sommige gebieden meer aangedaan zijn dan andere gebieden. Ook 
technieken die macrovasculaire parameters analyseren (zoals bijvoorbeeld MFVMCA) kunnen deze 
heterogeniteit niet vaststellen. Perfusie computer tomograﬁe maakt het mogelijk om cerebrale 
perfusie te evalueren en om cerebrale vaatspasmen en ischemie vast te stellen [51]. Deze techniek 
kan behulpzaam zijn in monitoring van de hersenen bij sepsis patiënten voor diagnose, behandeling 
en prognosebepaling, maar wordt niet routinematig toegepast en benodigt verder onderzoek [52].
Toekomstig onderzoek moet zich focussen op het vergroten van inzicht in de effecten van sepsis 
op cerebrale perfusie, vasoreactiviteit, autoregulatie en microcirculatie. Dit moet resulteren 
in de ontwikkeling van strategieën die de hersenen en SAE voorkomen. Meer onderzoek is ook 
noodzakelijk om cerebrale perfusie parameters te onderzoeken en om zo uiteindelijk een optimale, 
individuele cerebrale perfusie te bewerkstelligen (om hyperperfusie en hypoperfusie te voorkomen) 
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en niet alleen een bepaalde systemische bloeddruk. Dit vereist studies volgens een strak en op 
gelijke manier uitgevoerd protocol in duidelijk omschreven populaties. 
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Dankwoord
Mijn proefschrift is klaar. Geloof het of niet, maar ik heb het proces van dit promotie-onderzoek 
vaak vergeleken met het in elkaar zetten van mijn Ikea-kast. Een proces met als belangrijkste tip uit 
de montagehandleiding: “Regel 14: U kunt de kast ook in delen afmaken. Het hoeft niet in één keer 
klaar te zijn”.
Zonder “materialen” geen kast. Bijzonder waren de momenten van metingen bij patiënten, overdag 
of in de nacht, met hun familieleden op de kamer. Technische metingen, maar altijd in combinatie 
met persoonlijke gesprekken waardoor een bijzondere band ontstond. Wederzijdse dankbaarheid…
menselijk en waardevol! De LPS-jongens ben ik dankbaar voor hun deelname aan het onderzoek, 
maar ben ik ook dankbaar voor nieuwe inzichten in “de man en zijn beleving van ziekte”.
Beste Astrid, de totstandkoming van dit proefschrift verliep zeker niet zonder horten en stoten. 
Hoewel we moesten wennen aan samenwerken met elkaar, gingen we altijd constructief en 
voortvarend aan de slag. Metingen bij nacht en ontij. Combinatie van kliniek en wetenschap. En 
wat hebben we gelachen om jouw poging jezelf, zonder sedatie, gecontroleerd te laten beademen 
met een tube in je mond en je lippen strak op elkaar. Je was er zo van overtuigd dat het kon… Maar 
wat ben ik geschrokken toen je als test voor een van je eigen experimenten zelf een anafylactische 
reactie kreeg en ik ineens als intensivist moest optreden. Bijzonder is/was dat door dit promotie-
onderzoek kliniek/onderzoek/privé in elkaar verweven werden, waardoor we mooie en verdrietige 
momenten met elkaar gedeeld hebben. Dank voor jouw inzet als Dr. Cornelia Hoedemaekers, maar 
zeker dank om jou beter te leren kennen als Astrid!
Prof. Dr. J.G. van der Hoeven, beste Hans, hoewel iedereen tegen me zei dat jij geen cardioloog als 
fellow intensive care wilde, nam je mij toch aan. Dat was het begin van mijn samenwerking met jou; 
jij als opleider, afdelingshoofd, collega en promotor en altijd charismatisch en inspirerend. Ik heb 
veel van je geleerd en ben nog steeds een beetje jaloers op jouw ervaring en kennis (en je grijze 
haar). 
Lex van Loon en Eline Vinke mede dankzij jullie als technisch-geneeskundigen is dit proefschrift 
van de grond gekomen. Dank voor jullie ﬁjne samenwerking en voor het slaan van een brug tussen 
kliniek en techniek. Ruud Kaam, nadat de basis door jouw voorgangers gelegd was, bouwde jij 
de technisch-geneeskundige aspecten van ons onderzoek en de MATLAB-analyse verder uit. Jou 
ben ik echt heel veel dank verschuldigd; voor het samen sparren, je kritische blik, de eindeloze 
dataverwerking en de constructieve gezelligheid!
Collega’s, dank voor al jullie telefoontjes! Hoe bizar was het dat ik juist de eerste “reanimant” moest 
includeren tijdens een etentje met collega’s bij mij thuis?! Fijn dat jullie al die jaren meegedacht en 
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meegeleefd hebben. Jan en Laurens, jullie hebben als kamergenoten natuurlijk het meeste lief en 
leed met mij gedeeld. Jan, een Barolo op cruciale momenten (kan een maandagavond zijn) is goud 
waard! Laurens, dank voor de hulp bij de extrinsieke motivatie (…)! Murielle, met jou deel ik veel 
meer dan alleen werkgerelateerde zaken….jij vergroot mijn werkplezier!
Beste verpleegkundigen, ik wil jullie heel erg bedanken voor alle hulp bij de metingen, maar ook 
voor de belangstelling en de gezelligheid tijdens al die uren (vooral als dat in de nacht was).
Jurgen Claassen, dank voor het delen van jouw kennis op het gebied van cerebrale autoregulatie en 
voor je kritische blik op onze metingen en resultaten.
Matthijs, Peter, Mark, Tijn, Hetty, Noortje en alle andere medewerkers van “de research”, veel dank 
ben ik jullie verschuldigd voor de talrijke tips op het gebied van statistiek, Hora Est, CCMO, inclusie 
etc. Matthijs, extra dank aan jou als “native english speaker” en voor je medeleven op belangrijke 
momenten. Roeland en Guus, jullie wil ik apart bedanken omdat ik mee mocht liften op jullie LPS-
experimenten. Altijd gezellig in de research-kamer.
Beste leden van de manuscriptcommissie, Prof. dr. C.J.M. Klijn, Prof. dr. ir. P.H. Veltink en Prof. dr. N.
van Royen, veel dank voor het vakkundig beoordelen van het manuscript. Tevens dank aan de leden
van de promotiecommissie voor de bereidheid te willen opponeren.
Hartelijk dank aan Caroline, Rachel, Sjoukje, Jennie en Nelly voor de secretariële ondersteuning.
Oscar en Frenk, ik heb veel geleerd door jullie aanpak van het in elkaar zetten van mijn Ikea-kast. 
Ik leerde afhankelijk te zijn van anderen bij iets dat ik niet in mijn eentje kon. Ik leerde daardoor 
rustig af te wachten tot anderen tijd hadden en ik leerde ook dat een proces een tijdje stil kan 
liggen (terwijl het materiaal er al wel is, terwijl het geraamte al helemaal staat of terwijl alleen de 
afwerking nog nodig is). Het was een mooi proces vol levenswijsheden en volledig toepasbaar op 
dit promotie-onderzoek. Gelukkig ging het in elkaar zetten van de kast samen met veel gezelligheid, 
goede gesprekken en lekker eten. Jullie zijn mijn beste vrienden, we staan altijd voor elkaar klaar 
en delen leuke, verdrietige, mooie en zware momenten…echte vrienden! Oscar, onze carrières 
begonnen in jouw witte Volvo op weg naar het Rijnstate en we hervonden elkaar als vrienden op de 
brug in het Radboud. Het is een eer dat je mijn paranimf bent!
Vincent, uren hebben we samen door Heumensoord gerend en tijdens die duurlopen bespraken we 
alle aspecten van het leven. Zo ontstond een warme vriendschap. Jij staat als paranimf als een soort 
Jungfrau of Eiger naast mij. Simone, ik ben dankbaar dat ik je heb leren kennen als prachtig mens en 
als vrouw van Vincent.
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Aan alle hardloopmaatjes, hardlopen is mijn uitlaatklep. Heerlijk om het hoofd leeg te lopen en ook 
heerlijk om te kijken hoever je kunt gaan. Langzaamaan zijn we een hechte groep geworden, van 
Roelandrunners werden we Richardrunners. We stimuleren elkaar en dagen elkaar uit, maar we 
delen ook de mooie en de moeilijke momenten in het leven. En jullie zijn degenen die begrijpen: 
“Als je iets wilt winnen, ren de honderd meter. Als je iets wilt leren over het leven, loop de marathon 
(Emil Zatopek)”.
Pap en Mam, jullie zijn altijd enorm trots ondanks dat jullie vinden dat ik te weinig over mijn werk 
vertel. Al jaren vragen jullie om een keer bij een presentatie op een congres te mogen zijn...bij deze 
promotie is het eindelijk zover. Dank voor jullie eeuwige en onvoorwaardelijke steun!
Ellen, Ferry, Tijn en Anne, jullie zijn er altijd op de cruciale momenten en ook op vele momenten 
tussendoor. Bijzonder om zo’n band te hebben en te voelen.
Ruud, hallo Sonnenschein!
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Curriculum vitae
Judith Maria Dimphena van den Brule werd geboren op 19 december 1976 te Breda. Zij groeide op 
in Oosterhout NB. In 1995 behaalde zij haar gymnasium diploma aan het St.-Oelbert gymnasium in 
Oosterhout NB. 
Aansluitend begon zij met haar studie geneeskunde aan de Katholieke Universiteit Leuven. Aan 
deze universiteit behaalde zij in 2002 haar artsexamen met de grootste onderscheiding.
In 2002 begon zij als AGNIO cardiologie in het RadboudUMC, waarna zij in 2003 met haar opleiding 
tot cardioloog begon. Prof. Dr. F.W.A. Verheugt en Prof. Dr. J.L.R.M. Smeets waren de opleiders in het 
RadboudUMC en Dr. H.A. Bosker was haar opleider in het Rijnstate ziekenhuis.
In 2008 startte zij haar tweejarige fellowship intensive care in het RadboudUMC met Prof. Dr. J.G. 
van der Hoeven als opleider. Sinds 2010 is zij als cardioloog-intensivist werkzaam op de afdeling 
intensive care van het RadboudUMC. Naast patiëntenzorg verricht zij ook wetenschappelijk 
onderzoek. Dit heeft geresulteerd in dit proefschrift.
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Cerebral hemodynamics
After cardiac arrest, 
in sepsis and in the
 
human endotoxemia model
judith van den brule
uitnodiging
voor het bijwonen van de openbare 
verdediging van het proefschrift
Cerebral hemodynamics 
After cardiac arrest,
in sepsis and in the 
human endotoxemia model
donderdag 21 februari 2019
om 12.30 uur precies
in de aula van de
Radboud Universiteit Nijmegen
Aansluitend aan de plechtigheid 
is er geen receptie in de aula 
Vanaf 14.15 uur bent u uitgenodigd  
voor de borrel bij Mi Barrio, 
Fransestraat 58 te Nijmegen 
(tot ongeveer 19.30 uur)
Paranimfen
Oscar Hoiting
o. hoiting@me.com
Vincent Bronkhorst 
vincent-en-simone@fo.nl
judith van den brule
Professor van Weliestraat 12 
6524 NN  Nijmegen
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